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SUMMARY 
A number of environmental contaminants and pharmaceutical agents including heav> 
metals and antibiotics dramatically alter the structure and function of various tissues 
and produce multiple adverse effects in the liver, kidney, intestine and heart (Soberon 
et al, 1979; Ozturk et al, 1997; Kohn et al, 2005). These environmental variables 
are also known to influence the incidence and expression of various diseases. The 
heavy metals such as mercury, lead, chromium, platinum and uranium have been 
shown to cause severe damage to kidney leading to acute renal failure (ARF) 
(Sanchez et al, 2001; Fatima et al, 2004, 2005; Barbier et al, 2005). 
Cisplatin (CP) is an anti-neoplastic agent that has a remarkably broad spectrum of 
clinical activity in the treatment of solid tumors, while gentamicin (GM), an 
aminoglycoside is used in a variety of infections caused by Gram negative bacteria. 
The limiting side-effect of both these drugs is the nephrotoxicity associated with their 
use (Humes, 1988; Tulkens, 1989; Barry, 2000). 
The specificity of GM for renal toxicity is apparently related to its accumulation in the 
renal proximal convoluted tubule causing a number of morphological and biochemical 
alterations in humans and experimental animals (Kacew and Bergeron, 1990; Ali, 
1995; Mingeot-Leclercq and Tulkens, 1999). GM has been shown to cause marked 
histological damage in particular to renal proximal convoluted tubules (SI and S2 
subsegments) (Humes and Connor, 1988; Abdel-Gayoum et al, 1994) resulting in 
swelling, vacuolization and necrosis of epithelial cells and accumulation of myelin-
like bodies (Ali and Bashir, 1994; Pedraza-Chaverri et al, 2000). The adverse 
interaction of the drug with critical intracellular processes leads to renal cortical 
phospholipidosis disrupting functions of membranes and organelles including BBM, 
BLM, mitochondria, lysosomes and microsomes (Laurent et al, 1990; Cronin and 
Henrich, 1996; Mingeot-Leclercq e/a/., 1999). 
The optimal use of cisplatin as a chemotherapeutic drug has been limited by its 
nephrotoxicity. Following administration, CP is widely distributed into body fluids 
and tissues. The highest concentration can be seen in the kidneys, liver and intestine 
although it has also been found in all other tissues (McEvoy, 1992). Induction of 
nephrotoxicity is assumed to be a rapid process involving reactions with proteins in 
renal tubules. In tubular cells a primary target for CP is probably the genomic DNA. 
Light and electron microscopy have shown that the CP induced injury and necrosis in 
the rat kidney are predominantly localized in the S3 segment of proximal tubule in the 
corticomedullary region (Townsend et al, 2003). CP toxicity in proximal tubular 
epithelial cells is morphologically characterized by tubular necrosis, loss of microvilli, 
alterations in the number and size of lysosomes and mitochondrial vacuolization 
accompanied by functional disturbance of various cell organelles (Kuhlmann et al, 
1997). 
Although both GM and CP cause alterations in the structure and functions of the 
kidney and other major tissues, these appear to be two dissimilar models of ARF 
(Annie et al, 2005). GM appears to primarily affect the structure and function of 
membrane phospholipids (Cronin et al, 1986) whereas CP causes renal damage due 
to interactions wdth enzyme protein thiol groups in the membrane (Nakano and 
Gemba, 1989). GM produces marked histological damage in particular to SI and S2 
subsegments whereas CP primarily affects the S3 segment of renal proximal tubule 
(Abdel-Gayoum et al, 1994; Townsend et al, 2003; Banday et al, 2008a). A 
relationship between oxidative stress and nephrotoxicity has been well-demonstrated 
in many experimental animal models (Devipriya and Shyamaladevim, 1999). 
Evidence points out that cisplatin and gentamicin induce nephrotoxicity partly via 
oxidative stress. Another mechanism proposed is that cisplatin induces renal damage 
by free-radical generation, by altering arginine metabolism and by increasing the 
activity of calcium independent nitric oxide synthase (Devipriya and Shyamaladevim, 
1999). Gentamicin activates phospholipases and alters the lysosomal membrane in 
addition to causing oxidative stress (Lindquist, 1986). 
There is a continuous search for agents which provide nephroprotection against the 
renal impairment by the drugs, GM and CP. Several approaches, utilizing different 
mechanisms, have been attempted to reduce GM nephrotoxicity and related 
aminoglycoside antibiotics. These mechanisms include decreasing or preventing drug 
accumulation by the kidneys or decreasing binding to BBM (Mingeot-Leclercq et al.. 
1989). Many different agents and strategies have been reported to ameliorate GM 
nephrotoxicity in experimental animals (Ali, 2003; Nagai and Takano, 2004). Among 
them protection against GM nephrotoxicity was mainly focused on the use of various 
antioxidant agents including the extracts from medicinal plants with antioxidant 
properties (Ali, 2003). Similarly several agents have been tested to see whether they 
could ameliorate the nephrotoxicity of platinum drugs (Ali and Al-Moundhri, 2006). 
The agents that have been shown to prevent experimental CP nephrotoxicity include 
antioxidants, modulators of nitric oxide, agents interfering with metabolic pathways 
and cytoprotective and antiapoptotic agents. Only few of these agents have been 
tested in humans. However, none of these approaches have been found safe/suitable 
for clinical practice due to known and unexplored side effects. 
In past few years, much interest has been centered on the role of naturally occurring 
dietary substances for the control and management of various chronic diseases such as 
cancer and cardiovascular disorders (Alschuler, 1998; Weisburger, 1999; Connor, 
2000). From ancient times the physicians and scholars in Asia have understood that 
food have both preventive and therapeutic value and are integral part of health. 
Omega-3 polyunsaturated fatty acids (co-S PUFA) enriched fish oil and green tea 
provide such dietary sources of biologically active components that has been shown to 
be co-preventive and co-therapeutic in a wide variety of ailments (Doughman et al., 
2007; Khan and Mukhtar, 2007). 
Since ancient times GT consumption has been known to maintain and improve health. 
It has been shown to have extensive health benefits. GT consumption has been linked 
to lowering of various forms of cancers (Katiyar and Mukhtar, 1997; Ahmad and 
Mukhtar, 1999). GT and its constituents have been shown to have cardioprotective, 
neuroprotective, antidiabetic, anti-inflammatory, antiatherosclerotic, anti-microbial 
and anti-aging properties (Alschuler, 1998; Liao, 2001). In addition, GT has been 
found to be useful in the treatment of arthritis, high cholesterol levels, and impaired 
immune function (Van het Hof et al, 1999). GT consumption has also resulted in 
improved kidney function in animal models of renal failure (Yokozawa et al, 1996, 
2005). GT polyphenols have been shown to exhibit strong antioxidant properties 
(Alschuler, 1998). Most beneficial health effects ascribed to GT are considered to be 
mediated by potential antioxidant properties of GT polyphenols that scavenge free 
radicals and reduce oxidative damage (Augustyniak et al, 2005). 
In a preliminary report, GT has been shown to mitigate gentamicin and CP induced 
nephrotoxicity by lowering the level of serum urea, creatinine and tissue LPO content 
(Upaganlawar et al, 2006). Green tea extract has also been found to offer significant 
protection from cisplatin induced oxidative damage in rat kidney and testes (Leena 
and Balaraman, 2005). Aithough there are several studies supporting the preventive 
potential of green tea, a proper understanding of the mechanisms by which they 
reduce the risk is necessary to establish the efficacy. In view of numerous beneficial 
health effects of GT we hypothesized that: "Green tea enriched in polyphenols 
would he able to prevent/reduce GM/CP induced nephrotoxicity and other adverse 
effects caused by them in rat kidney, intestine and liver". 
To address this hypothesis the present work was undertaken to study the detailed 
biochemical events/cellular response/mechanism of GM and CP induced nephrotoxic 
and other adverse effects in rat kidney and intestine. The effect of GT was also 
determined to observe any protection provided by it against GM/CP nephrotoxicity. 
The following parameters were determined under various experimental conditions: 
(a) Certain biochemical parameters in serum. 
(b) The activhies of BBM and lysosomal marker enzymes in the renal cortical, 
medullary, mucosal and liver homogenates and BBM marker enzymes in 
isolated BBM preparations from renal cortex and intestinal mucosa. 
(c) The transport, of •'^ Pi in renal cortical BBM. 
(d) The activities of certain enzymes of carbohydrate metabolism involved in 
glycolysis, TCA cycle, gluconeogenesis, HMP-shunt pathway in the renal 
cortex, medulla, small intestine and liver. 
(e) The enzymic and non-enzymic parameters of antioxidant defense system in 
the renal cortex, medulla, small intestine and liver. 
THE RESULTS OBTAINED ARE SUMMARIZED AS FOLLOWS: 
Part I: 
Effect of Green tea (GT) consumption via diet (GTD) or via drinking fluid (GTE) 
(a) Serum parameters: 
In general, GT consumption either via diet (GTD) or drinking GT extract (GTE) 
resulted in slight loss of body weight and BUN that was associated with decrease in 
serum glucose, cholesterol and Pi and increase in phospholipids. 
(b) Marker enzymes ofBBMand lysosomes: 
The effect of GT consumption was determined on marker enzymes of BBM and 
lysosomes in different rat tissues. GT consumption caused significant increase in the 
activities of BBM enzymes, ALP, GGTase, LAP and sucrase and lysosomal enzyme 
ACPase in mucosal homogenates. The activity of BBM enzymes except ALP was 
also increased in BBM preparations isolated from intestinal mucosa. The activities of 
BBM and lysosomal enzymes were differentially altered by GT in the cortex, medulla 
and liver homogenates. In the liver, the activity of ALP and GGTase were 
significantly decreased whereas LAP and ACPase were not changed. However, the 
activities of ALP and ACPase increased but GGTase and LAP decreased in cortical 
homogenates whereas the activities of ALP, GGTase and ACPase also slightly 
increased but LAP decreased in renal medulla. The activities of ALP and GGTase 
markedly increased but LAP significantly lowered in BBM vesicles isolated from 
renal cortex by GT consumption. The differential effects of GT on BBM and 
lysosomal enzymes observed in different tissues can be attributed to their different 
organization in the thickness of BBM and/or to differential accumulation/accessibility 
of GT in different tissues. 
(c) Enzymes of carbohydrate metabolism: 
GT consumption caused significant increase in the activities of various enzymes of 
carbohydrate metabolism, however, to different extent in different rat tissues. The 
activity of HK, LDH (glycolysis), MDH (TCA cycle) significantly increased to much 
greater extent in the intestine and renal cortex but to a lesser extent in the liver. The 
activity of HK and LDH increased, whereas MDH activity decreased in the medulla 
by GT consumption. The activity of G6Pase and FBPase, enzymes of 
gluconeogenesis significantly increased in the intestine, renal cortex and medulla but 
decreased in the liver. The activity of G6PDH (HMP-shunt pathway) significantly 
lowered by GT consumption in the intestine, liver and medulla whereas profoundly 
increased in the cortex. The activity of NADP-malic enzyme (ME), however, 
decreased in all the tissues although to much different extent. 
(d) Enzymic and non-en^mic parameters of antioxidant defense mechanism: 
GT consumption appeared to perturb antioxidant defense system although 
differentially in different rat tissues. The activity of Cu, Zn superoxide disinutase 
(SOD) significantly decreased in the intestine and liver but significantly increased in 
the renal cortex and medulla. In contrast, catalase activity markedly increased in the 
intestine and liver but did not change in renal tissues by GT ingestion. The alterations 
in the activity of SOD and catalase were associated with significant lowering of lipid 
peroxides (LPO), measured as malondialdehyde in the liver and renal cortex. 
However, LPO levels were enhanced in the intestine and renal medulla by GT 
consumption. Taken together, the results imply that biological defense system 
perturbed by GT as a resuh of free radical scavenging properties chiefly of its 
polyphenols. 
=> Interpretation: In general, GT consumption significantly enhanced the activities 
of the enzymes of carbohydrate metabolism involved in glycolysis, TCA cycle, 
gluconeogenesis, BBM and oxidative stress in the intestine and kidney. GT 
consumption appeared to exert numerous beneficial health effects by improving 
nutrition/energy metabolism and in part by strengthening cellular antioxidant 
defense mechanism. 
Part 11: 
Influence of2reen tea (GT) consumption on sentamicin (GM) induced nephrotoxic 
and other adverse effects 
(a) Serum parameters: 
GM administration caused severe nephrotoxicity as characterized by significant 
increase in serum creatinine, cholesterol, phospholipids and BUN accompanied by 
significant decrease in serum glucose and Pi. Prolonged GT consumption prior to and 
together with 10 day GM treatment significantly lowered GM induced increase in 
serum creatinine and BUN, indicating reduction in GM nephropathy. GM elicited 
increase in serum cholesterol was also lowered whereas serum glucose remained 
depressed but serum Pi and phospholipids increased. 
(b) Marker enzymes ofBBM: 
GM treatment to control rats caused significant decrease in the activities of ALP. 
GGTase and LAP in renal cortex and medulla, indicating GM induced damage to the 
kidney. However, the activities of these enzymes along with sucrase increased in the 
intestine. GM caused small decrease in BBM enzymes in liver homogenates. GT 
consumption caused significant reversal in GM induced decrease in BBM enzyme 
activities in the cortex and medulla, whereas the enzyme activities further enhanced in 
the intestine by GT in GM co-administered rats. GM induced alterations and GT 
elicited changes in BBM enzyme activities were more apparent in isolated renal and 
mucosal BBM vesicles compared to the effect observed in the respective 
homogenates. The activity of ACPase (a lysosomal enzyme) variably decreased by 
GM whereas GT partially restored ACPase activity in various tissues. 
(c) Na-dependent transport of Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of ^^ Pi in the presence of a Na-gradient 
measured at 30 s was markedly decreased by GM but significantly increased by GT. 
GM induced decrease in Pi uptake was not only prevented by GT consumption but 
remained significantly higher in GM and GT co-administered than in control rats. The 
uptake of "^Pi in the absence of Na-gradient and after equilibrium at 120 min did not 
change under any experimental conditions, indicating the specificity of the effect on 
Pi transport by GM or GT or their combination. 
(d) Enzymes of carbohydrate metabolism: 
The activities of various enzymes involved in glycolysis, TCA cycle, gluconeogenesis 
and HMP shunt pathway were variably altered by GM/GT and GM+GT in different 
tissues. The activity of HK and LDH significantly increased but MDH activity 
decreased in the intestine, cortex and medulla by GM treatment. In the liver, GM 
increased the activity of HK and MDH but decreased LDH activity. The activity of 
G6Pase and FBPase increased in the intestine and liver but decreased in renal tissues. 
However, G6PDH acfivity decreased in the liver but increased in the intestine and 
renal tissues whereas ME activity decreased in all the tissues. 
As shown in Part I, many of these metaboUc enzymes were enhanced by GT. GT 
consumption by GM treated rats resulted not only in the prevention of GM induced 
decrease in many of the enzyme activities but their activities remained significantly 
higher compared to control/GM treated rats. The activity of LDH was especially 
enh^ced to much greater extent by GT in GM treated rats. 
(e) Enzymic and non-enzymic parameters of antioxidant defense mechanism 
GM caused significant decrease in the activities of SOD and catalase in the intestine, 
liver and renal cortex and medulla which was associated with marked increase in LPO 
and decrease in total-SH, indicating that GM caused severe damage to various tissues 
by generating free radicals and by suppressing the activities of antioxidant enzymes. 
GT consumption protected well against GM induced perturbation of 
oxidants/antioxidants or GM induced oxidative damage. GM induced decrease in 
SOD and/or catalase activity was markedly reverped/reduced by GT consumption. 
GM induced increase in LPO was also lowered by GT components at least in the liver 
and renal tissues. 
=> Interpretation: GM caused severe damage to kidney and produced multiple 
adverse effects to other tissues as reflected by nephrotoxicity parameters, 
decrease in BBM and lysosomal enzymes, certain enzymes of carbohydrate 
metabolism and suppression of antioxidant enzymes SOD and catalase. GT 
consumption markedly reversed/reduced GM induced oxidative damage and 
cellular functions by enhancing carbohydrate metabolism and antioxidant 
defense mechanism most likely due to intrinsic biochemical and antioxidant 
properties of GT polyphenols. 
Part HI: 
Influence of sreen tea (GT) consumption on cisplatin (CP) induced nephrotoxicity 
and other adverse effects 
(a) Serum parameters: 
CP administration resulted in marked nephrotoxicity as manifested by increased 
serum creatinine and BUN, Serum cholesterol, phospholipids significantly increased 
but serum glucose and Pi significantly declined by CP treatment. GT significantly 
decreased glucose, cholesterol and Pi but phospholipids increased. CP elicited 
increase in serum creatinine and BUN was markedly lowered by GT consumption, co-
administered to CP treated rats. CP induced increase in serum cholesterol was also 
prevented by GT. 
(b) Marker enzymes ofBBM and lysosomes: 
CP treatment to control rats caused significant decrease in the activity of ALP, 
GGTase, LAP and sucrase (only in the intestine) in the homogenates of intestine, 
liver, renal cortex and medulla and in BBMV isolated from renal cortex and intestinal 
mucosa. GT, in general significantly increased the activities of ALP, GGTase, LAP 
and sucrase in the intestine; the activity of ALP in the cortex and ALP and GGTase in 
the medulla were increased by GT consumption. CP induced decrease in most BBM 
enzymes in the intestine and ALP and GGTase in the cortex and medulla was 
markedly prevented/reduced by GT co-administration to CP treated rats. The changes 
observed by CP and/or GT were more apparent in the BBMVs isolated from renal 
cortex and intestinal mucosa than observed in the respective homogenates. The 
protection provided by GT against CP induced alterations was also more marked in 
isolated BBM preparations. 
(c) Na-dependent transport of^^Pi in the BBM^'' isolated from renal cortex: 
The rate of concentrative uphill uptake of ^^ Pi in the presence of a Na-gradient 
measured at 30 s was markedly decreased by CP but significantly increased by GT. 
CP induced decrease in ^^Pi uptake was not only prevented by GT consumption but 
remained significantly higher in CP and GT co-administered than in control rats. The 
uptake of Pi in the absence of Na-gradient and after equilibrium at 120 min did not 
change under any experimental conditions, indicating the specificity of the effect on 
^^ Pi transport by CP or GT or their combination. 
(d) Enzymes of carbohydrate metabolism: 
The activities of various enzymes involved in glycolysis, TCA cycle, gluconeogenesis 
and HMP shunt pathway were variably affected by CP and GT and CP+GT in 
different rat tissues. The activity of LDH and to some extent that of HK significantly 
increased, whereas MDH activity significantly decreased in the intestine, cortex and 
medulla by CP treatment. However, the activity of HK and MDH increased but LDH 
activity decreased in the liver. The activity of G6Pase (enzyme of gluconeogenesis) 
significantly increased in the intestine but significantly decreased in the live , cortex 
and medulla by CP. In contrast to GM, CP significantly decreased the activity of 
G6PDH in all the tissues along with significant increase in NADP-malic enzyme 
(ME) activity in the intestine, cortex and medulla. As shown in Part I, many of these 
metabolic enzymes were increased by GT consumption. Prolonged GT consumption 
by CP treated rats markedly prevented CP induced decrease in MDH, GoPase, 
G6PDH activities in the cortex, medulla and liver. The decrease of MDH activity by 
CP was also prevented by GT in the intestine. However, the activity of LDH remained 
significantly higher in the intestine, cortex and medulla in CP treated rats after GT 
consumption. 
(d) Enzymic and non-enzymic parameters of antioxidant defense mechanism: 
CP caused significant decrease in the activities of SOD and catalase in the intesnne 
and renal cortex and medulla which was associated v/ith marked increase in LPO and 
decrease in total-SH, indicating that CP caused severe damage to these tissues by 
generating free radicals and by suppressing the activities of antioxidant enzymes. In 
the liver, the increase in LPO was however associated with a sJight decrease in SOD 
but increase in catalase activity. GT consumption protected well against CP induced 
perturbation of oxidants/antioxidants or CP induced oxidative damage. CP induced 
decrease in SOD and/or catalase activhy was markedly reversed/reduced by GT 
consumption in most tissues. CP induced increase in LPO was also lowered by GT in 
the intestine, liver and renal cortex. 
^ Interpretation: CP caused severe damage to kidney and produced multiple 
adverse effects to other tissues as reflected by increase in nephrotoxicity 
parameters, decrease in BBM and lysosomal enzymes, certain enzymes of 
carbohydrate metabolism and suppression of antioxidant enzymes, SOD and 
catalase. GT consumption markedly reversed/reduced CP induced oxidative 
damage and cellular functions by enhancing carbohydrate metabolism and 
antioxidant defense mechanism most likely due to intrinsic biochemical and 
antioxidant properties of GT polyphenols. 
\0 
Conclusion: 
In conclusion, GM/CP elicited deleterious nephrotoxic effects by causing major 
damage to mitochondria, lysosomes and in particular to BBM of renal proximal 
tubule and intestinal mucosa as reflected by significant decrease in the activities of 
their specific biomarker enzymes, confirming the morphologic and toxicogenomic 
observations that showed these organelles as prime GM/CP targets. Both GM and CP 
seem to enhance glycolytic enzyme LDH in order to increase energy dependence on 
glycolysis due to mitochondrial damage and depressed TCA cycle enzymes. These 
nephrotoxic and other adverse effects appeared to be mediated in part due to GM/CP 
elicited oxidative damage. GT consumption to a larger extent prevented GM/CP 
induced nephrotoxicity parameters by enhancing nutrition/energy metabolism and ^^ Pi 
transport capacity, by strengthening antioxidant defense mechanism and by altering 
membrane organization. It is apparent that green tea is a source of a wide range of 
phytochemicals that are digested, absorbed and metabolized by the body and that tea 
constituents exert their effects at the cellular level. Tea's status as a functional food 
lends credibility to what has been believed by tea drinkers for centuries. Based on our 
present observations and already known numerous health benefits, we propose that 
GT polyphenols may provide a cushion for a prolonged therapeutic option against 
drug/chemical induced nephropathy without harmful side effects. 
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INTRODUCTION 
GENERAL 
A number of environmental contaminants, chemicals and drugs including antibiotics 
dramatically alter the structure and function of various tissues and produce multiple 
adverse effects in the liver, kidney, heart and intestine (Soberon et al, 1979; Ozturk et 
al, 1997; Kohn et al, 2005). These environmental variables also influence the 
incidence and expression of various diseases. The heavy metals such as mercury, lead. 
chromium, platinum and uranium have been linked to certain forms of cancers. 
depression, cardiovascular and renal disorders (Sanchez et al, 2001; Fatima et al, 
2004, 2005; Banday et al, 2008b). Histopathological studies revealed that exposure 
;M uranium, chromium and platinum cause severe.damage t©4ddney leading to acute 
renal failure (ARF) (Dobyan et al, 1980; Kaloyanides, 1984; Humes and Connor, 
1988). Aminoglycoside antibiotics including gentamicin (GM) frequently used in the 
treatment of life threatening bacterial infections .also cause nephrotoxicity (Nagai and 
Takano, 2004). Loss of microvilli, increased apical vacuolization, mitochondrial 
swelling and eventual cell necrosis at specific sites within renal proximal tubule have 
been reported in nephrotoxic models induced by GM (Ali and Bashir, 1994; Pedraza-
Chaverri et al, 2000) and/or heavy metals including uranium, chromium, mercuric 
chloride and cisplatin (CP) (Kuhlmann et al, 1997). These structural changes 
resul^M' in profound alterations in cell integrity, metabolism and reabsorption 
properties of the kidney. GM is known to damage the S1 and S2 segments of the pars 
convoluta (Humes and Connor, 1988; Abdel-Gayoum et al, 1994), whereas cisplatin 
(CP) preferentially injures the S3 segment of the pars recta (Dobyan et al, 1980; 
Safirstein et al, 1984). The drug-and chemical "induced nephrotoxicity can be 
\A 
visualized by increased serum creatinine and blood urea nitrogen (BUN) (Banday et 
al, 2008a, 2008b). In addition to the kidnej^the structure and function of other major 
tissues e.g. gastrointestinal tract and liverjare also reported to be affected (Farooq ct 
al, 2007). 
In past few years, much interest has been centered on the role of naturally occurring 
dietary substances for the control and management of various chronic diseases. Since 
ancient times, green tea (GT) consumption has been considered as Nature's gift for 
promoting health. Important progress has been made in the last five years concerning 
the effects of green tea on health (Mukhtar and Ahmad, 2000; Khan and Mukhtar. 
2007). Experimentation with new accurate tools provide useful information about the 
metabolism of green tea components in the body, their mode of action as antioxidants 
at the cellular level and their protective role in the development of cancer, 
cardiovascular disease and other pathologies. The use of green tea components as 
nutraceuticals and functional foods is also gaining importance (Dufresne and 
Famworth, 2001). Green tea is a "non-fermented" tea and contains more catechins, 
than any other tea type. Catechins are in vitro and in vivo strong antioxidants 
(Wiseman et al, 1997). In addition, its content of certain vitamins and minerals 
increases the antioxidant potential of this type of tea (Graham, 1999). Recent human 
studies suggest that green tea may contribute to .a reduction in the risk of 
cardiovascular disease and some forms of cancer, as well as to the promotion of ora^ 
health and other physiological functions such as anti-hypertensive effect, body weight 
control, antibacterial and'tntiviras^ activity, solar ultraviolet protection, bone mineral/ 
density increase, anti-fibrotic properties, and neuroprotective power (Cabrera et al, 
2UO6). Thus medical research is confirming the ancient oriental wisdom that therapy 
of many diseases resides in a teapot. 
h' Ky 
The kidneys are another area where green tea has.shown to have protective effects. 
Green tea extract consumption has been found to ameliorate cyclosporine A and 
cisplatin-induced renal dysfunction in experimental rats (Mohamadin et al, 2005; 
Leena and Balaraman, 2005). It has also been found to exert a protective effect on the 
gastrointestinal mucosa and was found to prevent atrophy of the intestinal mucosa 
(Safare/a/,2003). 
Several clinical studies have revealed physiological responses to tea which may be 
relevant to the promotion of health and the prevention or treatment of some chronic 
diseases (Khan and Mukhtar, 2007). Studies on possible beneficial effect^of GT on 
drug/chemical induced gastro- and nephrotoxicity are very limited. A proper 
understanding of the mechanisms by which green tea reduces the risk of several 
human diseases!^ is necessary to establish its efficacy for the population where it could 
be most useful. 
In view of the numerous health benefits of GT, the present work was undertaken to 
study detailed mechanisms of GM and CP induced tissue injury and possible 
mechanisms of protection/prevention by means of green tea consumption against 
GM/CP nephropathies. A o^fiapajative effect of green tea as extract and green tea in 
diet was also^rtjafe to mleout agy disrrepaiteies that coTild arise due to different mode 
of intake. ifi^ -e^ctensteft/IIie effects of GM/CP and GT were also studied in small 
intestine and liver, which are known targets of the toxic insult of these agents. The 
results embodied in this thesis showed that GT consumption"via diet or drinking fluid 
resulted in enhanced metabolic activity and antioxidant defense parameters. The 
results further demonstrated that GT consumption markedly reversed GM/CP induced 
nephrotoxicity parameters in the serum and GM/CP induced alterations in the 
enzymes of carbohydrate metabolism, BBM and antioxidant system. The present 
results suggest that GT consumption can be an option- for long-term clinical use of 
GM/CP without nephrotoxic and other harmful side effects. 
BENEFICIAL EFFECTS OF GREEN TEA: 
"Better to be deprived of food for three days, than tea for one " 
This ancient Chinese Proverb amptly describes the importance of tea in our day-to-
day lifestyle and the enormous health benefits ascribed to tea. 
Green tea and its composition: 
Tea is one of the most widely consumed beverages in the world today second only to 
water (Chantre and Lairon, 2002). Tea brewed from the plant Camellia sinensis, a 
member of Theaceae family is consumed in different parts of the world as green, 
black and oolong tea. Of the tea produced worldwide, 78% is black tea, which is 
usually consumed in Western countries, 20% is green tea, which is commonly 
consumed in Asian countries mostly in China and Japan, and 2% is oolong tea which 
is produced by partial fermentation in southern China. Green and black teas are 
processed differently during manufacturing. Green tea (GT) is prepared by steaming 
fresh leaves to prevent any oxidation to c^atechini^ Omajor polyphenols. By contrast 
black tea is produced by crushing fresh tea leaves and allowing enzyme-mediated 
oxidation to occur in a process known as fermentation. In the process, major 
polyphenols such as catechins are converted to unique- oxidants such as theaflavins, 
bisflavanols and thearubigens (polymers of simple polyphenols). The chemical 
composition of green tea is similar to that of the young shoots initially cultivated. It 
contains many polyphenolic compounds, which account for 30-40% of the extractable 
solids of green tea leaves, with most of the polyphenols being flavanols more 
commonly known as catechins. The primary catechins (Fig 1) are epicatechin (EC). 
epicatechin-3-gallate (ECG), epigallocatechin (EGC) and epigallocatechin-3-gallate 
(EGCG) (Graham, 1999). EGCG is the major catechin in GT and may account for 50-
80% of total catechin in tea. GT also contains caffeine (3.5%), theanine (4%), lignin 
(6.5%)), organic acids (1.5%), protein (15%) and chlorophyll (0.5%). A typical tea 
beverage prepared in a proportion of 1 g leaf to 100 ml water in 3-min brew, usually 
contains 250-300 mg tea solids, comprised of 30-42% catechins and 3-6% caffeine 
(Mukhtar and Ahmad, 1999). 
The potential health effects of GT polyphenols depend on the amount consumed and 
on their bioavailability. Following oral administration of GT polyphenols to rats, the 
four principal catechins have been identified in the portal vein indicating that tea 
catechins are readily absorbed in the intestine (Okushio et al, 1996). Yang et al 
(1998) demonstrated a dose dependent increase in plasma polyphenols accompanied 
by dose dependent increase in the excretion of these compounds and/or their 
metabolites in the urine and feces. It has been shown that GT catechins are more 
stable in a fasted stomach than in a fed stomach and that the oral bioavailability can 
be enhanced in the fasting conditions (Safar et al, 2003). 
Substantial amounts of tea polyphenols were found in esophagus, large intestine, 
kidney, bladder, lung and prostate and relatively low.amounts in the liver, spleen, 
heart and thyroid after oral administration (Higdon and Frei, 2003). Holding of GT 
solution in the mouth or slow repeated ingestion sh^i^d high concentration of GT 
polyphenols in the saliva and oral cavity. Such local high levels may support the use 
of GT in the prevention oloral cancer and carries (Yang et al, 1999). It appears that 
GT polyphenols can be variably accumulated in certain tissues and thus can exert 
biological effects accordingly. 
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Figure 1: Structure of green tea (GT) catechins 
Since ancient times GT consumption has been known to maintain and improve health 
(Weisburger, 1997). It has been shown to have extensive health benefits. Gl' 
consumption has been linked to lowering of various forms of cancers (Ahmad and 
Mukhtar, 1999). GT and its constituents have been shown to have cardioprotective, 
neuroprotective, antidiabetic, anti-inflammatory, antiatherosclerotic, anti-microbial 
and anti-aging properties (Alschuler, 1998; Liao, 2001). In addition, GT has been 
found to be useful in the treatment of arthritis, high cholesterol levels, and impaired 
immune function (Van het Hof et al, 1999). GT consumption has also resulted in 
improved kidney function in animal models of renal failure (Yokozawa et al, 1996; 
2005). GT polyphenols have been shown to exhibit strong antioxidant properties 
(Alschuler, 1998). Most beneficial health effects ascribed to GT are c^sidered to be 
mediated by potential antioxidant properties of GT polyphenols that scavenge free 
radicals and reduce oxidative damage (Augustyniak et al, 2005). Several lines of 
evidence suggest that prooxidant and antioxidant actions of plant (GT) polyphenols 
may be important mechanisms for their anticancer properties (Azam et al, 2004). 
Health Benefits of Green tea: 
The various health benefits of GT have been reviewed extensively (Mukhtar and 
Ahmad, 1999; Higdon and Frei, 2003; Khan and Mukhtar, 2007), and are described in 
detail in the following pages. 
Anticancer properties of Green tea: 
It is believed that almost one third of the cancers are caused by dietary habits and the 
manipulation in the diet is increasingly being recognized as a potential strategy 
against cancer (Katiyar and Mukhtar, 1997; Weisburger, 1999). The epidemiological 
as well as laboratory studies have shown an inverse association between GT 
consumption and the development of certain cancer types. Animal studies have shown 
that both green and black tea have cancer preventive activity against ultraviolet light, 
chemically induced and genetic models of carcinogenesis. These include various 
types of cancers e.g. skin, lung, breast, oral cavity, esophagus, stomach, pancreas, 
liver, small intestine, bladder, colon and prostate (Weisburger, 1999; Katiyar and 
Elmets, 2001; Yang et al, 2002). The majority of studies assessing the usefulness of 
tea in prevention of cancer have been conducted with GT whereas in few studies the 
chemopreventive potential of black tea was assessed (Katiyar and Mukhtar, 1997; 
Ahmad era/., 1997). 
Green tea polyphenols, known as catechins.are strong antioxidants and are believed to 
be responsible for most of the chemopreventive properties of GT. The anti-
carcinogenic and anti-mutagenic activity of GT polyphenols was first reported almost 
two decades ago (Khan et al, 1988). The ability of GT to prevent cancer is so well 
established that new studies are testing GT polyphenols and EGCG as 
chemotherapeutic agents (Khan et al, 2006; Khan and Mukhtar, 2007) against various 
types of cancers. In humans, most of the studies showing an inverse relationship 
between tea consumption and development of cancer were conducted on gastro-
intestinal cancers in Japan and China where GT is the maii^orm of tea consumed 
(Wang et al, 1999; Mu et al, 2003). Studies in northern Italy have suggested a 
protective effect of GT against oral, pharyngeal and laryngeal cancer. Frequent 
consumption of GT in China has been shown to be associated with lower incidence of 
esophageal cancer (Wang et al, 1999; Gao et al, 1994). A protective effect against 
gastric cancer by tea has been suggested from studies in Japan, Turkey and Sweden 
(Wang et al, 1999). In Japan women consuming more than 10 cups of GT daily were 
found to have lower risk for all cancers including breast cancer metastasis and 
recurrence (Nakachi et al, 1998; Wu et al, 2003). Tea drinking was shown to be 
associated with lower risk for digestive tract cancers and urinary tract cancers in 
women from Iowa, USA (Lambert and Yang, 2003a, 2003b). Individuals who 
consumed over 10 cups of GT per day showed remarkable reduction in risk for lung, 
colon and liver cancers (Sueoka et al, 2001). The preventive effect of GT against 
prostate cancer was also demonstrated (Jian et al, 2004). Oral administration of GT, 
black tea or EGCG inhibits the growth of well established skin tumors and in some 
cases tumor regression was also observed (Mukhtar and Ahmad, 2000; Mantena et al, 
2005). Recent research has suggested that dietary chemopreventive agents including 
EGCG may prevent cancers by modulating one or more cell signaling pathways 
including apoptosis in a marmer that interrupts the carcinogenic process (Surh, 2003; 
Khan e/a/., 2006). 
Cardioprotective properties of Green tea: 
Cardiovascular diseases, principally heart disease and stroke are the leading cause of 
mortality in Western countries, among both men and women in all racial and ethnic 
groups. The risk of atherosclerosis is increased by high blood pressure, diabetes, 
stress and lipid disorders. Underlying mechanisms for the beneficial effects of GT 
include vasculoprotective, antioxidative, antithrombogenic, anti-inflammatory and 
lipid-lowering properties of flavanoids (Stangl et al, 2006). The intake of GT has 
been inversely associated with the development and progression of atherosclerosis 
and it has been reported that dietary GT intake preserves and improves arterial 
compliance and endothelial fanction (Murakami and Oshato, 2003). GT has been 
shown to mitigate risk factors associated with heart disease and stroke (Khan and 
Mukhtar, 2007). GT catechins have been shown to affect lipid metabolism by 
different pathways and prevents the appearance of atherosclerotic plaques (Crespy 
and Williamson, 2004). Animal experiments have also studied the protective effects 
of GT against cardiovascular disease (Young et al, 1967; Sano et al, 1986; De 
Whalley et al, 1990). Ingestion of extract of GT in rats and humans has been shown 
to significantly decrease plasma cholesterol and triacylglycerol concentrations 
(Muramatsu et al, 1986; Chisaka et al, 1988; Ikeda et al, 1992; Deng et al, 1998; 
Tokunaga et al, 2002). Possible mechanisms of action include down regulation of 
liver fatty acid synthase, 3-hydroxy-3-methyl glutaryl coenzyme A reductase, a key 
enzyme in cholesterol synthesis and intestinal acyl CoA: cholesterol acyltransferase 
(Van het Hof et al, 1999; Maron et al, 2003). Increased consumption of GT was 
associated with decreased serum concentration of total cholesterol and 
triacylglycerols and an increased proportion of high density lipoprotein cholesterol 
together with a decreased proportion of low and very low lipoprotein cholesterols, 
which resulted in a decreased atherogenic index (Imai and Nakachi, 1995; Yang et al, -
1997). An inverse assjDciation of GT intake and myocardial infarction and its genetic^ 
variation has also been reported (Hirano et al, 2002; Mukamal et al, 2002). GT is a 
natural angiotensin-converting enzyme (ACE) inhibitor and has been shown to lower 
blood pressure in humans and animals (Imai and Nakachi, 1995). The use of tea to 
control hypertension and obesity may also have an impact on the incidence of 
cardiovascular diseases (CVD). The protective activities of tea and tea polyphenols 
against the oxidation of lipoproteins have been proposed to contribute to the 
prevention of atherosclerosis and other cardiovascular diseases. 
Antioxidant properties of Green tea: 
The potential health benefits associated with tea consumption have been partially 
attributed to the antioxidative property of tea polyphenols (Mukhtar and Ahmad. 
2000)jjea catechins and polyphenols have been found to be efficient scavengers of 
free ramtals^in vrfimnBSfoTinvitrosysiQm& (Rice-Evans, 1999).7kecently, it has been 
reported that GT consumed within a balanced controlled diet improves the overall 
antioxidative status and protects against oxidative damage in humans (Erba et al, 
2005)r)Tea preparations have been shown to trap reactive oxygen species, such as 
superoxide radical, singlet oxygen, hydroxyl radical, peroxyl radical, nitric oxide, 
nhrogen dioxide and peroxynitrite, reducing their damage to lipid membranes, 
proteins and nucleic acids in cell free systems (Paquay et al, 2000; Higdon and Frei, 
2003). The radical quenching ability of GT is usually higher than that of black tea. 
Among tea catechins, EGCG is most effective in reacting with most reactive oxygen 
species. Overproduction of nitric oxide and peroxynitrite, has been associated with 
chronic inflammation and may be associated with the etiology and pathology of a 
number of chronic diseases. GT has been found to be about five times more potent 
than black tea in scavenging of these radicals (Paquay et al, 2000). Additionally, 
EGCG was found to inhibit t l ^ ONOO" -mediated formation of 8-OHdG in calf 
thymus DNA more potently than vitamin C or glutathione (Fiala et al, 1996). The 
chemical structures contributing to effective antioxidant activity of catechins include 
the vicinal dihydroxy or trihydroxy structure, which can chelate metal ions and 
prevent the generation of free radicals. This structure also allows electron 
delocalization, conferring high reactivity to quench free radicals. GT catechins have 
been found effective in inhibiting in vitro and in vivo lipid peroxidation (Kondo et al, 
2001; Leena and Balaraman, 2005). A significant rise in plasma antioxidant capacity 
was detected after brewed GT was consumed (Leenen et al, 2000). GT may also 
increase the activity of antioxidant enzymes. Researchers found a significant increase 
in the activity of glutathione peroxidase, glutathione reductase, glutathione-S-
transferase, quinine reductase and superoxide dismutase, all of which are antioxidant 
and detoxifying enzymes in the small intestine, liver, kidney and lungs ( Serafini et 
al, 1996). 
Neurological and Psychological effects of Green tea: 
GT has been shown to protect the brain from oxidative stress and hence green tea 
might be useful in preventing age-related brain degeneration. Neurodegenerative 
diseases have been linked both to free radical damage and to excessive breakdown of 
neurotransmitters caused by high monoamine oxidase (MAO) activity. GT has been 
found to be effective at inhibiting monoamine oxidase (MAO) and lowering peroxide 
levels in glial cells in brain (Mazzio et al, 1998). Recently, it has been reported that 
catechins possess divalent metal chelating, antioxidant and anti-inflammatory 
activities to penetrate the brain barrier and protect neuronal death in a wide array of 
cellular and animal models of neurological diseases (Mandel et al, 2006). It has been 
shown that EGCG reduces focal ischemia/reperfusion-induced brain injury in a rat 
model (Choi et al, 2004). An excess of the neurotransmitter, nitric oxide, may lead to 
neural death and neurodegenerative disorders. GT polyphenols possibly protect 
against Parkinson's disease and have demonstrated neuroprotectant activity in cell 
cultures and animal models, such as the prevention of neurotoxin-induced cell injury 
(Pan et al, 2003). Japan has a much lower rate of Alzeihmer's disease than Western 
countries (Juneja et al, 1999). GT polyphenols have been found to inhibit or diminish 
iron-induced epileptic seizures and also the hyperactivity of dopaminergic neurons. A. 
study done on hypertensive rats has confirmed that epigallocatechin gallatey EGCG^ 
reduces the incidence of stroke and prolongs lifespan (Sato et al, 1989). The amino 
acid L-theanine is unique to tea. Theanine acts as a neurotransmitter in the brain and 
decreases blood pressure significantly in hypertensive rats (Khan and Mukhtar, 2007). 
Theanine io abcorbad, modulates brain serotonin and dopamine levels, improving 
memory, reaming ability and affects emotions (Juneja et al, 1999).(Thcrc-are^om6 
othor'rooulto which indicate that daily consumption of GT in sufficient amounts will 
have life prolonging effects by avoiding premature deaths caused by various chronic 
ailments such as cancer, CVD and neurological disorders (Nakachi et al, 2003). 
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Obesity, Thermogenesis and Green tea: 
It has been reported that the body weights of rats and their plasma triacylglycerol, 
cholesterol and LDL-cholesterol have been significantly reduced by feedings of 
oolong, black and green tea leaves to the animals (Lin and Lin-Shiau, 2006). In vitro 
experiments have demonstrated that GT inhibits lipogenesis (Hasegawa et ai, 2002; 
Mori and Hasegawa, 2003). EGCG purified from GT when given to mice in diet 
decreased diet-induced obesity in mice by decreasing energy absorption and 
increasing fat oxidation (Klaus et ai, 2005). Supplementation with tea catechins 
resulted in a significant reduction of high-fat diet-induced body weight gain, visceral 
and liver fat accumulation, and the development of hyperinsulinemia and 
hyperleptinemia in C57BL/6J mice (Murase et ai, 2002). EGCG also significantly 
reduced or prevented an increase in body weight in lean and obese male and female 
Zucker rats (Kao et ai, 2006). On the basis of the in vivo effects of EGCG on body 
weight loss, body fat, serum lipid nutrients, thermogenesis and fat oxidation and of 
the in vitro effects of EGCG on fat cell functions, long term consumption of GT may 
decrease the incidence of obesity and perhaps, GT components such as EGCG may be 
useful in treating obesity. It has been reported that GT extract rich in catechins and 
caffeine has thermogenic properties and promotes fat oxidation beyond than those 
explained by its caffeine content pgi>se^ ;' the GT extract may play a role in the control 
of body composition via sympathetic activation of thermogenesis, fat oxidation, or 
both (Dulloo et al, 1999). The increased and prolonged sympathetic stimulation of 
thermogenesis by the interaction between polyphenols and caffeine could be of value 
in assisting the management of obesity (Dulloo et al, 2000). 
Antibacterial properties of Green tea and GI tract: 
It is well established that GI tract plays a very significant role in the absorption, 
metabolism and conjugation of GT polyphenols (Spencer, 2003). In the GI tract, GT 
is found to activate intracellular antioxidants, inhibi^ pro-carcinogen formation, 
suppress^ angiogenesis and cancer cell proliferation (Mukhtar and Ahmad, 1999). 
GT IS effective to prevent derital carries and reduce cholesterol ami lipid absorption in 
GI tract as well as benefits subjects with CVD (Koo and Cho, 2004). Studies have 
shown that GT catechins interact and bind endogenous proteins in the small intestine 
limiting their absorption (Carbonaro et al, 2001). These protein binding properties of 
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catechins have been linked to their bactericidal abilities and other beneficial 
properties in the digestive tract. Tea may modify the intestinal microflora. b> 
selectively increasing the growth of bifidobacteria and lactobacilli in the gut wall 
(Yamamoto et al, 1997; Weisburger, 1999) while decreasing levels of numerous 
potential pathogens. Levels of pathogenic bacterial metabolites were also decreased 
(Goto et al, 1998). GT is an antimicrobial agent against a variety of gram positive 
and gram negative pathogenic bacteria that causes cystitis, pyelonephritis, diarrhea, 
dental caries (You, 1993), pneumonia and skin infections (Chou et al, 1999). The 
health promoting properties of GT have the potential to prevent gastrointestinal 
diseases (Suganuma et al, 1999). GT has been shown to reduce inflammation 
associated with Crohn's disease and ulcerative colitis, the two types of inflammatory 
Bowl disease (IBD) (Alic, 1999; Setiawan et al, 2001; Sano and Sasako, 2001). GT 
may have beneficial effectlgainst viral infection (Khan and Mukhtar, 2007). 
Antidiabetic properties of Green tea and kidney health: 
The kidneys are another ^ja^ where GT has been shown to have protective effects. In 
one particular studyithe antioxidant effect of GT was observed in rat kidney (Sano et 
al, 1995). In another study, GT supplementation decreased urinary oxalate excretion 
and calcium oxalate deposit formation and thus was seen to protect against calcium 
oxalate urolithiasis (Itoh et al, 2005). The concomitant administration of GT extract 
'a A'tj nA<" t • '^ • f 
to Cyclosporine A (CsA) recei^ang rats, markedly prevented the generation of 
thiobarbituric acid-reacting substances (TEARS) and significantly attenuated CsA-
induced renal dysfunction (Mohamadin et al, 2005). Kidney problems are often 
associated with highJpi^j^d sugar and consequent glycosylation of various proteins 
(hence thp^fray linkjj^tween kidney failure and diabetes). Since GT has the ability to 
lower serum glucose, this is another way by which it protects against kidney failure 
(Sabu et al, 2002). A study by Waltner-Law et al (2002) provided compelling in 
vitro evidence that EGCG decreases glucose production in rat hepatoma cells. Both 
green and black teas were shown to possess antidiabetic activity and were found to be 
effective both in the prevention and treatment of diabetes (Serafini et al, 1996; 
Yokozawa et al, 1996; 2005). EGCG was shown to induce antioxidant enzymes in 
the kidneys, as well as to reduce uremic toxins in the blood, suggesting improved 
kidney function in an animal model of renal failure (Yokozawa et al, 1996). 
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THE STRUCTURE AND FUNCTION OF KIDNEY: 
The kidney is a vital organ that plays an essential role in health and diseases. The 
main function of the kidney is to maintain total body fluid volume, its composition 
and pH within physiologic range. This is achieved collectively by the presence of 
several millions-'of architectural and functional units of the kidney, known as 
"nephron". A nephron is consisting of glomerulus with an extended tubular structure. 
A rat kidney contains 30,000-35,000 nephrons whereas a human kidney is made up of 
about 1, 30,000 nephrons. All these nephrons contribute to maintain renal functions 
by selective reabsorption of various ions and solutes. 
The structure of the mammalian kidney apparently looks very homogenous, however, 
can be viewed as a composite of several tissue organs, geometrically, functionally and 
metabolically (Schmidt and Guder, 1976). Thus each nephron consists of group of 
organs arranged in series coursing through four concentric tissue planes, the cortex, 
outer and inner zones of the outer medulla and the inner medulla (papilla) (Schmidt 
and Guder, 1976). Each tissue plane also has individual "organ" characteristics with 
respect to their ionic contents and metabolic rates (Guder, 1973; Schmidt and Guder, 
1976). The luminal brush border membrane (BBM) of renal proximal tubule is the 
major site for reabsorption of various solutes including amino acids, sugars and other 
nutrients, certain ions and minerals such as Na* and inorganic phosphate (Pi) 
(Hammerman and Schwab, 1984; Kempson and Dousa, 1986). Reabsorption of most 
ions and solutes from the tubular lumen is coupled by aft active transport with sodium 
(Na"^ ) via a carrier located on apical side and is driven by an electrochemical gradient 
of Na^ generated by Na^/K^-ATPase located on basolateral side (McCrory et al, 
1952; Massary and Fleisch, 1980; Bonjour and Caverzasio, 1984). Thus the transport 
of Na"^  is considered to be a major work function of the kidney upon which all other 
t , t _ * ' ' ^ ^ < » ^ 
transport are dependent (Ullrich et al, 1977). The energy for the sodium transport is 
mainly provided by the hydrolysis of ATP at antiluminal membrane site involving 
NaVK* ATPase (Balagura-Baruch et al, 1973; Evan et al, 1983). Since the 
production of ATP is usually coupled to oxidative metabolism occurring in 
mitochondria, Na"^  transport appears to be linked with the oxidative metabolism or 
oxygen tension (p02) of the renal tubular cells. A direct linear relationship between 
O2 uptake/ utilization and Na"^  reabsorption has been found (Thurau, 1961; Torelli el 
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ai, 1986). There appears to be a reverse cortico-medullary gradient for tissue oxygen 
tension (pOa) i.e. p02 in inner medulla is far lower than in cortical tissue (Auckland 
and Krog, 1960, 1961; Auckland, 1962; Aperia and Leibow, 1964). 
According to several studies, fatty acids, glutamine, lactate, citrate and in particular 
glucose are the major substrates which support the transport work of the kidney 
(Leal-Pinto et ai, 1973; Park et ai, 1974; Pitts and MacLeod 1975; Pitts, 1975; 
Mandel and Balaban, 1981). It is well established that various nephron subsegments 
located in different tissue zones of the kidney have different functions in solute and 
fluid transport, as well as in substrate metabolism. For example, the renal cortex is 
characterized mostly by aerobic oxidative metabolism (Lee et al, 1962) while the 
renal medulla is the site of anaerobic metabolism and glycolysis. Moreover, the renal 
cortex is also capable of producing glucose (Guder, 1973; Burch et al, 1978; Maleque 
et al, 1980). The oxidation of glucose in kidney may occur by several different 
metabolic pathways depending on the location and type of a particular nephron 
segment in the kidney: (1) the tricarboxylic acid (TCA) cycle, in which glucose 
undergoes glycolysis to pyruvate, which in turn may oxidize to CO2; (2) the hexose-
monophosphate (HMP) shunt pathway; and (3) the glycolysis in which glucose is 
partially oxidized to lactate. On the other hand glucose is known to be produced in the 
kidney by gluconeogenesis perhaps in the proximal tubule of the cortex (Schmidt and 
Guder, 1976; Burch et al, 1978; Maleque et al, 1980). The enzymes belonging to the 
above pathways are found to be present and distributed differentially in the kidney. 
The renal medulla is the major region for the production of lactate from glucose by 
glycolytic enzymes (Hems and Gaja, 1972; Guder, 1973) whiles the oxidative 
conversion of glucose to CO2 was shown in renal cortex (Lee et al, 1962; Cohen, 
1979). 
Nephron^ which ie consisting of various subsegments-showod distmct structural and 
functional differences (Francois and Danielle, 1985; Lise et al, 1987). Thus nephron 
heterogeneity alsa£fljQtaliute&4Q .^the v^iatioji.in the.kidriey functions. Both inter and 
intra-nephronal heterogeneity exists in the mammalian kidney that depends on the 
origin and location of the nephrons in the cortical region of the kidney (Francois and 
Danielle, 1985; Lise et al, 1987). The nephron which originates in the glomerulus 
located in superficial cortex is known as "superficial nephron" while the nephron 
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which originates from deep cortical region is called as "deep" or "juxtameduUary 
nephron". These populations of nephrons have been found to be distinct in structure^ 
as well as in functionV (Francois and Danielle, 1985). In hilbi-iitpliiuual 
hrtrrnErntiity;^rn"imnl convoluted tubules of superficial nephrons always touch the 
surface of the kidney. In intra nephron or axial huturogonoi'tyyThe proximal tubules 
have been divided into three distinct morphological subsegments SI, S2, S3. The 
early PCT both in superficial and juxtameduUary nephrons is defined as SI-segment 
and can be identified by its attachment with glomeruli on one side. S2 is defined as 
the late superficial proximal convoluted tubule, early superficial proximal straight 
tubule and late juxtameduUary proximal convoluted tubule. S3 is located principally 
in the outer stripe of outer medulla and is terminal superficial proximal straight tubule 
and entire juxtameduUary proximal straight tubule. S3 is identified by its medullary 
location and by its connection with thin limbs on distal part. All S3-subsegments (pars 
recta), as they descend from cortex into the outer stripe of the outer medulla change 
from S2 to S3 cell type. Thus the outer stripe of the outer medulla contains proximal 
tubular cells but only the S3 type (Woodhall et al, 1978). These segments can be 
characterized by their biomarker enzymes (Yusufi et al, 1994). 
Acute Renal Failure: 
A number of environmental variables and heavy metals like chromium, mercury, 
cadmium, lead, uranium (Bank et al, 1967; Sanchez et al, 2001) including drugs like 
aminoglycosides, cephalosporin, cisplatin etc. (Humes, 1988; Mahmood and Waters, 
1994; Mingeot-Leclercq and Tulkens, 1999) affects the structure and function of the 
kidney leading to acute renal failure (ARF). The term "Acute Renal Failure" denotes a 
dramatic clinical situation in which both the kidneys stop their function within a short 
period of time or immediately depending on the severity of ARF. Acute Renal Failure 
is a process rather than a state. Often it denotes a reversible insufficiency of the 
glomerular and tubular excretion functions which may be triggered by renal or 
extrarenal mechanisms. ARF isj>s^characterized by increase of nitrogenous waste 
products, such as serum creatinine and blood urea nitrogen and appearance of 
proteimic and enzymic components in the urine. 
ARF can be grossly divided into three phases; pathogenic phase, manifestation phase 
and recovery phase. In the first phase, a progressive disintegration and necrosis 
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especially of tubular epithelial cells has been observed, leading to the functional loss 
of the kidney which is manifested by the reduction of inulin clearance. In the second 
phase, long lasting effects are observed that severely affect the clearance of both 
creatinine and inulin and which can continue for several days after recovery begins, 
depending on the degree of renal damage. In the recovery phase there is an increase in 
concentrating ability of the kidney with eventual normalization of kidney function. 
Generally ARF caused by drugs and chemicals is much more severe and irreversible 
and the recovery sometimes is not possible (Loghman-Adham et al, 1987). The 
pathophysiologic mechanism of ARF has been investigated extensively in the last few 
decades (Maleque et al, 1980). Four major possible causes of ARF have been 
generalized which include renal vasoconstriction, glomerular permeability, tubular 
obstruction and tubular leakage (Maleque et al, 1980). 
THE STRUCTURE AND FUNCTION OF INTESTINE; 
The digestion and absorption of food components are major functions of the intestinal 
mucosa. It is the most metabolically active tissue in the body. Many complex 
compounds while passing through the small intestine are degraded into simple 
compounds which cross the intestinal epithelium before reaching the various body 
organs. Thus this epithelium not only regulates diverse absorptive and secretory 
processes but also process the substances that traverse it. The small intestine extends 
from the pyloric orifice where it is continuous with the stomach to the ileocecal 
junction where it continues to the large intestine. It is divided into three distinct 
structural and functional parts:-
(0 
(ii) 
(iii) 
Duodenum 
Jejunum 
Ileum 
To perform all these functions, the absorptive surface is greatly amplified b\ 
transverse folds. The small intestine is consisting of four layers 
(i) serosa (outermost) 
(ii) muscularis mucosa 
(iii) submucosa 
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(iv) mucosa (innermost) 
The absorptive cells of the small intestine are highly polarized tall columnar cells with 
a general architecture and structure that is similar to a number of other epithelial cell 
types whose major function is absorption (Grosser et al, 1992). They are 
distinguished by the presence of an apical striated border which forms the absorbing 
surface in contact with luminal contents. The plasma membrane of these enterocytes 
consists mainly of two different regions; brush border and the basolateral membrane 
which are morphologically, structurally and functionally different. 
Brush Border Membrane 
The small intestinal mucosa is one of the largest areas of contact of the human 
organism with the environment (Schumarm et al, 1999). The mucosa of the small 
intestine has transverse folds knowoi as villi, which are finger like projections 0.5-1.5 
mm in length. The villus is lined with a single layer of epithelial cells, containing a 
network of capillaries and lymphatic vessels (Lacteals). The plasma membrane 
covering the microvilli is covered with a polysaccharide coat referred to as glycocalyx 
and consists of glycolipids and glycoproteinic enzymes that hydrolyze carbohydrates 
and peptides. The cytoplasm beneath the microvilli contains fine filaments known as 
terminal web. The products of digestion may go through the microvillar membrane 
traversing the terminal web into cytoplasm. 
Brush Border membrane (BBM) lining the enterocytes (intestinal cells) constitutes 
one of the most important cellular membranes owing to its role in terminal digestion 
and absorption functions which are carried out by certain hydrolytic enzymes e.g. 
disaccharidase, dipeptidases, oligopeptidases, y-glutamyl transpeptidase, maltase, 
lactase, sucrase and alkaline phosphatase (Kenny and Booth, 1978). These enzymes 
are differentilly distributed in the thickness of BBM e.g. sucrase being superficially 
located (Brasitus et al, 1979) whereas alkaline phosphatase and ATPase are more 
deeply embedded within the membrane (Sigrist-Nelson et al, 1977). 
The absorption of digesfive food and various ions occurs by passive as well as active 
transport (Hopfer et al, 1973; Schultz, 1977). The transport of water, 
sugars and amino acids is a Na"" dependent secondary active transport energized by an 
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electrochemical gradient due to differences in Na"" concentrations across the BBM 
(Hopfer et al, 1973; Schultz, 1977; Hopfer, 1978; Ramaswamy et al, 1991). The 
role of proton motive force as a source of jenergj^OnJenns ^ f .ATP) has also been 
demonstrated (Rajendran et al^,\9%l\, Womm etqi, 1988; Ganapathy et al., 1991).' 
This is carried out by sodium pumps (Na'^ K '^ATPase); which are highly conserved 
integral membrane protein. 
The activities of certain enzymes belonging to glycolysis, TCA cycle, HMP shunt 
pathway, have been reported under various experimental conditions (Farooq et al., 
2004). The presence of hexokinase, glucokinase, 6-phosphofructokinase, G-6-
phosphatase, FBPase, oxoglutarate dehydrogenase, citrate synthase, PEP 
carboxykinase, NADP-malic enzyme and glutamines indicate that gluconeogenesis is 
also operational in the small intestine (Farooq et al, 2004). The function of small 
intestine appears to be metabolic as opposed to be absorptive. Thus the studies 
involving metabolic activities may'ln sbnie way reflect the absorption properties of 
the intestinal mucosa. 
The process of digestion as well as absorption is a regelatory process which is 
regulated by various drugs, hormones, and is also affected by nutritional and dietary 
status (Farooq et al, 2004, 2006). The small intestine is also the primary site for great 
exposure to hazardous and life threatening environmental toxicants such as hea\'y 
metals (uranium) and drugs (aminoglycoside antibiotics and antineoplastic agents). 
Recent studies have clearly demonstrated that the enzymes present in the small 
intestine are not only altered by dietary stress such as starvation and fasting (Farooq et 
al, 2004, 2006) but also by antibiotics such as gentamicin (Farooq et al, 2007). 
Most prominent pathophysiological mechanism of gastrointestinal toxicity include 
direct effects on cell membrane, inhibition or stimulation of mucosal proliferation, 
nerve damage, activation of emetic pathways, disruption of intracellular signal 
transduction, generation of reactive oxygen substances, activation pr inhibition of 
metabolic enzymes, intracellular toxicity/tc^eactive oxygen metabolites/species are 
the major causative factors for the mucosal lesions through oxidative stress. The 
major toxic effects of ROS include direct cytotoxicity towards epithelial cells, net 
fluid secretion into the lumen and alteration in functions of intestinal 
20 
microvasculature that lead to increased permeability and membrane damage (Grisham 
etal, 1990). 
STUCTURE AND FUNCTION OF LIVER: 
The liver weighing roughly 1.2-1.6 kg, performs many of the functions necessary for 
staying healthy. The liver is the first organ that comes into contact with enterally 
absorbed nutrients and xenobiotics via the portal blood (Kahl, 1999). Two large 
vessels carry blood to the liver: the hepatic artery comes from the heart and carries 
blood rich in oxygen, whereas the portal vein brings to the liver, blood rich in 
nutrients from the small intestine. These vessels are divided into smaller and smaller 
vessels, ending in capillaries, which further divide into thousands of lobules. Each 
lobule is composed of hepatocytes, and as blood passes through, they are able to 
monitor, add or remove substances from it (Sherwood, 1997). 
Among the most important liver functions are: 
• Removing and excreting body wastes and hormones as well as drugs and other 
foreign substances. Enzymes in the liver alter some toxins so they can be more 
easily excreted in the urine. 
• Synthesizing plasma proteins, including those necessary for blood clotting. 
Most of the 12 clotting factors are plasma proteins produced by the liver. 
• Producing immune factors and removing bacteria, helping the body fight 
infection. 
• Producing bile to aid in digestion. Bile salts aid in fat digestion and absorption 
• Excretion of bilirubin. Bilirubin is one of the waste products excreted in bile. 
Macrophages in the liver remove worn out red blood cells from the blood. 
Bilirubin results from the breakdown of hemoglobin and is excreted by 
hepatocytes. 
• Storing certain vitamins, minerals and sugars. The liver stores enough glucose 
in the form of glycogen to provide a day's energy. 
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One of liver's most interesting ability is.self-repair and the-regeneration of damaged 
tissueV. In clearing the body of toxins, the liver is damaged by exposure to harmful 
substances, demonstrating why this capability is important (Tzanakakis et al, 2000) 
Toxic damage to the liver parenchymal cells presents histologically as degenerative 
alterations of the cell or as abnormal storage, usually of fat (steatosis) (Arias et a!, 
1994). Cell death in liver injury may be of two types; it can be programmed cell 
death, or necrosis, a toxic lysis of the cell (Zimmerman, 1993). 
GENTAMICIN; PATHOPHYSIOLOGY 
Aminoglycosides such as gentamicin (GM) are the most commonly used antibiotics 
worldwide in the treatment of gram-negative bacterial infections (Nagai and Takano, 
2004). The high incidence of associated nephrotoxicity and ototoxicity (Lang and Liu, 
1997) represents an important concern in the use of aminoglycoside antibiotics which 
have been implicated as one of the primary causes of drug induced acute-renal failure 
(Appel, 1990). 
Gentamicin was isolated in 1963 by Weinstein and colleagues from the soil fungus 
Micromonospora purpura (of the Actinomycete group) (Sande and Mandell, 1985). It 
was introduced in the USA in 1969 and is a complex of gentamicins CI, CI a and C2 
and gentamycin A. Structurally, gentamicin comprises three aliphatic six-membered 
rings, two tetrahydropyrane rings and one cyclohexane ring (Fig. 5). Aminoglycosides 
are polycationic and consist, for the most part, of a central 2-deoxystreptamine 
molecule with glycosidic linkages to two or more amino sugars. They react basically 
(pKa > 8), are highly water-soluble, have low lipid solubility, and have a low capacity 
to penetrate membranes. The number of amino groups per aminoglycoside molecule, 
and their cationic structure, appears to be correlated to the nephrotoxic potential 
(Bennet, 1997) 
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Figure 5: Structure of Gentamicin 
Effect ofGentamicin on Kidney: 
Aminoglycosides are low protein-binding drugs and are freely filtered through the 
glomerulus in the kidney without being metabolized in the body. Most of the 
intravenously administered dose is excreted into the urine, whepeas a relatively 
sizeable portion is selectively accumulated at high concentrations in the renal cortex 
leading to renal damage such as structural changes and functional impairments of the 
plasma membrane, mitochondria and lysosomes (Mingeot-Leclercq and Tulkens, 
1999). 
The cellular uptake and accumulation of GM in the proximal tubule is a multistep 
process initiati<JE, with the binding of the cationic drug to the anionic sites on the 
brush border membrane (BBM) of the proximal tubular cells. This binding is 
mediated in part by electrostatic interaction with acidic phospholipids, predominantly 
to phosphatidylinositol (PI) which act as the principal receptor (Kaloyanides and 
Pastoriza-Munoz, 1980; Humes et al, 1982; Walker and Duggin, 1988; Hori and Inui, 
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1989; Mingeot-Leclercq et al, 1989). More recently, megalin, a'giant endocytic 
receptor protein, abundantly expressed at the apical membrane of renal proximal 
tubules, has been found to play an important role in the binding and endocytosis of the 
drug (Moestrup et al, 1995; Nagai and Takano, 2004). The adverse interaction of GM 
with one or more critical intracellular processes leads to renal cortical 
phospholipidosis and disruption of functions of membranes and organelles including 
mitochondria, lysosomes, microsomes, BBM and basolateral membrane (BLM) 
(Sundine/a/., 2001). 
GM accumulates in the renal cortex, mainly in the cells of the proximal convoluted 
tubule (Cojocel et al, 1983). The morphologic changes incurred by GM 
predominantly occur in SI and S2 segments of PCT and to lesser extent in pars recta 
(S3-subsegments) in animals and human kidneys. Histopathological studies stronglv 
support the concept that tubular necrosis is the primary gjbi^ of aminoglycoside 
toxicity (Kaloyanides, 1984). The ultrastructural changes in the proximal tubular cells 
include/the loss of the brush border, proliferation and multimembranous restructuring 
of lysosomes, formation of myeloid bodies, distension of the endoplasmic reticulum 
and swelling of the mitochondria (Kaloyanides, 1991) leading to total disorganization 
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and disruption of cellular organelles, with cellular necrosis (Kaloyanides and 
Pastoriza-Munoz, 1980; Humes et al, 1982). 
Aminoglycoside nephrotoxicity is opdn characterized b)^increase in serum creatmme 
and blood urea nitrogen (BUN) associated with a marked decrease in tubular transport 
of electrolytes, calcium and magnesium* glucose, protein and organic anion trflnaport 
(Cojocel and Lock, 1999). Tliii was fleeompaniod by massive proteinuria, enzymuna, 
glucosuria and phosphaturia (Cojocel and Hook, 1983). Gentamicin has been reported 
to inhibit the oxidative phosphorylation in the isolated renal cortex and to decrease the 
total ATP content of rat kidney (Simmons et al, 1980). Gluconeogenesis was found 
to be depressed in rabbit renal tubules incubated with gentamicin (Michalik el al 
1989). 
Recently CM has been shown to affect various enzymes of carbohydrate metabolism 
including glycolysis, TCA cycle, HMP shunt pathway and gluconeogenesis (Banday 
et al, 2008a). The damage caused by GM to lysosomes, BBM and BLM was 
demonstrated by .decrease in the activities of their biomarker enzymes in renal cortex 
associated with their increase in the urine (Banday et al, 2008a). GM also interacts 
with components of the protein/ and or phospholipid biosynthesis machinery from the 
lumen of golgi and endoplasmic reticulum resulting in inhibition of renal protein and 
phospholipid^^ metabolism (Sundin et al, 2001). Decreased expression of multiple 
genes by GM treatment has been elucidated by toxicogenomic studies (Amin et al 
2004; Kramer etal,'2004). 
Various nephrotoxins have been shown to generate ROS and produce oxidative stress 
leading to cellular injury. Reactive oxygen species (ROS) are considered important 
mediators of GM nephropathy (Walker et al, 1999; Cuzzocrea et al, 2002; AH. 
2003). Gentamicin has been shown to cause release of iron from renal cortical 
mitochondria (Baliga et al, 1997). Formation of ROS following bioactivation of GM 
has been reported (Sha and Schacht, 1999). GM induces superoxide anion (O2"), 
hydrogen peroxide and hydroxyl radical production from renal mitochondria (Yang 
et al, 1995; Walker et al, 1999). It has been reported that GM suppresses antioxidant 
enzymes whereas H2O2 generation, lipid peroxidation, and protein carbonyl content 
are increased in the renal cortex (Sandhya et al, 1995; Ali and Bashir, 1996; Walker 
et al, 1999; Naidu et al, 2000; Cuzzocrea et al, 2002; Pedraza-Chaverri et al, 2000 
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and 2003; Maldonaldo et al, 2003; Parlakpinar et al, 2004; Karahan et al, 2005; 
Bandayera/., 2008a). 
Effect of Gentamicin on Intestine: 
Nutritional stress and a number of environmental variables including certain 
chemicals, metal ions and antibiotics, dramatically alter the digestive and absorptive 
function of the intestinal mucosa, as well as dramatically alter the activities of 
enzymes oLintestine (Farooq et al, 2004, 2006, 2007). Aminoglycoside antibiotics 
are frequently used in the treatment of severe infections of the abdomen and urinary 
tract including bacteremia and endocarditis (Nagai and Takano, 2004). Although 
kidney is the major GM target, it has been show n^ to accumulate in various tissues 
including intestine, liver, heart and ear causing multiple adverse effects in these 
tissues (Soberon et al, 1979; Parker, 1990; Ozturk et al, 1997; Kohn et al, 2005). 
Aminoglycoside antibiotics such as neomycin and kanamycin, were shown to alter 
mucosal morphology and absorption of nutrients concomitant with nausea, vomiting, 
diarrhea (Jacabson et al, 1960; Faloon et al, 1966; Paes et al, 1967). They are 
known to interact with the intestinal epithelium,' its irmervations causing alterations in 
intestinal motility and contribute to the pathogenesis of antibiotic-associated diarrhea 
and colitis (Goldhill et al, 1996). Study on the impact of GM on absorptive function 
of small intestine in patients with chronic bronchitis revealed that GM inhibits 
intestinal fat, carbohydrate and protein absorptions (Akimovo and Shteingardt, 1992). 
GM is widely used in the organ culture of the intestine and caused decrease of 
intestinal lactase and alkaline phosphatase activity (Shimizu et al, 1991). Farooq et 
al (2007) have recently reported that activities of certain enzymes involved in 
terminal digestion and glucose metabolism were selectively altered in a time 
dependent manner by GM treatment. 
The proposed mechanisms include a) the direct action of antibiotic on intestinal 
function b) inducing predisposition to infection with an entire pathogen c) and factors 
secondary to disturbance of the normal intestinal llora that do not involve infection 
with a known pathogen (Borriello, 1992). 
ROS mediated injury to the small intestine has been demonstrated in several 
conditions such as ischemia/reperfusion, inflammatory bowel disease, surgical stress, 
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drug usage etc (Halliwell and Gutteridge, 1999; Arivarasu et al, 2007). GM 
administration also affects the antioxidant defenses in small intestine, indicated by 
elevated lipid peroxidation and depressed SOD and catalase activities (Farooq et al.. 
2007). 
Protection or prevention against Gentamicin toxicity: 
Gentamicin, an effective and widely used aminoglycoside antibiotic is known to be 
potentially nephrotoxic despite close attention to the pharmacokinetics and dosing 
schedules of the drug (Ishikawa et al, 1985). GM has been shown to cause marked 
histological damage in particular to renal proximal convoluted tubules (Humes and 
Connor, 1988; Abdel-Gayoum et al, 1994) resuhing in swelling, vacuolization and 
necrosis of epithelial cells and accumulation of myelin-like bodies (Ali and Bashir, 
1994). The proximal tubule injury and subsequent renal dysfunction has been 
attributed to the accumulation of the drug (Hori and Inui, 1989) in the tubule cells and 
its interactions with brush border and basolateral membranes and other organelles 
leading to disruption of their functions. GM-induced renal cortical phospholipidosis 
\hia<i afgn t-^ ig^ t^ cf^ H tr. disrupt the functions of various organelles including 
mitochondria, lysosomes, microsomes and plasma membranes (Cronin and Henrich, 
1996; Mingeot-Leclercq and Tulkens, 1999). 
Several approaches, utilizing different mechanisms, have been attempted to reduce the 
nephrotoxicity caused by GM and related aminoglycoside antibiotics. The 
mechanisms involved include (1)Ml'="?rffafiing nr prpventin£ drug accumulation by the 
kidney (2) nnmprntinn nr dgrrrmmr aminoglycoside binding to brush border 
membrane (3) protection against vascular^d glomerular effects (Ali, 1995; Mingeot-
Leclercq and Tulkens, 1999).^ave all helped in reducing the possibility of GM-
nephropathy. In human medicine, the single daily injection is the only approach 
actually used to reduce the renal toxicity of aminoglycosides. In experimental animals 
several strategies to ameliorate the toxicity have been attempted (Ali, 2003). These 
include controlling the time of administration of the antibiotics (Beauchamp et al, 
1994), modification of the diet (Paquette et al, 2002) and co-administration of 
antibiotics and certain agents such as thyroid hormone (Cronin et al, 1986) to 
mitigate renal toxicity. However all of.the different agents and strategies used were 
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not found suitable for clinical practice for reasons related to safety, practicality or 
effectiveness. 
Several workers have suggested that oxygen free radicals are co»sidefed-te" tre" 
important mediators of GM-mediated nephrotoxicity (Baliga et al, 1997; Walker et 
al, 1999). It has been shown that GM enhances the production of hydrogen peroxide 
by rat renal cortical mitochondria .AHJ JUggi-j.mdIimJULCujS> that hydroxyl scavengers 
such as metallothionein and iron chelators could prevent GM induced acute renal 
failure (Yang et al, 1991; Shah and Walker, 1992; Yang et al, 1995). It has been 
asserted that, among the main approaches used to ameliorate or protect against GM 
nephrotoxicity, the most consistent effects have been observed with the use of 
antioxidant agents (Mingeot-Leclercq and Tulkens, 1999). Examples of antioxidant 
agents that have been used to ameliorate GM nephrotoxicity in rats include 
deferrioxamine, methimazole, saireri-to, vitamin E, vitamin C and selenium. Other 
agents which have recently been studied include superoxide dismutase, SOD (Ali and 
Bashir, 1996), lipoic acid (Sandhya et al, 1995); dimethyl sulphoxide, DMSO (Ali 
and Mousa, 2001); the hormone melatonin (Ozbek et al, 2000; Shifow et al, 2000; 
Sener et al, 2002); the antihyperlipidemic drug probucol (Kumar et al, 2000), taurine 
(Erdem et al, 2000), N-acetylcysteine (Mazzon et al, 2001) and trans-reservatrol 
(Morales et al, 2002). Of special interest is the finding that the agent, M40403 (a 
SOD mimetic) protects against experimental GM nephrotoxicity (Cuzzocrea et al, 
2002). Howovot; M40403 has several advantages over native SOD enzyme *im^ 
includes stability, better penetration into cells and lack of immunogenicity of non-
human enzyme. DMSO is another promising agent to ameliorate GM nephrotoxicity 
(AH and Mousa, 2001). 
A recent interesting development is the attempt to use extracts from medicinal plants 
with antioxidant properties to ameliorate/protect against GM-induced nephrotoxicity 
in rats. Such medicinal plants include garlic (Pedraza-Chaverri et al, 2000), as well as 
diallyl sulfide, a compound isolated from garlic (Pedraza-Chaverri et al, 2003) and 
Nigella sativa oil (Ali, 2003). 4t may appear thatlhese natural antioxidants may offer 
comparatively safer alternatives to the other antioxidants (e.g. the beta-blocker 
carvediol), however, their adverse/side effectji have not been studied. In addition to 
the above-mentioned agents, some other miscellaneous drugs have been tested for 
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their protective/ameliorative effects in GM-induced nephrotoxicity. It has been 
suggested that the major pathway responsible for renal uptake and accumulation of 
GM is via megalin (Schmitz et al, 2002). Mice lacking megalin receptors were found 
to be completely resistant to GM nephrotoxicity. lUwas suggested that megalin could 
be fconoidcred a unique target for/^evention-of GM nephrotoxicity. 
In view of it^ excellent safety and efficacy profiles, antioxidant agents were found to 
produce the best nephroprotection. These agents, especially the natural antioxidants, 
7 •' ' 
seem to possess the highest potential for use in the clinic. Qf these natural 
antioxidants present in fish oil and green tea may be another .option whiftb \% gainiHg 
interest in recent times. Fish oil at high doses has been found to exert protection 
against gentamicin nephrotoxicity (Ali and Bashir, 1994; Abdel-Gayoum et al, 1995). 
Treatment with green tea modified the biochemical changes that occurred during 
gentamicin nephrotoxicity and thus was shown to have potential protective affect 
(Upaganlawar et al., 2006). 
CISPLATIN: PATHOPHYSIOLOGY 
Cisplatin (cis-diamminedichloroplatinum (II)) is an effective agent against various 
solid cancers. Despite its effectiveness, the dose of cisplatin (CP) that can be 
administered is limited by its nephrotoxicity. Hundreds of platinum compounds (e.g. 
carboplatin, explatin, nedaplatin) have been tested over the last two decades in order 
to improve the effectiveness and to lesser the toxicity of CP. Cisplatin was first 
synthesized by Michael Peyrone in 1845, and is historically known as Peyrone's 
chloride. The structure was first elucidated by Alfred Werner in 1893 [Fig. 6]. 
Cisplatin is a heavy metal platinum co-ordination complex containing a central atom 
of platinum surrounded by chloride and ammonium atoms in the cis position of a 
horizontal plane. 
NH3 
CI R NH3 
CI 
Figure 6: Structure of Cisplatin (CP) 
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Cisplatin and other related drugs form strong electrophilic intermediates that act via 
nucleophilic substitution reaction to form inter and intra strand DNA cross-Hnks. CP 
texas^Xied a major antineoplastic drug for the treatment of solid tumors such as 
metastatic testicular cancer, advanced ovarian carcinoma (Taguchi et al, 2005), 
advanced bladder carcinoma and squamous cell carcinoma of head and neck 
(Nakashima et al, 1990). It is given intravenously or intraperitoneally, bi«^-^o 
jerum prnlniii lij ii1iiTiit""f^ "^ n^  distributes to most tissues and is cleared unchanged 
from the kidney (Royer et al, 2005). Free CP in the plasma, by virtue of its low 
molecular weight and uncharged character, is freely filtered at the glomerulus 
(Safirstein et al, 1984). CP and its analogs accumulate^ in the kidney to a higher 
degree than other organs probably through energy-mediated transport (Arany and 
Safirstein, 2003; Kawai et al, 2005). Cisplatin concentrations in proximal tubular 
epithelial cells exceed plasma concentrations by a factor of five. Intracellularly, the 
highest concentrations of CP are found in the cytosol, mitochondria, nuclei and 
microsomes (Kuhlmarm et al, 1997). 
Effect of Cisplatin on Kidney: 
The toxic effect of the drug in mammals and animals include nephrotoxicit>, 
ottotoxicity, neurotoxicity and bone marrow suppression but its chief dose-limiting 
side effects is nephrotoxicity (Arany and Safirstein, 2003; Boulikas and Vougiouka, 
2003; Sastry and Kellie, 2005). Morphologically, the nephrotoxicity induces necrosis 
of the terminal portion of the proximal tubule and apoptosis, predominantly in cells in 
the distal nephron. Cisplatin treatment also induces extensive death of cells in 
proximal and distal tubules and loop of Henle (Arany et al, 2004; Taguchi et al. 
2005). Light and electron microscopy have shown that the CP induced injury and 
necrosis in the rat kidney are predominantly localized in the S3 segment of proximal 
tubule in the corticomeduUary region with or without accompanying distal changes 
(Townsend et al, 2003). Pathological changes were rarely observed in the SI and S2 
segments of pars convoluta of the proximal tubule. Cisplatin toxicity in proximal 
tubular epithelial cells is morphologically characterized by tubular necrosis, loss o\^ 
microvilli, alterafions in number and size of lysosomes, and mitochondrial 
vacuolization. These structural alterations are accompanied by functional disturbance 
of various cell organelles (Kuhlmann et al, 1997). Very few changes were noted 1 to 
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2 days after the injection of drug, although a focal loss in brush border, increased 
cytoplasmic vesicles and a necrotic cell were seen occasionally in the proximal 
tubules in the outer stripe region. More severe lesions became evident after 3 days, 
and the S3 segment showed a spectrum of morphologic aherations (Dobyan et al, 
1980). In some cells, the brush border was almost completely obliterated with only a 
few microvilli remaining. Clumping of nuclear chromatin and increased number of 
cytoplasmic vesicles could be seen in many of the injured cells (Nonclercq et al., 
1989). 
Functionally, the nephrotoxicity causes reduced renal perfusion and a concentrating 
defect, and changes in renal hemodynamics. Biochemical, morphological and 
ftinctional alteration^ induced by CP in renal mitochondria support^ the idea that 
mitochondria could be the primary target of toxicity as the S3 segment of the 
proximal tubule has a large number of mitochondria as compared to other parts of the 
kidney (Tisher, 1982; Santos et al., 2007). 
The alterations induced by CP in the kidney functions are characterized by change in 
urine volume, increase in BUN and serum creatinine levels (Dauggard, 1990). Some 
biochemical changes due to CP treatment include generation of free radicals, lipid 
peroxidation (Matsushima et al., 1998), loss of renal sulfhydryl groups, damage to 
mitochondria (Zhang and Lindup, 1993) and inhibition of DNA synthesis (Gomeva et 
al., 1993). 
Although the exact mechanism of cisplatin nephrotoxicity remains unclear, 
biotransformation of cisplatin could play an important role (Fillastre and Raguenez-
Viotte, 1989). CP undergoes ligand binding reactions which are virtually irreversible 
(Daley-Yates and McBrien, 1982). CP is biotransformed through binding to lower 
molecular mass substances such as glutathione, methionine, cysteine and to high 
molecular mass substances such as albumin and nucleic acids and the resulting 
metabolites are known as mobile and fixed metabolites respectively (Farris et al. 
1985). 
Once cisplatin is administered to cancer patients intravenously as a sterile saline 
solution, there are three possible mechanisms involved in CP toxicity. Once it enters 
the bloodstream, it remains intact due to the relatively high concentration of chloride 
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ions (-lOOmM). Cisplatin enters cells by diffusion where it is converted to its active 
form. Inside the cell (Fig. 7), the neutral cisplatin molecule undergoes hydrolysis in 
which a chlorine ligand is replaced by a molecule of water, generating a positively 
charged species. 
Inside the cell: Pt(NH3)2Cl2 + H2O > [ Pt(NH3)2Cl(H20)]^ + c r 
[Pt(NH3)2Cl(H20)]^ + H2O > [Pt(NH3)2(H20)2]' 
cr 
•^ h. 
th 
^ f X / < 
Cl 
\ / 
. H,N 
Fl f \ 
NHj 
Figure 7: Cellular uptake of cisplatin (CP). 
(FromyEncyclopedia of cancer by Pil and Lippard, 1997) 
These^quated forms are highly reactive with nucleophiles and can lose hydrogen ions 
to form cytotoxic hydroxyl radicals. Once inside the cell, cisplatin has a number of 
possible targets: DNA; RNA; sulfur containing enzymes such as metallothionein, 
glutathione and mitochondria. The principal target of cisplatin is DNA (Cohen and 
Lippard, 2001). It causes intrastrand cross-linking probably between N7 and 06 of the 
adjacent guanine molecules, which results in local denaturation of DNA chain. CP 
also damages cell mitochondria, arrest cell cycle in the G2 phase, inhibits ATPase 
activity, alters the cellular transport system, eventually causing apoptosis. 
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inflammation, necrosis and cell death (Boulikas and Vougiouka, 2003; Jo et al, 2005; 
Taguchi et al, 2005). 
There are two distinct genomes in the cell, mitochondrial and nuclear. It has been 
postulated that mitochondrial DNA damage induced by CP causes nephrotoxicity 
(Singh, 1989), the reasons being, that, mitochondrial DNA is less closely associated 
with proteins than nuclear DNA (Salazar et al, 1982) and thus will be more 
/tu d^A if* . . . 
accessible to attack by agpated species of CP. Secondly, DNA repair mechanisms 
play a major role in nucleus than in mitochondria. Damage of the mitochondrial 
DNA, would result in the inhibition of the de novo synthesis of mitochondrial 
proteins, leading to the degeneration of the organelles. Cisplatin nephrotoxicity has 
been demonstrated to be mediated by DNAsel (Basnakian et al, 2005).-^ 
Another mechanism proposed is that cisplatin induces renal damage by free-radical 
generation, by altering arginine metabolism and by increasing the activity of calcium 
independent nitric oxide synthase (Devipriya and Shyamaladevim, 1999). Glutathione 
is one of the most important antioxidant systems. The interaction of CP with sulph-
hydryl groups is an important factor in promoting cytotoxicity. Due to the compounds 
high affinity to SH groups, its chloride moieties are replaced by sulph-hydryl groups 
(Kuhlmann et al, 1997). The formation of stable protein-S-CP adducts results in 
dysfunction of membrane associated and cytoplasmic protein^ e.g. Na^/phosphate and 
NaVglucose cotransporters (Courjault-Gautier et al, 19951 and decreases the activity 
of important enzyme systems such as glutathione-S transferase, reductase and 
peroxidase (Bompart, 1989). In addition, stable glutathione-CP adducts lead to a 
decrease in the amount of reduced glutathione available to scavenge free reactive 
oxygen metabolites (Mistry et al, 1991). This may effectively harm the cellular 
oxidant defense systems, eventually leading to lipid peroxidation. The depletion of 
renal glutathione level has been observed in rats in response to oxidative stress caused 
by CP (Nakano and Gemba, 1989). 
A recent study suggests that apoptosis may also play an important role in 
development of CP induced acute renal failure (Lee et al, 2001). CP has been 
reported to induce apoptosis in renal epithelial cells (Lieberthal et al, 1996; Zhan ei 
al, 1999; Lau 1999). Metabolic responses, cell cycle events and the inflammator> 
cascade seem to be important determinants of the degree of renal failure induced by 
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cisplatin (Arany and Safirstein, 2003). Different studies have demonstrated that the 
cytotoxicity of CP is probably due to combination of insuhs, including peroxidation 
of cell membrane, mitochondrial dysfunction, inhibition of protein synthesis and 
DNA damage in kidney and intestine thereby inducing renal dysfunction and diarrhea 
(Santosera/., 2007). 
Effect of Cisplatin on Intestine: 
CP a widely used chemotherapeutic agent has profound effect on the kinetics, 
morphology and function of the mouse/human small intestine. Studies on CP 
distribution in experimental animals showed the highest,conceiiitrations not only in the 
excretory organs but also in ovary and uterus, whereas the lowest were in brain 
(Litterst e/a/., 1979). 
Nausea and emesis are important factors that reduce drug compliance in patients 
receiving anticancer chemotherapeutic drugs such as cisplatin (McCarthy and 
Borison, 1984; Kris et al, 1985). CP is thought to be absorbed by simple passive 
diffusion through the peritoneum, and evidence has been found for active transport 
after ingestion of an oral dose (Gale et al, 1973; Andrews et al, 1987; Casey et al, 
1989; Binks and Dobrata, 1990) although some evidence exists for carrier-mediated 
uptake of cisplatin by an amino acid mediated transport system (Byfield and Calabro-
Jones, 1982). 
The first obvious effect of CP toxicity is marked degeneration and desquamation of 
intestinal villi in jejunum in cisplatin treated rats/mice along with significant 
reduction in villus height (Ikuno et al, 1995). Destruction of the crypt cells containing 
large Paneth (secretory) granules in the ileum and the changes in the crypt height 
resulting from CP toxicity are related to the loss of regenerative capacity of crypts 
owing to the cytotoxic insult of CP. Histological analysis of small intestine of CP 
treated experimental animals has revealed that cisplatin also impairs the mucosal 
structure of the ileum by causing acute epithelial necrosis (Choie et al, 1983) 
Cisplatin elicited oxidative stress increased free fatty acids in intestinal mucosal cells, 
thereby inducing permeability transitions in plasma membrane and subcellular 
membranes and subsequent release of cytochrome C from mitochondria, leading to 
apoptosis (Chang et al, 2002). 
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In studies assessing the gastrointestinal toxicity of cytotoxic chemotherapeutic agent 
administration it is evident that severe morphological changes occur during drug— 
induced epithelial damage in the mucosa of the intestines, thus resulting in necrosis 
and/or haemorrhagic enterocolitis (Schaeppi et al, 1973). Thus, CP toxicity-induced 
diarrhea may be caused by abnormalities of intestinal absorption or secretion. CP^ 
induced diffuse mucosal damage in the intestine from the jejunum to colon in mice 
may cause malabsorption and subsequently diarrhea (Ikuno et al, 1995). Crypt cell 
damage ^ Si cisplatin administration reduces the disaccharidase activity, resuhing in a 
decrease in water reabsorption causing diarrhea. Several studies have demonstrated a 
reversal of CP induced intestinal damage by 5-HT3 receptor antagonists (De Mulder et 
al, 1990; Marty et al, 1990; Gandara et al, 1993), suggesting a role of 5-HT in 
cisplatin-induced GI symptomatology (Bearcroft et al, 1999). Cisplatin has been 
found to induce mitochondrial oxidative stress with impairment of energetic 
metabolism, membrane rigidification and apoptosis in rat liver (Martins et al, 2007). 
Protection or prevention against Cisplatin toxicity: 
Cisplatin (CP) is an antineoplastic agent that has a remarkably broad spectrum of 
clinical activity in the treatment of solid tumors (Cohen and Lippard, 2001). However, 
CP-4nduced nephrotoxicity limits its use in cancer therapy. Hundreds of platinum 
compounds have been tested over the last two decades in order to improve the 
effectiveness and to lesser the toxicity of CP (Ali and Al-Moundhri, 2006). Several 
agents have been tested to ameliorate the nephrotoxicity of platinum drugs (Ali and 
AI-Moundhri, 2006). The agents that have been shown to prevent/reduce experimental 
CP nephrotoxicity include antioxidants, modulators of nitric oxide, agents interfering 
with metabolic pathways of CP, diuretics and cytoprotective and apoptotic agents. 
Only few of these have been tested in humans. 
The nephrotoxicity of cisplatin is closely related to the activity of reactive oxygen 
species (ROS). Platinum complexes are very reactive towards the cysteine residue of 
GSH, which detoxifies these enzymes by a rapid binding mechanism (Jansen et al, 
2002). Administration of GSH was protective against lethal CP toxicity (Anderson et 
al, 1990). The antioxidant agents that have been reported to either ameliorate or 
prevent the nephrotoxicity of cisplatin include melatonin (Sener et al, 2000; Hara et 
al, 2001; Saad and Al-Rikabi, 2002), selenium (Hu et al, 1997), vitamin E 
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(Naziroglu et al, 2004) and N-acetylcysteine (Wu et al, 2005). Among the 
antioxidants that have boon triod against-nephrotoxicity of cisplatiry include those that 
have been extracted from natural products (Conklin, 2004). An ethyl acetate extract of 
Phellinus rimosus, fungus, has been shown to protect mice against cisplatin 
nephrotoxicity (Ajith et al., 2002). Shirwaiker et al. (2003) reported that treatment of 
rats with extract of the flowers of the plant Pongamia pinnata ameliorated cisplatin 
nephrotoxicity in a dose-dependent manner. It has been recently reported that 
treatment of rats with capsaicin, was effective in protecting against cisplatin-induced 
nephrotoxicity (Shimeda et al, 2005). The flavanoid naringenin has been shown to 
have strong in vitro and in vivo antioxidant and antiproliferative actions, which may 
be the basis of its protection against cisplatin nephrotoxicity (Totta et al, 2004). 
It has been suggested that NO is involved in CP nephrotoxicity (Srivastava et 
a/., 1995, 1996) and it has been reported that the inhibitor of NO synthase, NG-nitro-
1-arginine methyl ester, was effective in mitigating lipid peroxidation and other 
biochemical changes associated with nephrotoxicity caused by cisplatin (Saad et al. 
2000). L-Arginine (precursor of NO) was also shown to have nephroprotective effects 
on CP nephrotoxicity. 
It has recently been shown that the nephrotoxicity of cisplatin can be blocked by 
inhibiting either of ^ two enzymes expressed in the proximal tubules, y-glutamyl 
transferase or cysteine-S-conjugate-P-lyase (Townsend et al, 2003). Erythropoietin 
(EPO) has been shown to exert cytoprotective and antiapoptotic effects in 
experimental cisplatin-induced nephrotoxicity and ischaemic acute renal injury 
(Yalcin et al, 2003; Vessey et al, 2004). 
Recent evidence suggests that apoptosis and inflammatory mechanisms play an 
important role in the pathogenesis of cisplatin nephrotoxicity (Jo et al, 2005). 
Treatment of rats with anti-inflammatory agent, salicylate, reduced cisplatin 
nephrotoxicity (Li et al, 2002). The broad- spectrum cytoprotective agent, amifostine. 
has been approved by the US Food and Drug Administration for use in patients 
receiving cisplatinw with the aim of reducing its nephrotoxicity. Both human and 
animal studies have shown that the use of diuretics (furosemide, mannitol and others) 
and hydration substantially mitigate cisplatin nephrotoxicity (Cornelison and Reed. 
1993; Yoshizawa et al, 1998; Santoso et al, 2003; Hanigan et al, 2005). 
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In past few years, much interest has been centered on the role of naturally occurring 
dietary substances for the control and management of various chronic diseases such as 
cancer and cardiovascular disorders (Alschuler, 1998; Weisburger, 1999; Connor, 
2000). From ancient times the physicians and scholars in Asia have understood that 
food have both preventive and therapeutic value and are integral part of health. Green 
tea is one such dietary source of biologically active components that has been shown 
to be co-preventive and co-therapeutic in a wide variety of ailments (Khan and 
Mukhtar, 2007). 
In a preliminary report, GT has been shown to mitigate gentamicin and CP-induced 
nephrotoxicity by lowering the level of serum urea, creatinine and tissue LPO content 
(Upaganlawar et al, 2006). Green tea extract has also been found to offer significant 
protection from cisplatin induced oxidative damage in rat kidney and testes (Leena 
and Balaraman, 2005). 
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SCOPE OF THE THESIS 
The concept of disease prevention by administration of naturally occurring or 
synthetic compounds is gaining increasing attention. The past five years have been 
rich in information coming from laboratories all around the world concerning the 
positive impact of food on human health. Much interest has been centered on the role 
of oxidant/antioxidant activity in regards to ageing and degenerative diseases like 
cancer, cardiovascular and diabetes (Khan and Mukhtar, 2007). 
Tea produced from the leaves of the plant Camellia sinensis, is, next to water, the 
most widely consumed beverage in the world. It provides a dietary source of 
biologically active compounds that help prevent a wide variety of diseases (Alschuler, 
1998). For many generations, tea has been considered to possess health-promoting 
potential in some parts of the world (Weisburger, 1997). Tea's status as a functional 
food lends credibility to what has been believed by tea drinkers for centuries. Among 
all teas, green tea (GT) has been best studied for health benefits (Khan and Mukhtar, 
2007). 
Epidemiological studies strongly suggest that the consumption of green tea is 
associated with a lower risk of several human diseases, including cancer, 
cardiovascular disorders, obesity, neurological disorders, diabetes etc (Sueoka et al. 
2001; Mukamal et al, 2002; Lambert and Yang, 2003a, 2003b). GT is an excellent 
source of polyphenolic compounds, known as catechins, with epigallocatechin-3-
gallate (EGCG) being the major catechin present in green tea. GT catechins and their 
derivatives are known to contribute beneficial health effects ascribed to tea (Zloch, 
1996) by their antioxidant (Higdon and Frei, 2003), antimutagenic and 
anticarcinogenic properties (Mukhtar and Ahmad, 1999, 2000). The cancer preventive 
effect of GT has been observed in pancreatic, rectal and colon cancers (Ji et al. 
1997). GT has been found to decrease the risk of esophageal cancer (Gao et al, 1994) 
as well as improved prognosis in breast cancer has been reported (Nagata et al. 
1998). GT has been shown to mitigate risk factors associated with heart disease and 
stroke, and has been inversely associated with the development and progression of 
atherosclerosis (Murakami and Oshato, 2003). In addition, GT has been found useful 
in the treatment of arthritis, high cholesterol levels, infection and impaired immune 
function (Van hetHofe/a/., 1999). 
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The kidneys play an essential role in the maintenance of total body fluid volume, its 
composition and acid-base balance by selective reabsorption. A number of 
environmental contaminants, chemicals and drugs including antibiotics and anticancer 
drugs dramatically alter the structure and function of various tissues and produce 
multiple adverse effects in the liver, kidney, heart and intestine (Soberon et al. 1979; 
Ozturk et al, 1997; Kohn et al, 2005). Gentamicin (GM), an aminoglycoside 
antibiotic, is still considered to be an important antibiotic against life threatening 
infections despite its known nephro and ototoxicity (Humes, 1988; Tulkens, 1989; 
Mingeot-Leclercq and Tulkens, 1999). The antineoplastic nature of liganded platinum 
compounds, especially cisplatin (CP), has led to its increasing clinical use for the 
treatment of malignancies (Safirstein, 1984). The therapeutic use of cisplatin however 
is limited by myelotoxicity, ototoxicity, intestinal toxicity, and most notably renal 
toxicity (Fillastre and Raguenez-Viotte, 1989; Mahmood and Waters, 1994). Recent 
studies indicate an important role of reactive oxygen species (ROS) in GM and CP 
induced tissue injury (Masuda et al, 1994; Matsushima et al, 1998; Baliga et al, 
1998; Walker etal, 1999). 
Several approaches, utilizing different mechanisms, have been attempted to reduce 
GM and CP toxicity. Many different agents and strategies have been reported to 
ameliorate GM as well as CP toxicity in experimental animals (Ali, 2003; Nagai and 
Takano, 2004; Ali and Al-Moundhri, 2006). Cisplatin induced toxicity in human and 
experimental animals has been shown to be protected by prior treatment with various 
antioxidants such as ebseleen (Yoshida et al, 2000), Vitamin C (Antunes et al, 2000; 
Fatima et al, 2007) and selenium (Caffery and Frenkel, 2000; Antunes et al, 2001). 
However, none of these strategies were found to be suitable/safe for clinical practice. 
GT consumption has been found to improve kidney function in animal models of 
renal failure (Yokozawa et al, 1996). In a preliminary report, GT has been shown to 
mitigate gentamicin and CP-induced nephrotoxicity by lowering the level of serum 
urea, creatinine and tissue LPO content (Upaganlawar et al, 2006). GT extract has 
also been found to offer significant protection from cisplatin induced oxidative 
damage in rat kidney and testes (Leena and Balaraman, 2005). Although there are 
several studies supporting the preventive potential of green tea, a proper 
understanding of the mechanisms by which they reduce the risk is necessary to 
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establish the efficacy. Exploration at the cellular level allows a better understanding 
of the underlying mechanisms regulating functions in normal and pathologic states 
Considering potential beneficial health effects of GT, we hypothesized that: Green tea 
consumption would be able to prevent/reduce GM/CP induced nephrotoxic} ahd 
other adverse effects in various rat tissues. 
To address this hypothesis, the present work was undertaken to study detailed 
biochemical events/cellular response/mechanisms of GM and CP induced nephrotoxic 
and otheraiivLers©---el¥eets-4ft~?aL._ i^dn^ intestine and Uyeiv Xlae-eSect t>f GT 
msumption was ^t-nrmiir*'^-^" "^^ '^ ^Wf^  ^^y prntpf-tjori pr^yidftl against GM/CP 
lephrotoxicity wr th^r long-term clinical use without -harmftrr'side effects. The 
specific objectives of the plarmed research included:-
Par t l 
Experiments were conducted to study the effect of green tea (GT) given to rats in the 
diet or drinking water as extract on various biochemical parameters in the serum and 
on the enzymes of carbohydrate metabolism, brush border membrane, lysosomes and 
oxidative stress in renal cortex, medulla, intestine and liver of normal rats. 
Part II 
Experiments were carried out to determine the effects of GM and GT alone and in 
combination on various serum biochemical parameters and on the enzymes of 
carbohydrate metabolism, BBM, lysosomes and antioxidant defense mechanism in the 
kidney tissues (cortex and medulla), intestine and liver. The effect of GM and GT was 
also determined on transport of ^^ Pi in BBMV isolated from renal cortex. 
Part III 
Experiments were carried out to determine the effects of CP and GT alone and in 
combination on various serum biochemical parameters and on the enzymes of 
carbohydrate metabolism, BBM, lysosomes and antioxidant defense mechanism in the 
kidney tissues (cortex and medulla), intestine and liver. The effect of CP and GT was 
also determined on transport of-^ ^Pi in BBMV isolated from renal cortex. 
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The results of the present studies showed that GM and CP administration caused 
specific alterations in various serum parameters and in the enzyme activities of 
various systems in different tissues confirming nephrotoxic and other adverse toxic 
effects caused by GM/CP. The results further demonstrated that GT consumption 
largely prevented/ameliorated GM/CP induced alterations in various parameters. The 
studies W0tlld help us in furthering our understanding of GM/CP induced 
ft 
nephropathies and in possible prevention/protection by GT consumption for the safe 
use of GM, as an important antimicrobial and CP as antineoplastic agents. 
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MATERIALS AND METHODS 
MATERIALS: 
Animals: 
Adult male albino rats (Wistar strain) were purchased from.local animal supplier and 
also from Laboaids, Meerut, U.P. India. 
Substrates of carbohydrate metabolism and lysosomal enzymes: 
D-glucose-6-phosphate for yvglucose-6-phosph^te dehydrogenase and glucose-6-
phosphatase. Sodium pyruvate for^  lactate dehydrogenase, oxaloacetate for.malate 
dehydrogenase, L-malic acid for malic enzyme, fructose 1, 6 diphosphate for fructose 
1,6-bisphosphatase, p-nitrophenyl phosphate for acid phosphatase were purchased 
from Sisco Research Laboratorary (SRL, Mumbai, India). ATP for hexokinase 
was purchased from Sigma Chemical Co., USA. 
Substrates of marker BBM enzymes: 
p-nitrophenyl phosphate for alkaline phosphatase, y-glutamyl-p-nitroanilide for 7-
glutamyl transferase and L-leucine-p-nitroaniline for leucine amino peptidase were 
purchased from Sigma Chemical Co., USA. Sucrose for sucrase was purchased from 
Sisco Reserch Laboratory (Mumbai, India). 
Substrates for enzymes involved in free radical scavenging: 
Pyrogallol for superoxide dismutase and hydrogen peroxide for catalase were 
purchased from Sisco Research Laboratory (Mumbai, India). 
Radio Chemicals: 
Radioactive phosphate (^ ^Pi) was purchased from Bhabha Atomic Research Centre, 
India. 
Diet: 
The standard rat pellet diet was obtained from Aashirwaad Industries, Chandigarh, 
India. 
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Green tea: 
Green tea (Kangra, Himachal Pradesh, India and Lipton-Unilever, Englewood Cliffs, 
NJ, USA) was purchased from Jain Pan House, New Delhi, India. 
Miscellaneous: 
The chemicals used were of finest quality commercially available and their sources 
are indicated against them. Glass double distilled water was used in all experiments. 
The following chemicals were purchased from various sources as mentioned below:-
SRL 
Acetic acid. Ammonium molybdate. Bovine serum albumin, calcium chloride, 
cholesterol, Cocktail-T (Scintillation fluid), copper sulphate, creatinine, cysteine 
hydrochloride, 5,5'-Dithio-bis 2-nitrobenzoic acid (DTNB), ethylene diamine tetra 
acetic acid (EDTA), ferric chloride, ferrous sulphate, Folin's phenol reagent, 
glucose, glycine, glycylglycine, maleic acid, mannitol, nicotinamide adenine 
dinucleotide phosphate (NADP), nicotinamide adenine dinucleotide phosphate 
reduced (NADPH), nicotinamide adenine dinucleotide reduced (NADH), sodium 
acetate, sodium azide, sodium carbonate, sodium chloride, sodium hydroxide, 
sodium potassium tartarate, sodium dodecyl sulphate, tris-(hydroxymethyl) 
aminomethane (Tris base). 
Qualigens 
Calcium carbonate, chloroform, Di-potassium hydrogen orthophosphate, Di-sodium 
hydrogen orthophosphate, hydrochloric acid, hydrogen peroxide, magnesium 
chloride, perchloric acid, picric acid, potassium dihydrogen orthophosphate, sodium 
arsenate, sodium dihydrogen orthophosphate, sodium fluoride, succinic acid, 
sulphuric acid, trichloroacetic acid, zinc sulphate 
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Sigma 
Adenosine triphosphate, cisplatin, N-2-Hydroxyethyl-piperazine-N-2-ethane 
sulphonic acid (HEPES), p-nitroaniline, thiobarbituric acid (TBA). 
Miscellaneous 
3,5-Dinitro salicylic acid from Lancaster, England; Gentamicin from Nicholas, 
Mumbai, India; p-nitrophenol from Loba Chem Co., India 
METHODS: 
1. Animal Protocol: 
The animal experiments were conducted according to the guidelines of Committee for 
Purpose of Control and Supervision of Experiments on animals, Ministry of 
Environment and Forests, Government of India. Adult male Wistar rats, weighing 
150-180 g, fed with a standard pellet diet (Aashirwad Industries, Chandigarh) and 
water ad libitum, were conditioned for one week before the start of the experiment. 
All animals were kept under conditions that prevented them from experiencing 
unnecessary pain and discomfort according to guidelines approved by Ethical 
Committee. 
2. Preparation of Green tea Extract and Green tea Diet: 
Green tea ( 30 g ) was added to 500 ml of boiling water and Was ste'eped for 15-20 
mill. Infosion was cooled to room temperature and then filtered^Fhe tea leaves were 
extracted a second time with 500 ml of boiling water and filtered, and the two filtrates 
were combined to obtain 3% green tea extract (3 g tea leaves/100 ml H2O). The 
resulting clear solution is similar to tea brews consumed by humans. Green tea diet 
was prepared by adding green tea (3 g/100 g diet) in powdered rat diet, mixed well 
with small amounts of water, and then made in form of cookies^jfef drying in oven 
(50-60°C) for 30 minutes. Green tea polyphenols havo bren detected by Thin Layer 
Chromatography as reported by Malik et al. (2003). According to manufacturers 
informafion the anfioxidant content was 95 mg/g of GT. 
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3. Analysis of Serum Parameters: 
The serum samples were deproteinated with 3% TCA in the ratio of 1:3. After 
incubation for 10 min at room temperature, the samples were centriftiged at 4000 rpm 
(Remi centrifuge, India) for 10 min. The protein free supernatant was used to 
quantitate serum creatinine (SCr) and inorganic phosphate (Pi) and the precipitate was 
saved to quantitate total phospholipids. Cholesterol was determined directly in the 
serum samples. 
(i) Quantitative determination of Creatinine: 
Creatinine was determined by the method of Levinson and MacFate (1969). To 0.5 ml 
of the deproteinated serum supernatant, 250 |J.1 of 10% NaOH and 0.5 ml of saturated 
picric acid were added and incubated for exactly 20 min at room temperature. A 
calibration curve was simultaneously prepared using a known concentration of 
creatinine solution ranging between 2.0-5.0 [xg. The samples and the standards were 
read at 520 nm on Cintra 5 or 10 spectrophotometer against a reagent blank. 
(ii) Determination of Inorganic Phosphate: 
The inorganic phosphate (Pi) was measured in protein free, TCA precipitated serum 
supernatant by the method of Tausky and Shorr (1953). The serum supernatant (1ml) 
was diluted to 3 ml with glass distilled water and 2 ml of FeS04 reagent (5 gm FeS04 
was dissolved in 10 ml 10% w/v ammonium molybdate in 10 N H2SO4 and was 
diluted to 100 ml with glass distilled water) was added. A calibration curve was 
simultaneously prepared with test samples using the known concentration of KH2PO4 
(0.018 nmoles to 0.28 |imoles). The blue colour obtained was read at 820 nm after 20 
min incubation at room temperature on Cintra 5 or 10 spectrophotometer against a 
reagent blank. 
(iii) Quantitave determination of phospholipids: 
Phospholipids were determined in the serum TCA-precipitates by the method of 
Bartlett (1959) as modified by Marinetti (1962). The precipitates were digested with 1 
ml 70% perchloric acid on an electric digestion unit. 0Wcooling to room temperature • 
3 ml of glass distilled water was added. The phosphate (inorganic) released was 
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estimated by adding 2 ml of FeS04 reagent by the method of Tausky and Shorr (1953) 
as described above in Pi estimation. The phospholipids values were obtained after 
multiplying the phospholipid phosphorus by a factor of 25. 
(iv) Quantitave determination of Cholesterol: 
Cholesterol was determined by the method of Zlatkis et al. (1953). To 3 ml acetic 
acid, 30 |al serum sample was added. To this, 2 ml of FeCb reagent (prepared by 
diluting 1 ml of 10% FeCb w/v in glacial acetic acid to 100 ml of concentrated 
H2SO4) was added carefully from the side to allow the formation of a brown ring. The 
samples were shaken thoroughly, cooled and colour density was read in Cintra 5 or 10 
spectrophotometer at 560 nm against a reagent blank. A calibration curve was 
simultaneously prepared using known concentration (0.02 to 0.2 mg) of cholesterol. 
(v) Determination of Urea nitrogen and Glucose: 
Levels of urea and glucose were assayed by standard calorimetric procedures, urea by 
reaction with diacetyl monoxime and glucose by reaction with o-toluidene using kits 
from Span Diagnostics (Surat, India). 
4. Preparation of Tissue Homosenatefs): 
After the completion of the expeririiejatJiyer^^kidQey and intestine, v/ere extracted. 
The intestines were washed by flushing them with ice cold buffered saline (1 mM 
Tris-HCl, 9 g/L NaCl, pH 7.4). The liver and kidney were put in Tris buffered saline 
(TBS). The washed intestines (from control and treated groups) were slit in the middle 
and the entire mucosa was gently scraped with a glass slide and weighed. A 6.5% 
homogenate of this mucosa was prepared in 50 mM mannitol, pH 7.0, in a glass 
Teflon homogenizer (Remi motors, Mumbai, India) with 5 complete strokes. The 
homogenate was then subjected to high speed Ultra-Turrex homogenizer (Type T-25, 
Janke & Kunkel GMBH & Co. KG. Staufen) for 3 pulses of 30 s each with an interval 
of 30 s between each stroke. 
The kidneys were decapsulated and kept in ice-cold 154 mM NaCl and 5 mM Tris-
HEPES buffer, pH 7.5. The cortical and medullary regions were carefully separated as 
described by Yusufi et al. (1994) and homogenized (as mentioned above) in 50 mM 
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mannitol buffer to get 10% (w/v) homogenate. A10% liver homogenate was similarly 
prepared in 10 mM Tris-HCl buffer, pH 7.5. 
One part of the homogenates (of intestine, kidney, liver) was centrifuged at 2000 g, 
for 10 min, at 4°C and the supernatant was saved for assaying the enzymes of 
carbohydrate metabolism, second was centrifuged at 3000 g for 15 min at 4°C and 
supernatant was used for assay of free-radical scavenging enzymes and the third was 
used for estimation of total thiol (-SH) and lipid peroxidation. 
5. Preparation of Brush border membrane(s) (BBM): 
The lenal BBM vesicles (BBMV) were prepared by \he method of ScMmitz ef ul 
(1973) using MgCh for precipitation of membranes other than BBM as described by 
Yusufi and Dousa (1987). The intestinal BBMV was prepared as described by Ke^er 
et al. (1978), using differential precipitation by CaCb- Mucosa scraped fro|h 4-5 
washed intestines was used for each BBM preparation (Fig. 8). 
In each experiment, tissues from<three to six animaj^^control and experimental) were 
pooled to obtain a sufficient amount of starting material. All the steps involved were 
strictly carried out at 0-4° C unless otherwise specified. 
(i) Renal BBM preparation: 
a) The cortical tissue for the preparation of BBMV was homogenized in a buffered 
solution containing 50 mM mannitol, 5 mM Tris base/HEPES pH 7.5 (5 
ml/gtissue) with four complete passes by glass-teflon homogenizer. 
b) The homogenate was diluted with above solution (20 ml/g tissue) followed by 
high speed homogenization (Ultra-Turrex T25) with three pulses of 30 s each 
with 30 s interval in between each pulse. Aliquots of homogenates were saved 
and quickly frozen for further analysis. 
c) IM MgCb was added to the homogenate (final cone. 10 mM) and was kept for 
20 min on ice, with intermittent stirring. 
d) The homogenate was then centrifuged at 2000 g (5000 rpm) for 10 min in a 
Beckman J2-M1 refrigerated centrifuge using a JA-17 rotor. 
e) The pellet was discarded and the supernatant was recentrifuged at 35000 g 
(17,000 rpm) for 30 min. 
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DECAPSULATED AND KEPT 
IN TRIS BUFFERED SALINE 
DH7.5 
5 mM TRIS, 50 mM MANNITOL 
pH 7.5 ULTRA-TURREX 
HOMOGENIZATION 
PELLET DISCARDED BBMV IN SUPERNATANT 
SUPERNATANT 
DISCARDED 
BBMV PURIFICATION BY 
CENTRIFUGATION AT 
35000 g FOR 30 MIN 
BBMV IN PELLET 
SUSPENDED IN 50 mM SODIUM 
MALEATE BUFFER pH 6.8 
CENTRIFUGATION AT 
35 000 g FOR 30 MIN 
SUSPENDED IN 300 mM 
MANNITOL BUFFER pH 7.4 
CENTRIFUGATION AT 
35 000 g FOR 30 MIN 
INTESTINAL BBMV RENAL BBMV 
Figure 8: Schematic representation of intestinal and renal BBMV preparation 
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f) The pellet thus obtained was resuspended in a solution containing 300 niM 
mannitol, 5mM Tris base/HEPES pH 7.5, with four complete passes by a loose 
fitting Dounce homogenizer (Wheaton, USA) and centrifuged at 35,000 g 
(17,000 rpm) for 30 min in 15 ml corex glass tube using JA-20 rotor. 
g) The white outer fluffy portion of the pellet was resuspended carefully in a small 
volume of the above mentioned buffers, leaving the dark brown centre of the 
pellet undisturbed ( mitochondrial contamination). 
The suspension thus obtained was homogenized by hand held Dounce/ The 
membrane suspension was quickly frozen in small aliquots and used for enzyme 
analysis while aliquots of freshly prepared membranes were used for transport studies. 
(ii) Intestinal BBMpreparation: 
a) The mucosal scrapings were collected in a beaker containing 50 mM mannitol, 5 
mM Tris-HCl, pH 7.5. 
b) The mucosal homogenate was diluted with the above Tris-mannitol buffer (15 
ml/g tissue) and fiirther homogenized using Ultra-Turrex T25 homogenizer with 
three pulses of 30 s each with 30 s interval between each pulse. Aliquots of 
mucosal homogenate were saved and quickly frozen for further analysis. 
c) CaCh was added to the filtrate, to a final concentration of 10 mM and was kept 
for 20 min on ice, with intermittent stirring. 
d) The homogenate were then centrifuged at 2000 g (5000 rpm) for 10 min in a 
Beckman J2-M1 refrigerated centrifuge using a JA-17 rotor. 
e) The pellet was discarded and the supernatant was recentrifuged at 35000 g 
(17,000 rpm) for 30 min. 
f) The pellet was resuspended in a small volume (1-2 ml) of 50 mM sodium 
maleate buffer, pH 6.8, with four complete passes by a loose fitting Dounce 
homogenizer (Wheaton, USA) and centrifuged at 35,000 g (17,000 rpm) for 30 
min in 15 ml corex glass tube using JA-20 rotor. 
g) The white outer fluffy portion of the pellet was resuspended carefully in a small 
volume of the above mentioned buffer, leaving the dark brown centre ol~ the 
pellet undisturbed (mitochondrial contamination). 
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The suspension thus obtained was homogenized by hand held Douncey. The BBM 
suspension was quickly frozen in small aliquots and used for enzyme analysis. 
6. Enzyme Assays 
All enzymes were assayed at zero order kinetics unless otherwise specified. The 
activity of each enzyme from various groups was determined simultaneously under 
similar conditions by using same solutions to avoid day-to-day experimental 
variations. One unit of enzyme activity is defined as the amount of enzyme required 
to catalyze the formation of 1 (imole of product per min or hour under the specified 
experimental conditions. Specific activity is defined as the enzyme units per mg 
protein. Absorbance was read in a Cintra 5 or Cintra 10 spectrophotometer. 
(a) Assay of carbohydrate metabolism enzymes 
The assays were carried out by measuring the extinction changes on Cintra 5 or 10 
spectrophotometer fixed for 340 rmi in a final volume of 3.0 ml at room temperature 
(28-30°C). The net reaction rate was measured by difference of the extinction values 
obtained from addition of the substrates and for actual enzymatic reaction following 
the addition of substrate. 
(i) Lactate dehydrogenase (LDH, E.C.I. 1.1.27) 
The acfivity of LDH was measured by the method of Romberg (1955). The reaction 
mixture in a total volume of 3 ml contained Tris-HCl buffer pH 7.4, 150 |xmoles, 
MgCb 10 ^moles, sodium pyruvate 5 |imoles, NADH 0.24 ^imoles and 4.0-6.0 i^ g 
protein. The activity was measured as pyruvate dependent NADH oxidation to NAD^ 
for 3 min at 340 nm. 
(ii) Malate dehydrogenase (MDH, E.C.1.1.1.37) 
The activity of MDH was measured according to the method of Meyer et al. (1948). 
The reacfion mixture in a total volume of 3 ml contained Tris-HCl buffer pH 7.4, 
100 limoles, oxaloacetate (OAA, pH neutralized to 7.4) 2.5 fimoles, NADH 0.24 
lamoles and 2.0-3.0 ^g protein. The activity was measured as OAA dependent NADH 
oxidation to NAD^ for 3 min at 340 nm. 
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(iii) Malic enzyme (ME, E.C. 1.1.1.40) 
It was assayed according to the method of Ochoa (1948). The reaction mixture in a 
total volume of 3 ml contained Tris-HCl buffer, pH 7.4, 100 ^imoles; MnCb 10 
limoles; L-malic acid (pH neutralized to 7.4) 5 lamoles; NADP"" 0.24 i^moles; and 0.6-
1.2 mg protein. The activity was measured by monitoring the malic acid dependent 
reduction of NADP^ to NADPH for 3 min at 340 nm. 
(iv) Glucose-6-phosphate dehydrogenase (G6PDH, E.C. 1.1.1.49) 
G6PDH was assayed according to the method of Shonk and Boxer (1964). The 
reaction mixture in a total volume of 3 ml contained Tris-HCl buffer pH 7.4, 150 
l^moles; MgCb 10 ^moles; glucose-6-phosphate 5 [imoles; NADP"" 0.24 [imoles; and 
0.6-1.2 mg protein. The activity was measured by monitoring the increase in 
absorbance, G6PDH dependent reduction of NADP^ to NADPH (e = 6.22 mM"'cm"') 
for 3 min at 340 nm. 
(v) Glucose-6-phosphatase (G6Pase, E.C. 3.1.3.9) 
It was assayed according to the method of Shull et al. (1956). The reaction mixture in 
a total volume of 1.5 ml contained Tris-HCl buffer pH 7.4, 50 i^moles; MgCh 10 
^moles; Glucose-6-phosphate 10 f^ moles and 2-3 mg protein. The reaction was 
carried out at 37 °C and stopped with 1 ml of 10 % TCA after 60 min. The samples 
were centrifuged at 4000 rpm (Remi Centrifuge, India) and phosphorus was estimated 
in the protein free supernatant by the method of Tausky and Shorr (1953). 
(vi) Fructose-1, 6-bisphosphatase (FBPase, E.C. 3.1.3.11) 
It was assayed according to the method of Freedland and Harper (1959). The reaction 
mixture in a total volume of 1.5 ml contained Tris-HCl buffer pH 8.4, 50 ^moles; 
MgCl2 10 i^moles; Cysteine-HCl 12 |amoles; F-1,6-DP 10 ^imoles; 0.6-0.8 mg protein. 
The reaction was carried out at 37 °C and was stopped with 0.1 ml of 10% TCA after 
60 min. The samples were centrifuged at 4000 rpm (Remi Centrifuge, India) and the 
phosphate released was estimated in protein free supernatant by the method of Tausky 
and Shorr (1953). 
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(vii) Hexokinase (HK, E.C. 2.7.1.1) 
It was assayed according to the method of Crane and Sols (1953). The reaction 
mixture in a total volume of 1 ml contained Tris-HCl buffer, pH 7.4, 50 jxmoles: 2 
^moles KH2PO4; 10 fxmoles MgCb; 5 i^ moles ATP; 2 |j.moles glucose and 1-1.5 mg 
protein. The reaction was carried out at 37 °C and stopped with 0.5 ml of 10% ZnS04 
and Ba(0H)2 each, after 60 min. The samples were centrifuged at 4000 rpm (Remi 
centrifuge, Mumbai, India) and the remaining glucose was estimated in the protein 
and phosphorylated derivative free supernatant by the method of Nelson and Somogyi 
(1944). A calibration curve was simultaneously prepared using a known concentration 
of glucose solution ranging between 5-45 \ig. 
(b) Assay of lysosomal marker enzyme: 
Acid Phosphatase (ACPase E.C.3.1.3.2) 
The activity of acid phosphatase was determined in cortical and intestinal 
homogenates by the method of Verjee (1969). The reaction mixture contained 2.4 ml 
acetate buffer (0.5 M sodium acetate, pH 4.5) and 100 |il enzyme (34-40 ^g protein). 
The reaction was started by the addition 0.5 ml p-nitrophenyl phosphate (final 
concentration 0.8 mM in 3 ml) and incubated for 15 min at 30 °C. The reaction was 
stopped by adding 2 ml of 2 N NaOH. A calibration curve of known concentrations 
(0.05-0.4 iimoles) of p-nitrophenol was prepared simultaneously. The yellow colour 
developed was read at 405 nm in Cintra 5 or 10 spectrophotometer against a reagent 
blank. 
(c) Assay of marker enzymes of brush border membrane 
The enzymes were assayed simultaneously in homogenates and BBMVs (cortical and 
mucosal) under similar conditions by using same solutions to avoid day-to-day 
experimental variations. Aliquotis of homogenates and BBMVs were diluted with 10 
mM Tris-HCl buffer, pH 7.5 to obtain suitable enzyme protein concentration. 
(i) Alkaline phosphatase (ALP, E.C. 3.1.3.1) 
The activity of ALP in the homogenates and BBMV was determined according to the 
method of Shah et al (1979) as modified by Kempson et al. (1979). The reaction 
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mixture contained 1.4 ml assay buffer (55 mM glycine, 36 mM NaCl and 45 mM 
NaOH, pH 10.5) and 100 \il enzyme protein ( 10-25 |ig protein for homogenate and 4-
8 |ig protein for BBM). The reaction was started by adding 15 \i\ p-nitrophenyl 
phosphate (final concentration 5.8 mM in 1.5 ml) and incubated at 37°C for the 
required time (5-20 min). The reaction was stopped by adding 50 |al of 5 N NaOH. A 
calibration curve was prepared simultaneously by using known concentrations of p-
nitrophenol (0.01-0.2 ^moles). The yellow colour was read at 405 nm against a 
reagent blank. 
(ii) Y-Giutamyl transferase ( GGTase, E.C. 2.3.2.2) 
GGTase was assayed by the method of Glossmann and Neville (1972). The reaction 
was started by addition of 100 \xl enzyme protein (15-20 ng for homogenate, 2-5 ^g 
for BBM) to 1.9 ml substrate buffer ( 20 mM MgCb, 2 mM y-glutamyl p-nitroanilide, 
4 mM glycylglycine, 100 mM Tris-base pH 8.2) and incubated in a shaking water 
bath maintained at 37°C for the required time (3-15 min). The reaction was stopped by 
adding 100 |il of 15 M acetic acid. A calibration curve of known concentration of 
standard p-nitroaniline (0.025-0.2 ^imoles) was prepared simultaneously. The yellow 
colour was read at 405 nm against a reagent blank. 
(iii) L-Leucine aminopeptidase (LAP, E.C. 3.4.11.2) 
LAP was assayed by the method of Goldman et al. (1976). The reaction was started 
by the addition of 100 |j,l homogenate or BBMV ( 40-60 \i% protein for homogenate 
and 10-15 }ig for BBMV) to 1.9 ml substrate buffer (50 mM sodium phosphate buffer, 
0.33 mM L-leucine p-nitroanilide, pH 7.2) and incubated at 25 °C for the required 
time (15-30 min). The reaction was stopped by the addition of 100 |al of 15 M acetic 
acid. A calibration curve of standard p-nitroaniline (0.025-0.2 lamoles) was also 
prepared simultaneously. The yellow colour obtained was read at 405 nm against a 
reagent blank. 
(iv) Sucrase ( E.C. 3.2.1.48) 
Sucrase was assayed by the method of Goldstein and Lampen (1975). The reaction 
mixture (0.3 ml) contained 50 \i\ of 0.1 M sodium maleate buffer, pH 6.0, 200 ^1 of 
diluted BBM or intestinal homogenate and 50 |al of 0.1 M sucrose solution. The assay 
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mixture was incubated at 37 °C for 10 min and the reaction was terminated by 
addition of 200 i^l of 0.2 M phosphate buffer, pH 7.0, immediately followed by 
heating in a boiling water bath. The tubes were cooled and 0.5 ml of distilled water 
was added. Glucose thus liberated was determined by adding 1.0 ml of 3,5-
dinitrosalicylic acid reagent and kept in a boiling water bath for 5 min, and 3.0 ml of 
distilled water was again added. A calibration curve was simultaneously prepared 
using known amounts of glucose (0.5-2.5 iimoles) and the colour was read at 540 nm 
against a reagent blank. 
(d) Assay ofenzymic and non-enzymic parameters of antioxidant defense system: 
Homogenates were centrifuged at 5000 rpm for 15 min at 4°C and the supernatants 
were used for enzyme assays. 
(i) Superoxide dismutase (SOD, E.C.I.15.1.1) 
SOD was assayed by the method of Marklund and Marklund (1974). To 0.08 ml of 
homogenate (75-150 |xg protein), 2.82 ml of 0.05 mM Tris-succinate buffer, pH 8.2 
was added, mixed well and incubated at 25°C for 20 min. The reaction was started by 
adding 0.1 ml of 8 mM pyrogallol solution. The change in absorbance per min was 
immediately recorded for the initial 3 min at 420 nm. A reference set, without enzyme 
was also run simultaneously. 
(ii) Catalase (CAT, E.C. 1.11.1.6) 
Catalase activity was assayed by the method of Claiborne (1985) as described by Giri 
et al. (1996). The assay mixture consisted of 1.95 ml of 0.05 M potassium phosphate 
buffer pH 7.0, 1 ml of 0.019 M hydrogen peroxide and 0.05 ml homogenate ( 50-100 
|ag protein) in a final volume of 3 ml. Change in absorbance (s = 0.043 mM"' cm'') 
was recorded at 240 nm. 
(iii) Total-SH 
Total SH groups were determined by the method of Sedlak and Lindsay (1968). To 
0.4 ml of 10% tissue homogenate 2.1 ml of 0.1 M Tris- HCl (pH 8.2), 0.5 ml of 10% 
SDS and 0.3 ml of 0.1 M EDTA were added. The reaction was incubated in a boiling 
water bath for 5 min. Then, 0.1 ml DTNB (40 mg/100 ml methanol) was added. After 
54 
30 mill at room temperature, the absorbance was read at 412 nm. A calibration curve 
with different amounts of cysteine (20-160 nmoles) was constructed by the same 
procedure as described above and used to calculate the^^»fSfei»'8HlW)ifi^^ the 
samples. / * / ^ - ^ ^ ^ ^ A A 
i>|Aw«. M*. ) ^ | 
(iv) Lipid Peroxidation ^ $ y^  ) ^h 
Lipid peroxidation in intestinal homogenates was determineo'^j^^c^iitorW^tfically 
by the method of Ohkawa et al (1979). To 0.1 ml of tissue homogenate 1.5 ml of 
20% trichloroacetic acid, 0.2 ml of 8% SDS, 0.7 ml of distilled water and 1.5 ml of 
0.8 % thiobarbituric acid were added and after mixing incubated at 95°C for 20 min. 
After cooling to room temperature and centrifugation at 10,000 rpm for 10 min.the 
absorbance of the supernatant was read at 532 nm against a reagent blank (s = 1.56 x 
10^M"'cm"'). 
7. Transport of ^Pi 
Measurement of phosphate (^ ^Pi) (BARC, India) uptake in brush border membrane 
vesicles was carried at 25°C by rapid filtration technique as described by Yusufi et al. 
(1994) either in the presence or absence of.Naj^radient. Uptake was initiated by 
addition of 30 ^1 incubation medium (NaCl/KCl 100 mM, 5 Mm Tris-HEPES, pH 
7.5, 5 mM K2HPO4 and radioactive substrate ^¥i to 15 i^ l BBM suspension (50-100 
tig protein) and incubated for desired time intervals. At the end of the incubation 
period, the uptake was stopped by rapid addition of 3 ml cold stop solution (delivered 
by a Cornwall Syringe type pipette) containing 135 mM NaCl, 5 mM Tris-HEPES 
with 10 mM sodium arsenate, pH 7.5 and filtered immediately through 0.45 |j,m 
DAWP millipore filters and washed 3 times with the same ice-cold stop solution. 
Correction for non specific binding to filters was made by subtracting from all data 
the value of the corresponding blank obtained by filtration of the incubation medium 
without vesicles. The radioactivity of the dried filters was measured by liquid 
scintillation counting (Pharmacia, Sweden) with 10 ml scintillation fluid (Cocktail T, 
SRL, India). 
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8. Protein Estimation 
Protein was measured by the method of Lowry et al. (1951) with minor modifications 
as described by Yusufi et al. (1983). The samples were made to 0.8 ml with 0.5% 
SDS. Then 2 ml alkaline copper reagent was added and after 10 min incubation at 
room temperature 0.2 ml of 1 N Folin's reagent was added with brisk shaking and 
incubated for 30 min at room temperature. A calibration curve of bovine serum 
albumin (5-80 f^ g) was prepared simultaneously. The blue colour obtained was read at 
660 nm. 
9. Statistical Analysis 
All data are expressed as Mean ± SEM for at least 4-5 different preparations. 
Statistical evaluation was conducted by one-way ANOVA and by unpaired Student's 
/-test using SPSS 7.5 software. A probability level of p<0.05 was selected as 
indicating statistical significance. Most of the changes.between various groups were 
compared with control values for better understanding and clarity. However, specific 
differences and statistical significance between other groups were evaluated 
separately e.g. GM vs. TGM; CP vs. TCP. 
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^tee^n/ l€4t/ 
c€4t<^4€^nfilif>n^ 
Hypothesis I: 
The present investigation was undertaken to test the hypothesis as to Vifhettwr green 
tea (GT), consumed in diet (GTD) or in drinking fluid as extract (GTE) would have 
comparable effects on certain enzymes involved in various pathways of carbohydrate 
metabolism, biomarkers of brush border membrane (BBM) and various parameters of 
antioxidant defense mechanism in different rat tissues. 
Experimental design I: 
Adult male Wistar rats, weighing 150-180 g, fed with a standard pellet diet 
(Aashirwad Industries, Chandigarh) and water ad libitum, were conditioned for one 
week before the start of the experiment (Fig 9). Three groups of rats (6-8 
rats/group/cage) were studied. The rats of Group 1 (Control) received standard diet 
and water for 25 days. The rats of Group 2 (GT extract) were given standard diet and 
green tea extract (3% w/v) in drinking water whereas the rats of Group 3 (GT diet) 
received green tea leaves in diet (3% w/w) and water 250 ml also for 25 days. After 
25 days of tea administration, the rats were sacrificed under light ether anaesthesia. 
Blood samples were collected from non-fasted rats and the liver, kidney and intestine 
were extracted and processed for the preparation of homogenates and BBMVs. All the 
preparations and analyses of various parameters were carried out simultaneously 
under similar experimental conditions to avoid any day-to-day variations. Body 
weights of rats were recorded at the start and completion of the experimental 
procedure. 
Results I: 
Considering reported numerous health benefits of green tea (GT), the effect of green 
tea given in the diet (GT diet) or as tea extract (GT extract) in drinking water was 
determined on certain enzymes involved in various pathways of carbohydrate 
metabolism, biomarkers of renal and intestinal BBM and various parameters of 
antioxidant defense mechanism were determined in different rat tissues used as a 
model for humans. 
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Blood 
Intestine 
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Cortex Medulla 
Figure 9: Experimental Design I 
(ND normal diet; GTE green tea extract; GTD green tea diet). 
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Effect of green tea (GT) on body weisht and serum parameters: 
In general, the rats remained active and alert throughout the study. The daily food and 
fluid intake were similar in control and GT rats (data not shown). The amount of GT 
ingested in the diet or by drinking was approximately the same. As shown in Table 1, 
GT consumption resulted in slight loss of body weight (—11%) compared with 
control rats. Serum glucose, cholesterol and inorganic phosphate (Pi) significantly 
declined whereas phospholipids significantly increased by both forms of GT 
consumption. BUN was slightly lowered (Table 2). The changes caused by GT diet or 
GT extract on various parameters varied in magnitude, but the changes were always in 
the same direction. 
Effect of green tea (GT) on the biomarkers of brush border membrane and 
lysosomes in different tissues: 
The influence of GT consumption was determined on BBM and lysosomal enzymes 
in the liver, intestine and renal cortical and medullary homogenates and in BBM 
vesicles (BBMV) isolated from the renal cortex and intestinal mucosa. The results 
summarized in Table 3 (Fig 10) show that the activities of ALP, GGTase, LAP, 
sucrase and ACPase significantly increased in intestinal homogenates in GT 
compared to control rats. The activities of ALP and ACPase increased whereas 
GGTase and LAP decreased in renal cortical homogenates (Table 4; Fig 11). The 
activities of ALP, GGTase and ACPase also slightly increased, whereas LAP 
decreased in the renal medulla. In liver homogenates ALP and GGTase decreased, 
whereas LAP and ACPase were not affected. Similar to homogenates, the activity of 
ALP decreased, whereas GGTase, LAP and sucrase activities significantly increased 
in intestinal BBM by GT consumption (Table 5a; Fig 10). The activities of ALP and 
GGTase increased, whereas LAP activity significantly lowered in BBMV isolated 
from the renal cortex (Table 5b; Fig 11). 
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Table 1: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on body weight (grams) of rats. 
Groups Before After Vo change 
Treatment Treatment 
Control 166.7 ±5.3 162.5 ±8.53 -2.5 
GT extract 168.8 ±6.3 150 ±7.9 -11.1 
GTdiet 164.3 ± 7.4 145 ±10* -11.7 
Results are expressed as Mean ± SEM for 6-8 rats. 
* Significantly different at p< 0.05 from control 
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Table 2: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on serum parameters 
Groups BUN 
(mg/dL) 
Glucose 
(mg/dL) 
Cholesterol 
(mg/dL) 
Phosphate 
()a,mol/mL) 
Phospholipid 
(Hg/mL) 
Control 25.43±0.36 14L09±4.64 137.60±30.20 L64±0.04 109.40±L96 
GT extract 20.99±0.61* 116.11±5.62* 103.97±2.03 L29 ± 0.04* 162.0±13.8* 
(-17%) (-18%) (-24%) (-21%) (f48%) 
GTdiet 21.09±1.17* 107.78±6.89* 98.35 ± 2.80 1.07±0.14* 141.9±9.30* 
(-17%) (-24%) (-29%) (-35%) (f30%) 
Results are Mean ± SEM of six different samples. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 3: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on brush border membrane enzymes in intestinal and liver homogenates. 
Tissue 
Intestine 
Control 
GT extract 
GT diet 
Liver 
Control 
GT extract 
GT diet 
ALP 
(|xmol/mg 
protein/h) 
1.30 ±0.04 
1.61 ±0.02* 
(+24%) 
1.38 ±0.06 
(+6%) 
1.24 ±0.03 
1.03 ±0.06* 
(-17%) 
1.05 ±0.06* 
(-15%) 
GGTase 
([imol/mg 
protein/h) 
4.46 ±0.14 
6.63 ± 0.26* 
(+49%) 
4.94 ±0.15* 
(+11%) 
2.25 ± 0.08 
1.12±0.13* 
(-50%) 
1.48 ±0.08* 
(-34%) 
LAP 
(|imol/mg 
protein/h) 
7.26 ±0.15 
8.45 ±0.14* 
(+16%) 
9.07 ± 0.09* 
(+25%) 
0.59 ±0.02 
0.63 ± 0.02 
(+7%) 
0.59 + 0.03 
ACPase 
(|i.mol/mg 
protein/h) 
3.50 ±0.08 
3.93 ±0.15* 
(+12%) 
4.97 + 0.15* 
(+42%) 
7.33 + 0.24 
7.07 + 0.35 
(-4%) 
6.89 + 0.50 
(-6%) 
Sucrase 
(jimol/mg 
protein/h) 
22.53 ± 0.88 
24.46+ 1.45 
(+9%) 
25.99+ 1.36 
(H5%) 
Results are Mean + SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 4: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on brush border membrane enzymes in cortical and medullary homogenates. 
Tissues 
ALP 
(|j,niol/mg 
protein/h) 
GGTase 
(|a,mol/mg 
proteln/h) 
LAP 
(fa.mol/mg 
protein/h) 
ACPase 
(|a,mol/mg 
protein/h) 
Cortex 
Control 
GT extract 
GT diet 
Medulla 
Control 
GT extract 
GT diet 
2.93 ±0.14 
3.56±0.11* 
(+22%) 
3.35 ±0.08* 
(+14%) 
1.71+0.1 
2.07 + 0.18* 
(+21%) 
1.71+0.08 
40.52 + 0.56 
37.42 + 0.65* 
(-8%) 
33.54+1.29* 
(-17%) 
10.59 + 0.41 
12.64 + 0.72* 
(+19%) 
10.65 + 0.54 
(+0.6%) 
4.75 + 0.32 
3.18 + 0.27* 
(-33%) 
2.91+0.19* 
(-39%) 
13.04 + 0.81 
7.19 + 0.22* 
(-45%) 
7.44 + 0.22* 
(-43%) 
6.04 + 0.14 
6.40 + 0.22 
(+6%) 
7.93 + 0.33* 
(+31%) 
6.29 + 0.26 
7.53 + 0.2* 
(+20%) 
8.06 + 0.39* 
(+28%) 
Results are Mean + SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 5a: Effect of green tea (GT) consumption via drinking fluid (GT extract) or 
diet (GT diet) on BBM enzymes in BBMV isolated from small intestine. 
Groups ALP 
(|imol/mg 
protein/h) 
GGTase 
(|xmol/mg 
protein/h) 
LAP 
(}j.mol/mg 
protein/h) 
Sucrase 
(|a,mol/mg 
protein/h) 
Control 8.51 ±0.40 
GT extract 7.56 ± 0.52 
(-11%) 
32.09 ± 0.96 
40.06 ±0.60* 
(+25%) 
49.98 ±4.51 196.60 ±12.63 
90.33 ± 2 . 3 1 * 273.15 ±21.80* 
(+81%) (+39%) 
GTdiet 3.44 + 0.12* 36.53+1.36* 97.92 ±1.95* 425.96 ± 72.53* 
(-60%) (+14%) (+96%) (+117%) 
Table 5b: Effect of green tea (GT) consumption via drinking fluid (GT extract) or 
diet (GT diet) on BBM enzymes in BBMV isolated from renal cortex. 
Groups ALP 
(|imoi/mg 
protein/h) 
GGTase 
(|j,mol/mg 
protein/h) 
LAP 
((xmol/mg 
protein/h) 
Control 6.58 + 0.24 430.76 ±2.19 48.16 ±4.57 
GT extract 7.47 ±0.36 570.17 ±26.4* 23.77 ±2 .21* 
(+14%) (+32%) (-51%) 
GTdiet 9.1 + 0.24* 463.29 + 22.72 27.85 ± 0.98* 
(+38%) (+8%) (-42%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
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BBM. 
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Figure 11: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on (A) ALP (B) GGTase (C) LAP in Cortex Homogenate and BBM. 
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Effect ofereen tea (GT) on the enzvmes of carbohydrate metabolism in different rat 
tissues: 
The effect of green tea consumption was determined on the activities of carbohydrate 
metaboHsm enzymes in the intestine, Uver and kidney (Tables 6 and 7). The activity 
of hexokinase slightly increased in the liver (+25%) and renal medulla (+20%) when 
GT was given in the diet, and in the intestine (+18%) when given in the drinking 
water but did not change in the renal cortex with either method. However, the activity 
of LDH markedly increased in the intestine and kidney tissues but onl^ slightly 
increased in the liver. The effect on LDH activity was moret^xpressive in GT extract 
than in GT diet compared with control rats in the intestine (+672%) and renal cortex 
(+111%). The activity of MDH, an enzyme of TCA cycle was similarly enhanced in 
the intestine (+31%)) and renal cortex (+67%) to a greater extent by GT extract than 
GT diet but was slightly lowered in the renal medulla (-18%). 
The effect of GT was also determined on the activities of enzymes involved in 
gluconeogenesis and the HMP-shunt pathway (Tables 8 and 9). The activities of 
G6Pase, FBPase, G6PDH and ME changed similarly with the GT-extract and the Gl -
diet in all the tissues. The activity of G6Pase significantly increased in the intestine 
(+34 to +42%), renal cortex (+13 to +16%) and medulla (+27 to +42%) but decreased 
in the liver (-13 to -20%). The activity of FBPase also increased but to much lesser 
extent than G6Pase in these tissues. The activity of FBPase similarly to G6Pase was 
lowered in the liver. The activity of G6PDH (HMP-shunt) significantly decreased in 
the intestine (-40 to -48%); liver (-73 to -79%) and renal medulla (-32 to -58%) but 
profoundly increased in the renal cortex (+121 to +146%). The activity of ME, which 
is a source of cellular NADPH together with G6PDH significantly decreased in all 
tissues except in renal cortex. It should be noted that the activities of various 
metabolic enzymes studied in the liver altered in a narrow range except G6PDH, 
which was significantly lowered by GT consumption. 
Effect ofsreen tea (GT) on activities of antioxidant enzvmes and related parameters 
of oxidative stress: 
Because GT exert its biological effects primarily by perturbation of the antioxidant 
defense system, the activities of SOD and catalase and related parameters of oxidative 
stress were determined in control and GT rats. It was observed that GT given in the 
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Table 6: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on the activity of metabolic enzymes in intestinal and liver homogenates. 
Tissue 
Intestine 
Control 
GT extract 
GT diet 
Liver 
Control 
GT extract 
GT diet 
Hexokinase 
(|j,mol/mg protein/h) 
116.92 ±3.58 
138.02 ±6.36* 
(+18%) 
117.68 ±5.25 
(+0.65%) 
30.08 ±1.03 
30.71 ±1.13 
(+2%) 
37.68+1.72* 
(+25%) 
LDH 
()j,mol/mg protein/h) 
1.13 + 0.27 
8.72 ± 0.26* 
(+672%) 
4.98 ± 0.34* 
(+341%) 
35.85 + 2.41 
40.41 ± 0.99 
(+13%) 
43.13+1.76* 
(+20%) 
MDH 
(|imol/mg protein/h) 
21.52+1.29 
28.11+4.24 
(+31%) 
22.41 ± 1.38 
(+4%) 
3.78 + 0.24 
3.97 + 0.38 
(+5%) 
4.58 + 0.14* 
(+21%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control. 
Values in parentheses represent percent change from control. 
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Table 7: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on the activity of metabolic enzymes in cortical and medullary 
homogenates. 
Tissue Hexokinase 
(p,mol/mg protein/h) 
LDH 
(ixmol/mg protein/h) 
MDH 
(|j.mol/mg protein/h) 
Cortex 
Control 
GT extract 
GT diet 
Medulla 
Control 
GT extract 
GT diet 
86.88 ± 2.09 
82.39 ±2.34 
(-5%) 
80.92 ±1.46* 
(-7%) 
66.60 ±1.191 
70.13 ±1.80 
(+5%) 
80.18 ±1.87* 
(+20%) 
6.46 ±0.56 
13.6 ±1.22* 
(+111%) 
7.23 ± 0.46 
(+12%) 
11.69 + 0.60 
15.89 ±0.86* 
(+36%) 
15.83 + 0.96* 
(+35%) 
23.26 + 0.90 
38.92 ±5.55* 
(+67%) 
33.43 + 2.66* 
(+44%) 
26.99 + 0.65 
22.24+ 1.85* 
(-18%) 
26.17+1.25 
(-3%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 8: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on the activity of metabolic enzymes in intestinal and liver homogenates. 
Tissue G6Pase (|j,mol/mg 
protein/h) 
FBPase 
(fimol/mg 
protein/h) 
G6PDH 
(|a.mol/mg 
protein/h) 
ME 
(|imol/mg 
protein/li) 
Intestine 
Control 
GT extract 
GT diet 
Liver 
Control 
GT extract 
GT diet 
1.96 ±0.05 
2.79 ±0.17* 
(±42%) 
2.62 ±0.13* 
(±34%) 
0.15 ±0.002 
0.12 ±0.002* 
(-20%) 
0.13 ±0.005* 
(-13%) 
2.70 ±0.09 
2.89 ±0.09 
(±7%) 
2.81 ±0.06 
(±4%) 
0.85 ± 0.02 
0.77 ±0.02* 
(-9%) 
0.75 ± 0.03* 
(-12%) 
1.08 ±0.05 
0.56 ±0.13* 
(-48%) 
0.65 ±0.08* 
(-40%) 
3.23 ± 0.21 
0.87±0.11* 
(-73%) 
0.69 ±0.11* 
(-79%) 
0.68 ± 0.09 
0.35 ±0.06* 
(-49%) 
0.42 ±0.05* 
(-38%) 
0.69 ±0.05 
0.60 ± 0.06 
(-13%) 
0.58 ±0.07 
(-16%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
70 
Table 9: Effect of green tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on the activity of metabolic enzymes in cortical and medullary 
homogenates. 
Tissue 
Cortex 
Control 
GT extract 
GT diet 
Medulla 
Control 
GT extract 
GT diet 
G6Pase 
(|a.mol/mg 
protein/h) 
0.56 ±0.01 
0.65 ± 0.02* 
(+16%) 
0.63 ±0.01* 
(+13%) 
0.45 ±0.01 
0.57 + 0.02* 
(+27%) 
0.64 ± 0.02* 
(+42%) 
FBPase 
(|j,moi/mg 
protein/h) 
2.57 + 0.05 
2.85 ± 0.06* 
(+11%) 
2.72 + 0.15 
(+6%) 
1.76 + 0.04 
2.08 ±0.12* 
(+18%) 
2.05 ± 0.06* 
(+17%) 
G6PDH 
((xmol/mg 
protein/h) 
0.24 ± 0.02 
0.53 ± 0.03* 
(+121%) 
0.59 + 0.01* 
(+146%) 
0.57 ±0.05 
0.24 ± 0.04* 
(-58%) 
0.39 ±0.01 
(-32%) 
ME 
(|j.mol/mg 
protein/h) 
0.45 ± 0.08 
0.44 ± 0.06 
(-2%) 
0.42 ± 0.09 
(-7%) 
1.53±0.11 
1.19±0.15 
(-22%) 
0.86 ±0.09* 
(-44%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 10: Effect ofgreen tea (GT) consumption via drinking fluid (GT extract) or diet 
(GT diet) on/^nzyraic and non-^nzymic antioxidant parameters in intestinal and li\er 
homogenat4s>--^ 
Tissue 
Intestine 
Control 
GT extract 
GT diet 
LPO 
(nmol/gm 
tissue) 
61.42 ±2.60 
87.20 ±6.75* 
(+42%) 
105.60 ±7.04* 
(+72%) 
Total-SH 
(|a.mol/gm 
tissue) 
1.88 + 0.05 
2.00 ± 0.08 
(+6%) 
2.45 ± 0.08* 
(+30%) 
SOD 
(Units/mg 
protein) 
7.04 ± 0.63 
4.73 ± 0.40* 
(-33%) 
3.40 ± 0.30* 
(-52%) 
Catalase 
(jimol/mg 
protein/min) 
2.90 + 0.55 
6.30 + 0.45* 
(+117%) 
10.79+1.23* 
(+272%) 
Liver 
Control 408.20 + 43.20 10.67 ±0.40 
GT extract 265.4+14.4* 7.60 + 0.25* 
(-35%) (-29%) 
GTdiet 216.01 + 13.8* 6.89 + 0.59* 
(-47%) (-35%) 
82.90+1.94 
72.90+1.40* 
(-12%) 
75.80+1.30* 
(-9%) 
13.42 + 2.15 
36.75 + 5.90* 
(+174%) 
42.88 + 2.37* 
(+220%) 
Results are mean + SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 11: Effect of gr^rttea (GT) conWnption via drinking fluid (GT extract) or diet 
(GT diet) on ^zymi t and non-ei^ymic' antioxidant parameters in cortical and 
medullary hoil Snates. 
Tissue 
Cortex 
Control 
GT extract 
GT diet 
Medulla 
Control 
GT extract 
GT diet 
LPO 
(nmol/gm 
tissue) 
272.60 ± 20.43 
228.00 ±16.00 
(-16%) 
171.7 ±21.90* 
(-37%) 
73.26 ±5.58 
131.7± 10.55* 
(+80%) 
89.31 ±2.00* 
(+22%) 
Total-SH 
()a,mol/gm 
tissue) 
7.49 ±0.38 
5.73 ± 0.22* 
(-24%) 
6.42 ± 0.75 
(-14%) 
2.90 ± 0.04 
3.64 ±0.01* 
(+26%) 
4.66 ± 0.23 
(+61%) 
SOD 
(Units/mg 
protein) 
12.31 + 1.24 
18.2 ±1.60* 
(+48%) 
21.31 + 1.5* 
(+73%) 
22.92 ± 0.65 
28.6 ± 1.82* 
(+25%) 
36.9 + 0.75* 
(+61%) 
Catalase 
(|a,mol/mg 
protein/min) 
108.40 + 9.80 
129.90 + 5.20 
(+20%) 
135.9 + 6.90 
(+25%) 
139.40 + 7.34 
104.5 + 3.88* 
(-25%) 
132.03 + 5.42* 
(-5%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different at p< 0.05 from control by one way ANOVA. 
Values in parentheses represent percent change from control. 
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diet or in drinking water caused similar alterations in these parameters. Lipid 
peroxidation measured as the level of malondialdehyde was significantly lowered in 
the liver and renal cortex but significantly enhanced in the intestine (Table 10) and 
renal medulla by GT consumption. Total SH levels were significantly decreased in the 
liver and renal cortex but significantly increased in the renal medulla in GT compared 
with control rats. The activity of SOD significantly decreased in the intestine and liver 
but significantly increased in the renal cortex and medulla (Table 11). In contrast, 
catalase activity markedly increased in the intestine and liver but did not change in 
renal tissues by GT ingestion. 
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DISCUSSION 
Tea is the most consumed beverage in the world, aside from water. Studies carried out 
in the laboratories and on animals have suggested that green tea in particular has 
extensive health benefits. Most of these effects are considered to be due to the 
presence of chiefly tea catechins, polyphenolic compounds (Ahmad and Mukhtar, 
1999) that exhibit antioxidative, anti-inflammatory, anticarcinogenic, 
antiarteriosclerotic and antibacterial effects (Alschuler, 1998). We propose that green 
tea polyphenols and other constituents cause specific adaptive alterations in the 
cellular metabolism of certain tissues and thus improve their functioning. To address 
this proposal, the rats were given GT, in the diet or in drinking water and the activities 
of various enzymes involved in carbohydrate metabolism, antioxidant defense system, 
and BBM were determined in the intestine, liver and renal tissues. 
In general, GT consumption resulted in slight loss ^f body weight that was associated 
with lowering of blood glucose, cholesterol and Pi. These observations are in partial 
agreement with some of the previous reports in humans and animals (Imai and 
Nakachi, 1995). Oral administration of GT has been shown to decrease plasma total 
cholesterol and blood triacylglycerols and serum glucose in fasted and non-fasted 
human subjects (Sabu et al, 2002; Raederstoff e/ al, 2003). The suppressive effects 
of GT catechins on the postprandial levels of triacylglycerols £ind cholesterol have 
also been reported in humans (Unno et al, 2005). Taken together, these observations 
may be responsible for body weight loss and in lowering the incidence of 
cardiovascular diseases (Kao et al, 2000; Unno et al, 2005). 
The present results further demonstrate that GT causes selective adaptive alterations 
in the activities of certain enzymes involved in glycolysis, TCA cycle, 
gluconeogenesis and Hexose monophosphate (HMP)-shunt pathway in the intestine, 
liver and renal cortex and medulla. The activities of hexokinase except in renal cortex 
and that of LDH variably increased. The activities of MDH, a TCA cycle enzyme, 
except in renal medulla, were also increased in the same manner. These observations 
suggest that GT consumption enhanced glucose degradation in the intestine, liver and 
kidney albeit to different extents in these tissues. The profound increase of LDH 
activity in the intestine and renal medulla are suggestive ofuincrease in anaerobic 
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glycolysis as a major source of energy because these tissues function in aJow oxygen 
environment (Farooq et al, 2006). Further, GT consumption resulted in an increase in 
the activities of G6Pase and FBPase in the intestine and renal tissues, indicating that 
the production of glucose by gluconeogenesis was also enhanced in these tissues. 
However, the activities of these enzymes significantly decreased in the liver. Thus the 
effect of GT on glucose degradation and its production appear to be tissue specific. 
The effect of GT on carbohydrate metabolism has not been studied in detail in major 
tissues except in the liver and adipocytes. GT consumption increased glucose 
metabolism in adipocytes (Kao et al, 2000; Broadhurst et al, 2000), whereas hepatic 
glucose production was reported to be inhibited by GT, leading to lower blood 
glucose levels (Waltner-Law et al, 2002). A GT polyphenol, epigallocatechin-3-
gallate (EGCG) was reported to be insulin mimetic in that it lowered blood glucose in 
obese Zucker rats (Hii and Howell, 1984; Ahmad et al, 1989). Moreover, Waltner-
Law et al (2002) reported a significant decrease in the expression of genes that 
control gluconeogenesis such as phosphoenol pyruvate carboxykinase and G6Pase 
genes in liver cells. The observed decrease in the activities of gluconeogenic enzymes 
(G6Pase and FBPase) in liver homogenates is compatible with these observations. 
In contrast to the enzymes of glycolysis, TCA cycle and gluconeogenesis, the activity 
of G6PDH (HMP shunt) and malic enzyme were differentially altered by GT. The 
activity of G6PDH significantly declined in the intestine, liver and renal medulla, but 
profoundly increased in the renal cortex. The activity of malic enzyme was selectively 
decreased in the intestine and renal medulla but not affected in the liver and renal 
cortex. These enzymes act to produce cellular NADPH that play an important role in 
reducing anabolic pathways and antioxidant defense mechanism. The increased 
activity of G6PDH in the renal cortex might support reducing anabolic reactions e.gr"' 
»wrta»i*»M»*T«Li V**""*"****" 
lipid biosynthesis, and improve the antioxidant defense mechanism to lower oxidative 
damage. In contrast, lower activities of G6PDH and ME in the intestine, liver and 
renal medulla may have resulted in lower cholesterol synthesis and thus lower blood 
cholesterol. GT has been shown to increase energy expenditure and fat oxidation in 
humans (Dulloo et al, 1999; Diepvens et al, 2005). The observed increase in 
oxidative metabolism (mitochondrial enzymes) and increased glucose production by 
gluconeogenesis is in partial agreement with these reports. Phosphate (Pi) is an 
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essential component of intermediary metabolisn^ enei4^Conservatiori'*as''Al^^ 
biosynthesis of cellular membranes (as phospholip^ '^'^ other^ jrrff^/ant 
biomolecules such as NAD, NADP and various RNAs. The deCTea^^Sehiiti Pi may 
suggest its overutilization in these processes. Moreover, Pi may have been ponverted 
to phospholipids as indicated by higher serum phospholipids levels needed for much 
required synthesis of membranes such as the endoplasmic reticulum, mitochondria 
and plasma membrane to support higher metabolic activities. 
Most beneficial health effects ascribed to GT are considered to be mediated by 
potential antioxidant properties of its constituents that scavenge free radicals and 
reduce oxidative damage (Augustyniak et al, 2005). Several lines of evidence suggest 
that prooxidant and antioxidant actions of plant polyphenols may be important 
mechanisms for their anticancer properties (Azam et al, 2004). Reactive oxygen 
species (ROS) are normal byproducts of aerobic metabolism. Most intracellular ROS 
are generated via mitochondrial electron transport, although other normal biological 
processes contribute. It has been reported that GT exerts its biological effects on the 
basis of the redox state of a particular cell/tissue (Denu and Tanner, 1998; Robinson 
et al, 1999) and according to the level of GT polyphenols accumulated in the tissues 
(Kim et al, 2000). To maintain proper redox balance, many defense systems have 
evolved. A major cellular defense against ROS is provided by superoxide dismutase 
(SOD) and catalase, which together convert superoxide radicals first to H2O2 and then 
to water and molecular oxygen. Other enzymes e.g. glutathione peroxidase (GSH-Pxl 
use the thiol reducing power of glutathione to reduce oxidized lipids and protein 
targets of ROS. It has been reported that GT causes.increase in the activities of 
catalase, SOD, GSH-Px and GSH-transferase and reduces lipid peroxidation in the 
liver and kidney (Leena and Balaraman, 2005) The present resuhs demonstrated that 
GT consumption increased LPO in the intestine and renal medulla but markedly 
decreased in the liver and renal cortex. The activities of SOD and catalase were also 
affected |l^ <'^ fe\w by GT consumption in these tissues. The activity of SOD was 
significantly lower in the intestine and liver but increased in the renal cortex and 
medulla. In contrast, the activity of catalase profoundly increased in the intestine and 
liver and to a lesser extent in the renal cortex but decreased in the renal medulla. 
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The present results imply that the biological defense systemjvas perturbed Jby ^ T 
consumption as a result of free radical scavenging properties of its polyphenols and 
other active constituents. The profound lowering of LPO in the renal cortex and liver 
in GT compared with control rats suggests that oj^dative damage)even under normal 
physiologic conditions was significantly lowered by GT-constituents. The reduction 
in LPO in the liver was associated with a profound increase in catalase activity, 
whereas in the renal cortex it appeared to be 4uc tcr increases in catalase and SOD 
activities. In contrast, an increase in LPO in the intestine was associated with a 
marked decrease of SOD activity although there was a significant increase in catalase 
activity. However, in the renal medulla enhanced LPO can be attributed to decreased 
catalase activity. The cellular response to oxidative stress in the intestine and renal 
medulla compared with the liver and renal cortex might have been due to the nature of 
metabolic activities in these tissues. Although the liver and renal cortex have higher 
oxidative metabolism, anaerobic metabolism is more prevalent in the intestine and 
renal medulla due to lower oxygen tension in these tissues. The differential effects of 
GT consumption on various parameters in different tissues can also be attributed to 
the presence of active tea components after digestion / absorption / extraction or due 
to differential accumulation in various tissues. However, these observations clearl> 
demonstrate that GT consumption activates the antioxidant defense system in all 
tissues. jGTMnduced antioxidant defense mechanism in the intestine and liver 
''appeared to be largely catalase mediated, whereas in renal tissues it was 
predominantly SOD mediated^Jlhie activities of certain marker enzymes except LAP 
in the kidney and ALP in th( intestine were also increased significantly in BBMs, 
which is major target of oxi lative damage. It is very likely that the increase in 
activities of these enzymes vas due to protection provided by GT polyphenol-
induced lowering of oxidati e^ damage to membranes compared with non-GT-
consuming control rats. 
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Hypothesis II: 
To determine whether green tea (GT) consumption would protect against gentamicin 
(GM) induced nephrotoxic and other adverse effects in major rat tissues. 
Experimental designll: 
Adult male Wistar rats (8 rats/group) weighing 150-180 g fed with standard rat chow 
(Aashirwaad Industries, Chandigarh, India) and water ad libitum were conditioned 
for one week before the start of the experiment (Fig 12). Initially two groups of rats 
entered the study after acclimatization. They were fed on a normal rat chow diet with 
one group consuming water (control) and the other consuming GT extract (3% w/v) in 
drinking water for 25 days as described in "Experimental design I". After 15 days the 
rats were subdivided into two groups each (8 rats/group) and continued to receive 
their respective drinking fluids. Nephrotoxicity was induced by intraperitoneal 
administration of GM (80 mg/kg bwt/day), in 0.9% saline daily for 10 days to one of 
the sub-group designated as GM and TGM. The other sub-group from each group 
received an equivalent volume of normal saline for the same period. The rats were 
sacrificed 24 hours after the last injection under light ether anesthesia. Blood samples 
were collected and the liver, kidney and intestine were extracted and processed for the 
preparation of homogenates and BBMVs. All the preparations and analyses of various 
parameters were carried out simultaneously under similar experimental conditions to 
avoid any day-to-day variations. Body weights of rats were recorded at the start and 
completion of the experimental procedure. 
Results II: 
To address the above hypothesis, the effect of green tea was determined in detail on 
the biomarkers of nephrotoxicity in the serum and biomarker enzymes of oxidative 
damage, brush border membrane and carbohydrate metabolism in various rat tissues, 
e.g. intestine, liver and kidney. Na-dependent transport of Pi was determined in renal 
BBM to assess the role of kidney in the conservation of Pi under different 
experimental conditions. 
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Figure 12: Experimental Design II 
(ND normal diet; GT green tea; GM gentamicin; TGM green tea + GM;I I I I I 
= i.p. administration of GM for 10 days) 
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In general, there was no significant difference in body weight and food intake 
between GM administered and control rats. However a slight loss of body weight 
(-10%) was recorded in rats consuming GT alone and in combination with GM 
(Table 1). 
Effect of2reen tea (GT) on sentamicin (GM)-induced nephrotoxicity parameters in 
serum: 
GM treatment to control rats resulted in significant increase in serum creatinine (+ 
52%), blood urea nitrogen (BUN, + 36%), cholesterol (+21%) and phospholipids (PL. 
+122%) but decrease in inorganic phosphate (-38%) and glucose (-18%) compared to 
control rats (Table 2). GT, however had no effect on serum creatinine whereas BUN 
(-42%) conspicuously decreased. GT caused significant decrease in serum glucose (-
21%), cholesterol (-29%) and inorganic phosphate (-11%) but phospholipids 
significantly increased (+56%) after GT consumption. Prolonged GT consumption (25 
days) along with GM treatment (TGM) for 10 days significantly decreased the levels 
of serum creatinine and BUN as compared to animals treated with GM alone 
indicating reduction in GM induced nephrotoxicity. GM elicited increase in serum 
cholesterol was also lowered. lkjwyVyr,Serum glucose remained depressed but serum 
Pi and phospholipids increased (Table 2). 
Effect of ereen tea (GT) on sentamicin (GM)-induced alterations on biomarker 
enzymes ofBBM and lysosomes: 
To assess the structural integrity of various organelles, e.g. the plasma membrane 
(BBM) and lysosomes, the effect of GM and GT was determined on biomarker 
enzymes of BBM and lysosomes in the homogenates of intestine, liver and renal 
cortex and medulla and isolated BBM preparations from renal cortex and small 
intestine. 
a) Effect of gentamicin (GM) and green tea (GT) on biomarkers of BBM and 
lysosomes in the homogenates of different tissues: 
The activities of alkaline phosphatase (ALP), y-glutamyl transferase (GGTase), 
leucine aminopeptidase (LAP), sucrase and acid phosphatase (ACPase) were 
determined under different experimental conditions in the homogenates of various 
81 
Table 1: Effect of green tea (GT) consumption on body weight (grams) of rats 
with/without gentamicin (GM) treatment. 
Groups Before Treatment After Treatment % change 
Control 154.2 ±11.9 150 ± 10.2 -2.7 
GM 158.3 ±8.3 150 ±10.2 -5.2 
GT 
TGM 
160 ±6.1 
156.6 ±4.4 
145 ±5* -9.4 
-10.6 
^ • ^ H I.J 
Results are expressed as Mean ± SEM 
* Significantly different at p< 0.05 from control by one way ANOVA. 
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Table 2: Effect of green tea (GT) consumption on several serum parameters 
with/without gentamicin (GM) treatment. 
Groups Creatinine BUN Glucose Cholesterol Phosphate Phospholipid 
(mg/dL) (mg/dL) (mg/dL) (mg/dL) ((imol/mL) (^g/mL) 
Control 1.16 ±0.05 17.76 ±0.58 64.6 ±7.04 145.3 ±3.75 2.7 ± 0.35 118 ±23 
G M 1.76 ±0.04* 24.2 ±0.4* 52.8 ±4.33 175.6 ±3.8* 1.68 ±0.2* 261.8 ±26.2* 
(+52%) (+36%) (-18%) (+21%) (-38%) (+122%) 
G T 1.09 ± 0 10.35 ±1.75* 51.3 ±1.75 103.7 ±3.52* 2.4 ± 0.25 184.4 ±17.05* 
(-6%) (-42%) (-21%) (-29%) (-11%) (+56%) 
T G M 1.07±0.1*t 13.22 ±1.25*t 55 ± 3.0 98.35 ± 2.8*t 2.17 ±0.04 403.4 ±36.6*t 
(-8%) (-26%) (-15%) (-32%) (-20%) (+242%) 
Results are Mean ± SEM of six different samples 
* Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control 
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tissues (Tables 3 and 4). GM treatment to control rats caused significant decrease in 
the activities of ALP, GGTase and LAP in renal cortex and medulla as GM is known 
to damage the kidney (Banday et al, 2008a). However, the activities of these 
enzymes and sucrase (a biomarker of intestinal BBM) significantly increased in 
intestinal homogenate as reportediaarlicr (Fardoq et al, 2007). GM treatment caused r^ 
small increase in BBM enzymes in liver homogenates. GT consumption, however 
affected these enzymes differentially in different tissues (Tables 3 and 4; Fig 13 and 
14). The activities of ALP (+34%), GGTase (+25%), LAP (+27%) and sucrase 
(+44%) significantly increased by GT in the intestine. The activity of ALP (+14%) 
increased but GGTase (-9%) and LAP (-25%) decreased by GT in the renal cortex. 
The activities of ALP (+18%) and GGTase (+24%) increased whereas LAP (-11%) 
decreased in the medulla. However, except the decrease of GGTase (-24%) activity, 
ALP and LAP activities were not altered in the liver by GT. GT consumption in 
combination with GM treatment resulted in the reversal of GM-induced alterations in 
various enzyme activities in the renal cortex and medulla. The activities of ALP. 
GGTase and LAP were significantly higher in TGM compared to GM alone treated 
rats in the kidney. Since GT caused increase in all BBM enzyme activities in the 
intestine, its consumption by GM rats resulted in further improvement of BBM 
enzyme activities in intestinal homogenates. The activities of GGTase and LAP were 
also higher in liver homogenates in TGM compared to GM rats. It appeared from the 
results that GT produces an overall improvement in BBM enzyme activities in GM 
treated rats in most tissues. The activity of ACPase (a lysosomal enzyme) variably 
decreased by GM treatment in all the tissues studied. In contrast, GT increased 
ACPase activity in the intestine, renal cortex and medulla/As a resulp ACPase 
activity remained significantly higher in various tissues in TGN^^mpared to GM rats 
(Tables 3 and 4; Fig 13 and 14). 
b) Effect of green tea (GT) on gentamicin (GM)-mduced alterations on brush 
border membrane enzymes in isolated BBM preparations: 
The effect of GM/GT on BBM marker enzymes was fiarther analyzed in BBM 
preparations isolated from the intestine and renal cortex. The data summarized in 
Tables 5 and 6, showed a similar activity pattern of BBM enzymes as observed in 
intestinal and cortical homogenates. However, the magnitude of effects was different. 
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Table 3: Effect of green tea (GT) consumption on brush border membrane enzymes 
in intestinal and liver homogenates with/without gentamicin (GM) treatment. 
Tissue 
Intestine 
Control 
GM 
GT 
TGM 
Liver 
Control 
GM 
GT 
TGM 
ALP 
(^ .moi/mg 
protein/h) 
0.82 ± 0.02 
1.13 ±0.06* 
(+38%) 
1.1 ±0.06* 
(+34%) 
1.04 + 0.04* 
(+27%) 
0.64 ± 0.05 
0.63 ± 0.04 
(-2%) 
0.56 ± 0.005* 
(-13%) 
0.53 ± 0.03 
(-17%) 
GGTase 
()j.mol/mg 
protein/h) 
1.8 + 0.03 
1.93 + 0.03* 
(+7%) 
2.25 + 0.006* 
(+25%) 
1.8 + 0.02 
3.4 + 0.07 
3.98 + 0.2* 
(+17%) 
2.6 + 0.22* 
(-24%) 
5.2 + 0.04*t 
(+53%) 
LAP 
(|a,mo!/mg 
protein/h) 
3.7 + 0.1 
4.3 + 0.2* 
(+16%) 
4.7 + 0.2* 
(+27%) 
4.7 + 0.16* 
(+27%) 
0.5 + 0.01 
0.53 + 0.02 
(+6%) 
0.53 + 0.03 
(+6%) 
0.6 + 0.04 
(+20%) 
ACPase 
((j.mol/mg 
protein/h) 
1.44 + 0.02 
1.4 + 0.025 
(-3%) 
1.75 + 0.08* 
(+22%) 
1.8 + 0.06* 
(+25%) 
2.3 ± 0.08 
2.1+0.06 
(-9%) 
2.14 + 0.02 
(-7%) 
2.33 + 0.03 
Sucrase 
(lamol/mg 
protein/h) 
12.6 + 0.7 
16.8 ±0.65* 
(+33%) 
18.20 + 0.2* 
(+44%) 
18.2 + 0.56* 
(+44%) 
Results are Mean + SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
85 
Table 4: Effect of green tea (GT) consumption on brush border membrane enzymes 
in cortical and medullary homogenates with/without gentamicin (GM) treatment. 
Tissue 
Cortex 
Control 
GM 
GT 
TGM 
ALP 
(|j,mol/mg 
protein/h) 
6.8 ± 0.3 
5.0 ±0.22* 
(-26%) 
7.74 ± 0.03 
(+14%) 
7.15±0.34t 
(+5%) 
GGTase 
(|u,mol/mg 
protein/h) 
40.3 ±1.56 
32.7 ±2.8* 
(-19%) 
36.8 ±4.2 
(-9%) 
36.5 ±1.56 
(-9%) 
LAP 
(|xmol/mg 
protein/h) 
5.2 ± 0.2 
3.4 ±0.08* 
(-35%) 
3.9 ±0.3* 
(-25%) 
4.1 ±0.15* 
(-21%) 
ACPase 
(|imol/mg 
protein/h) 
3.46 ±0.03 
2.8 ±0.06* 
(-19%) 
3.62 ±0.1 
(+5%) 
3.77±0.15t 
(+9%) 
Medulla 
Control 
GM 
GT 
TGM 
4.0 ±0.3 
3.5 ±0.2 
(-13%) 
4.7 ± 0.6 
(+18%) 
4.9±0.3*t 
(+23%) 
6.3 + 0.13 
5.2 ±0.24* 
(-18%) 
7.8 ±0.58* 
(+24%) 
9.1±0.6*t 
(+44%) 
5.7 + 0.1 
4.6 ±0.2* 
(-19%) 
5.1 ±0.0* 
(-11%) 
4.2 ±0.1* 
(-26%) 
2.51 ±0.01 
2.2 ±0.03* 
(-12%) 
2.97 ±0.05* 
(+18%) 
2.7 ± 0.07t 
(+8%) 
Results are mean ± SEM of 3-4 different preparations. 
•Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control 
86 
The activities of ALP (+28%), LAP (+21%) and sucrase (+69%) increased to a much 
greater extent but GGTase (-18%) decreased by GM treatment in intestinal BBM 
(Table 5; Fig 13). Except ALP, (which was decreased), the activity of GGTase 
(+24%), LAP (+39%) and sucrase (+82%) profoundly increased by GT ingestion. The 
activities of BBM enzymes except ALP were significantly enhanced upon drinking 
GT by GM treated rats as compared to GM alone rats. The enzyme activities were 
similarly lowered by GM treatment in cortical BBM as observed in cortical 
homogenates (Table 6; Fig 14). GT significantly increased ALP and GGTase but LAP 
activity decreased in the renal BBM. The activities of ALP and GGTase were 
significantly higher in GT extract consuming rats as compared to control rats and 
much higher than GM only treated rats. The decrease in LAP activity was to some 
extent arrested by GT with GM treatment and the activity was tended to be near 
control values. Thus GT consumption appeared to lowpr the-se^terity of^M effect on 
BBM enzymes. 
c) Effect of green tea (GT) consumption on gentamicin (GM) induced alterations in 
Na-gradient dependent transport of ^^Pi in BBMV(s) isolated from renal cortex: 
The bulk of filtered Pi in the kidney is reabsorbed by its proximal tubule. The Na-
gradient dependent {Na outside (Nao)>Na inside (Naj)} transport of Pi in renal proximal 
tubule across its luminal brush border membrane (BBM) is an initial and regulatory 
step. The Pi is transported by secondary active transport mechanism, requires 
expenditure of energy in the form of ATP that is generated by cellular metabolism. 
The uptake of Pi was determined in the presence and absence of Na-gradient in the 
initial uphill phase (30 s) and after equilibrium (120 min) in BBM preparations. The 
rate of concentrative uphill uptake of ^Pi in the presence of a Na-gradient (NaCl in 
the medium) was markedly decreased in GM treated compared to control rats (Table 
7; Fig 15). However, the uptake of ^^ Pi at the equilibrium phase (120 min) when 
Nao=Nai was not significantly different between the two groups. Also Na-independent 
uptake (in the absence of a Na gradient, when NaCl in the medium was replaced by 
KCl where Ko> Kj) of ''^ Pi at 30 s and 120 min was also not affected by GM 
treatment indicating specific alteration only when Na-gradient was present. The net 
uptake of Pi (Table-7c; Fig 15) was also significantly decreased. In contrast, 
dietary GT supplementation alone significantly increased the uptake of ^^ Pi in 
the uphill phase (30 s) in the presence of a Na-gradient. When GM treatment was 
87 
Table 5: Effect of green tea (GT) consumption on brush border membrane enzymes 
in BBMV isolated from small intestine with/without gentamicin (GM) treatment. 
Groups 
Control 
GM 
GT 
TGM 
ALP 
(|imol/mg 
protein/h) 
3.6 ±0.13 
4.6 ±0.6* 
(+28%) 
3.0±0.1* 
(-17%) 
3.1±0.1*t 
(-14%) 
GGTase 
(l^ mol/mg 
protein/h) 
9.14 ±0.22 
7.5 ±0.2 
(-18%) 
11.32 ±0.3* 
(+24%) 
11.2±1.3*t 
(+23%) 
LAP 
(fxmol/mg 
protein/h) 
34.6+1.6 
42+1.9* 
(+21%) 
48.2 ± 0.6* 
(+39%) 
47 + 3.2* 
(+36%) 
Sucrase 
(|j,mol/mg 
protein/h) 
127.8 + 2.7 
216.0 + 4.35* 
(+69%) 
233.2+18.8* 
(+82%) 
216.1 + 7.7* 
(+69%) 
Results are Mean + SEM of 3-4 different preparations 
* Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 6: Effect of green tea (GT) consumption on brush border membrane enzymes 
in BBMV isolated from renal cortex with/without gentamicin (GM) treatment. 
Groups 
Control 
GM 
GT 
TGM 
ALP 
(|j,mol/mg 
protein/h) 
35.53 ±4.63 
30.07 ± 0.5 
(-15%) 
40.2 ± 2.6 
(+13%) 
45.2 ± 0.09*t 
(+27%) 
GGTase 
(|iniol/mg 
protein/h) 
144.13 + 0.87 
118.4+1.95* 
(-18%) 
184.6 + 36.5* 
(+28%) 
224.5 ±9.5*t 
(+56%) 
LAP 
(}xmol/mg 
protein/h) 
28.2 + 4.8 
22.5 + 0.5* 
(-20%) 
22.15 + 5.15* 
(-21%) 
26.8+1.0 
(-5%) 
Results are Mean + SEM of 3-4 different preparations 
Significantly different from control, t significantly different at p< 0.05 from GM 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Figure 13: Effect of green tea (GT) consumption on (A) ALP (B) GGTase (C) LAP 
(D) Sucrase in Intestine Homogenate and BBM with/without gentamicin (GM) 
treatment. 
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Figure 14: Effect of green tea (GT) consumption on (A) ALP (B) GGTase (C) 
LAP in Cortex Homoeenate and BBM with/without eentamicin TGM) treatment. 
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Table 7: Effect of green tea (GT) consumption on uptake of -^ P^i in brush border 
membrane vesicles (BBMV) from renal cortex with/without gentamicin (GM) 
treatment. 
(A) Na^-gradient dependent uptake (Nao>Nai) (pmol/mg protein) 
Groups 
Control 
GM 
GT 
TGM 
Groups 
Control 
GM 
GT 
TGM 
30sec 
1519.33 ±82.4 
1039.31 ±79.30* 
(-32%) 
2070.82 ± 40.38* 
(+36%) 
2335.40 ±90.24*t 
(+54%) 
120 min 
384.42 ± 6.6 
343.08 ±13.3 
(-11%) 
435.36 ±14.05 
(+13%) 
397.08+16.67 
(+3%) 
B) K^-gradient dependent uptake (Ko>Ki) (pmol/mg protein) 
30sec 
183.7 ±7.3 
152 ±17.04 
(-17%) 
185.25 ±23.25 
(+1%) 
170.1 ± 18.72 
(-7%) 
(C) Net Na^-gradient dependent uptake 
Groups 
Control 
GM 
GT 
TGM 
Na^-gradient 
dependent uptake 
1519.33 + 82.4 
1039.36 + 79.3* 
2070.83 ±40.38* 
2335.42 ± 90.24* 
120 min 
338.43 + 0.88 
338.09 ±1.4 
334.9 ±1.1 
(+1%) 
334.5 ± 0.97 
(+1%) 
at 30 sec 
K'^ -gradient 
dependent uptake 
183.72 + 7.3 
152.00+17.04 
185.25 + 23.25 
170.11+57.9 
Net uptake 
(Na^-K^) 
1336.3 
888 
(-34%) 
1885.5 
(+41%) 
2165.3 
(+62%) 
Results are Mean ± SEM for five different preparations 
* Significantly different from control, t significantly different from GM: at p < 0.05 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Figure 15: Effect of green tea (GT) consumption on (A) Na*-dependent (B) K^ -
dependent (C) Net uptake of ^^ Pi in BBMV from renal cortex with/without 
gentamicin (GM) treatment. 
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was extended to GT rats, GM-kiduced decrease in ^^Pi transport was not observed. 
Moreover, the net rate of uptake of ^¥i remained significantly higher in TGM rats 
compared to control rats and significantly much more higher compared to GM treated 
rats. Similar to the effect of GM alone, the effect of GT alone or in combination with 
GM treatment was specific in the presence of a Na-gradient. The transport of Pi in 
the absence of Na-gradient (i.e. where Ko> K,) and after 120min were not affected by 
any of these treatment. 
Effect ofereen tea (GT) on sentamicin (GM) induced alterations on the enzymes of 
carbohydrate metabolism in various rat tissues: 
The effect of GM, GT and GM+GT was determined on the activities of various 
enzymes of carbohydrate metabolism in kidney and other major tissues (Tables 8 and 
9). GM treatment to control rats significantly increased hexokinase activity in 
intestine (+17%); liver (+20%), renal cortex (+8%) and medulla (+23%). The activity 
of LDH (a marker enzyme of anaerobic glycolysis), however profoundly increased in 
the intestine (+124%), renal cortex (+31%) and medulla (+34%) whereas decreased in 
the liver (-25%)). The effect of GM was differentially observed on MDH activity (an 
enzyme of TCA cycle) in different tissues. GM caused significant decline in MDH 
activity in the intestine (-40%), renal cortex (-55%)) and medulla (-30%) whereas 
increased in the liver (+32%)). As previously reported (Khan et al, 2007). GT 
consumption significantly enhanced metabolic activities in almost all tissues studied. 
The activity of HK, LDH and MDH signilficantly increased in the intestine, liver and 
renal cortex and medulla with the exception of MDH activity in renal medulla which 
was decreased by GT. When GM treatment was extended to GT drinking rats, GM 
induced decrease in most metabolic enzyme activities, was not only prevented but 
they remained significantly higher in TGM compared to either control or GM treated 
rats in most tissues (Tables 8 and 9). The activity of LDH was especially found to be 
profoundly enhanced in the intestine and renal cortex and medulla. The activity of 
MDH, however significantly increased in the liver and renal cortex by GT given to 
GM rats. 
The effect of GM and GT were also observed on enzymes of gluconeogenesis. GM 
significantly increased the activity of glucose-6-phosphatase (G6Pase) and fructose I. 
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Table 8: Effect of green tea (GT) consumption on the activity of metabolic enzymes 
in intestinal and liver homogenates with/without gentamicin (GM) treatment. 
Tissue 
Intestine 
Control 
GM 
GT 
TGM 
Hexokinase 
()a.mol/mgprotein/h) 
U6.8±1.55 
136.3 ±1.38* 
(+17%) 
134.3 ±1.25* 
(+15%) 
127.5 + 1.4 
(+9%) 
LDH 
(|j,mol/mgprotein/h) 
3.53 + 0.41 
7.9 ±0.8* 
(+124%) 
9.7 + 0.7* 
(+175%) 
10.52+ 0.2*t 
(+198%) 
MDH 
(|imoI/mg protein/h) 
8.30 + 0.6 
5.0 + 0.5* 
(-40%) 
12.7 + 0.88* 
(+53%) 
7.8±1.14t 
(-6%) 
Liver 
Control 
GM 
GT 
TGM 
16.7 + 0.44 
20.1 + 0.9* 
(+20%) 
21.3 + 0.7* 
(+28%) 
22.8 + 0.4* 
(+37%) 
55.04 + 2.56 
41.3 + 4.8 
(-25%) 
71.8 + 0.45 
(+31%) 
53.6 + 0.4 
(-3%) 
2.6 + 0.34 
3.44 + 0.06* 
(+32%) 
2.9 + 0.23 
(+12%) 
3.55 + 0.4* 
(+37%) 
Results are Mean + SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 9: Effect of green tea (GT) consumption on the activity of metabolic enzymes 
in cortical and medullary homogenates with/without gentamicin (GM) treatment. 
Tissue 
Cortex 
Medulla 
Hexokinase LDH MDH 
(|amol/mgprotein/h) (^mol/mgprotein/h) (|imol/mg protein/h) 
Control 
GM 
GT 
TGM 
70.2 ±1.12 
75.8 ±1.06* 
(+8%) 
65.6 ±3.98 
(-7%) 
75.8 ±1.06* 
(+8%) 
10.26 ±0.14 
13.4 ±0.49* 
(+31%) 
19.9 ±0.25* 
(+94%) 
17.2±0.5*t 
(+68%) 
15.65 ±1.95 
7.1+0.6* 
(-55%) 
23.8 + 3.1* 
(+52%) 
20.6 ± 2.2t 
(+32%) 
Control 
GM 
GT 
TGM 
49.7 ± 0.53 
60.9 ±1.08* 
(+23%) 
56.6 ±3.2* 
(+14%) 
68.1+0.25* 
(+37%) 
7.3 ± 0.3 
9.8 ±0.43* 
(+34%) 
11.35 + 0.03* 
(+55%) 
14.0+1.33*1 
(+92%) 
12.03 + 0.6 
8.4 + 2.4 
(-30%) 
7.11+0.6* 
(-41%) 
8.46 + 0.22* 
(-30%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control 
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6, bisphosphatase (FBPase) in the intestine and to some extent in the liver, whereas 
the activity of these enzymes decreased in renal cortex and medulla (Tables 10 and 
11). GT significantly enhanced the activity of both G6Pase and FBPase in the 
intestine, renal cortex and medulla but lowered in the liver. As a result GT 
consumption by GM treated rats resulted in significant increase of both G6Pase and 
FBPase in all the tissues. The effect of GT-extract alone and with GM was also 
determined on the activities of glucose-6-phosphate dehydrogenase (G6PDH, HMP-
shunt) and malic enzyme (ME), source of NADPH needed in reductive anabolic 
reactions (Tables 10 and 11). GM treatment to control rats significantly increased 
G6PDH activity in the intestine (+46%), renal cortex (+18%) and medulla (+71%) 
whereas decreased in the liver (-38%). The activity of ME however, significantly 
lowered by GM treatment in all the tissues (Tables 10 and 11). The activities of 
G6PDH and ME however were differentially altered by GT. The activity of G6PDH 
profoundly increased in renal cortex (+50%) whereas decreased in the intestine (-
60%), liver (-21%) and medulla (-29%). ME activity on the other hand was lowered 
by GT in all the tissues. GT consumption by GM treated rats was able to restore 
G6PDH activity and was significantly higher in the liver, renal cortex and medulla in 
TGM compared to control or GM rats. The activity of ME was also improved in TGM 
compared to GM or control rats. 
Effect of green tea (GT) on sentamicin (GM) induced alterations in antioxidant 
defense parameters in different rat tissues: 
GM induced nephrotoxicity can not only be cb^acterized by increased levels of 
serum creatinine/BUN but can also be .-determined, at least in part, by perturbation of 
antioxidant defense mechanism (Tables 12 and 13). GM caused significant decrease 
in the activity of superoxide dismutase (SOD) in the intestine (-27%), liver (-39%) 
and renal cortex (-46%) and medulla (-43%). The activity of catalase also 
significantly but differentially declined in most rat tissues. It was decreased to greater 
extent in the intestine (-53%) followed by liver (-25%), renal cortex (-17%) and 
medulla (-10%). GM induced decrease in SOD and catalase activities was associated 
with increased production of malondialdehyde (MDA); an end product of lipid 
peroxidation (LPO) in all the tissues. This was accompanied by decreased levels of 
total SH. Taken together, these results indicated that GM elicited production of 
free radicals and suppression of antioxidant enzymes caused significant damage to rat 
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Table 10: Effect of green tea (GT) consumption on the activity of metabolic enzymes 
in intestinal and liver homogenates with/without gentamicin (GM) treatment. 
Tissue 
Intestine 
Control 
GM 
GT 
TGM 
Liver 
Control 
GM 
GT 
TGM 
G6Pase 
((j.mol/mg 
protein/h) 
0.97 ± 0.08 
1.5 ±0.17* 
(+55%) 
1.2 ±0.03 
(+24%) 
1.3 + 0.02* 
(+34%) 
0.7 + 0.03 
0.8 + 0.03* 
(+14%) 
0.56 + 0.04 
(-20%) 
0.86 ± 0.02* 
(+23%) 
FBPase 
()amol/mg 
protein/h) 
1.6 + 0.03 
1.9 + 0.06* 
(+19%) 
1.77 + 0.01* 
(+11%) 
1.86 + 0.11* 
(+16%) 
0.32 + 0.01 
0.33 + 0.01 
(+3%) 
0.31 + 0.02 
(-3%) 
0.42 ± 0.005t 
(31%) 
G6PDH 
(|amol/mg 
protein/h) 
0.67 ± 0.02 
0.98 + 0.05* 
(+46%) 
0.27 + 0.05* 
(-60%) 
0.4 ± 0.02*t 
(-40%) 
0.24 + 0.003 
0.15 + 0.002* 
(-38%) 
0.19 + 0.006* 
(-21%) 
0.28 + 0.02t 
(+17%) 
ME 
(|amol/mg 
protein/h) 
0.32 + 0.06 
0.14 + 0.008* 
(-56%) 
0.2 + 0.005* 
(-38%) 
0.32±0.01t 
0.23 + 0.06 
0.20 + 0.01 
(-13%) 
0.18 + 0.04* 
(-22%) 
0.19 + 0.05 
(-17%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control 
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Table 11: Effect of green tea (GT) consumption on the activity of metabolic enzymes 
in cortical and medullary homogenates with/without gentamicin (GM) treatment. 
Tissue 
Cortex 
Control 
GM 
GT 
TGM 
Medulla 
Control 
GM 
GT 
TGM 
G6Pase 
(|j.mol/mg 
protein/h) 
0.30 ±0.01 
0.25 ±0.01* 
(-17%) 
0.38 ± 0.06* 
(+27%) 
0.38±0.01*t 
(±27%) 
0.30 ±0.01 
0.27 ±0.03* 
(-10%) 
0.38 ±0.01* 
(±27%) 
0.36 ± 0.01 *t 
(±20%) 
FBPase 
([xmol/mg 
protein/h) 
1.45 ±0.03 
1.28 ±0.03* 
(-12%) 
1.7 ±0.3 
(±17%) 
1.67 ± 0.03*t 
(±15%) 
1.20 ±0.03 
1.08 ±0.01* 
(-10%) 
1.65 ±0.08* 
(±38%) 
1.60±0.07*t 
(±33%) 
G6PDH 
(|j,mol/mg 
protein/h) 
0.22 ± 0.007 
0.26 ± 0.05 
(±18%) 
0.33 ± 0.005* 
(±50%) 
0.29 ±0.01 
(±32%) 
0.17 ±0.014 
0.29 ±0.05* 
(±71%) 
0.12 ±0.04* 
(-29%) 
0.26 ±0.01* 
(±53%) 
ME 
(|xmol/mg 
protein/h) 
0.41 ± 0.05 
0.19 ±0.01* 
(-54%) 
0.37 ± 0.05 
(-10%) 
0.39 ±0.06 
(-5%) 
0.57 ± 0.02 
0.30 ±0.004* 
(-47%) 
0.32 ± 0.04* 
(-44%) 
0.42 ± 0.005* 
(-26%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different at p< 0.05 from GM b>' 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 12: Effect of green tea (GT) consumption on enzymic and non-enzymic 
antioxidant parameters in intestinal and liver homogenates with/without gentamicin 
(GM) treatment. 
Tissue 
Intestine 
Control 
GM 
GT 
TGM 
LPO 
(nmol/gmtissue) 
34.7 ±3.5 
40.4 ± 0.08 
(+16%) 
42.3 ± 0.4 
(+22%) 
54.6±0.8*t 
(+57%) 
Total-SH 
(|j,mol/gmtissue) 
2.3 + 0.05 
2.1+0.10 
(-9%) 
2.5 + 0.10 
(+9%) 
2.7 + 0.13 
(+17%) 
SOD 
(Units/mgprotein) 
9.12+1.4 
6.7+1.30* 
(-27%) 
5.11+0.32* 
(-44%) 
8.02+1.3 
(-12%) 
Catalase 
(ixmol/mgprotein/iTiin) 
7.78 + 0.8 
3.65 + 0.25* 
(-53%) 
11.13 + 0.42* 
(+43%) 
12.1 + 1.15*1-
(+56%) 
Liver 
Control 
GM 
GT 
TGM 
244.2+10.5 
321.4 + 29.14* 
(+32%) 
224.0+13.30 
(-8%) 
196.3 +18. l t 
(-20%) 
15.44+1.33 
11.4 + 0.19* 
(-26%) 
6.6 + 0.30* 
(-57%) 
10.56 + 0.4* 
(-32%) 
25.5 + 3.4 
15.5 + 2.08* 
(-39%) 
22.4 + 0.17 
(-12%) 
20 + 0.15 
(-22%) 
4.8 + 0.24 
3.6 + 0.56 
(-25%) 
13.7 + 0.62* 
(+185%) 
13.3 + 0.27*t 
(+177%) 
Results are Mean + SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 13: Effect of green tea (GT) consumption on enzymic and non-enzymic 
antioxidant parameters in cortical and medullary homogenates with/without 
gentamicin (GM) treatment. 
Tissue 
Cortex 
Control 
GM 
GT 
TGM 
LPO 
(nmol/gmtissue) 
286.10 ±3.83 
367.10 ±21.6* 
(+28%) 
226.10 ±34.6 
(-21%) 
207.20 ± 9.5*t 
(-28%) 
Total-SH 
(^mol/gmtissue) 
9.50 ±0.99 
5.90 ±0.3* 
(-38%) 
7.56 ±0.28* 
(-20%) 
6.00 ±0.2* 
(-37%) 
SOD 
(Units/mgprotein) 
18.30 ±1.47 
9.90 ±0.8* 
(-46%) 
30.05 ±4.6* 
(+64%) 
27.40 ±1.6*t 
(+50%) 
Catalase 
(fimol/mgprotein/min) 
133.70 + 5.2 
110.90 ±4.2* 
(-17%) 
176.52 ±6.3* 
(+32%) 
177.71 ±2.6*t 
(+33%) 
Medulla 
Control 
GM 
GT 
TGM 
95.25 ± 5.22 
143.0 ±3.81* 
(+50%) 
176.75+1.35* 
(+86%) 
146.45 + 3.82* 
(+54%) 
2.50 + 0.15 
1.56 ±0.20* 
(-38%) 
3.94 ± 0.04* 
(+58%) 
1.62 + 0.32* 
(-35%) 
14.10 ±0.005 
8.0 ±0.88* 
(-43%) 
19.87 ±0.62* 
(+41%) 
16.53 ±0.44t 
(+17%) 
143.60 + 6.0 
128.91 + 3.2 
(-10%) 
105.72 + 0.11* 
(-26%) 
110.62 ±4.20* 
(-23%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different at p< 0.05 from GM by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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.tissues. In contrast, GT significantly enhanced the activity of either SOD or catalase 
or both in various rat tissues. The activity of SOD profoundly increased in renal 
cortex (+64%) and medulla (+41%). Catalase activity was also significantly increased 
in renal cortex (+32%) but decreased in medulla (-26%). These GT induced 
alterations in antioxidant enzymes were accompanied by lowering of LPO in the liver 
(-8%) and renal cortex (-21%). GT, by virtue of its known antioxidant properties 
prevented GM elicited adverse effects on various parameters of oxidative damage. 
The activities of SOD and catalase significantly increased in renal cortex in GT 
consuming GM treated rats compared to GM only rats. The activities of both the 
enzymes were also significantly increased in the liver, intestine and renal medulla in 
TGM compared to GM treated rats. The \eve\s of total SH and LPO were also 
improved indicating a marked protection by GT against GM induced oxidative 
damage in various tissues but especially noted in renal cortex and medulla. 
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DISCUSSION 
Gentamicin, an effective and widely used aminoglycoside antibiotic against severe 
infections, is known to be potentially nephrotoxic despite close attention to its 
pharmacokinetics and dosing schedules that limits its long term clinical use (Ishikawa 
et al, 1985). Several strategies and mechanisms ^& utilized to prevent GM 
nephropathy; however, a viable approach fof chnical practice could nofr-be achieved. 
TeaAost widely consumed beverage worldwide since ancient times, is known for its 
beneficial health effects. In particular, green tea (GT) has been shown to retard 
various forms of cancers due to its antimUtagenic and anticarcinogenic properties 
(Mukhtar and Ahmad, 2000; Khan and Mukhtar, 2007). Itjwas^lsoJmindlo be 
cardioprotective, neuroprotective, antidiabetic and antibacterial besides other health 
benefits (Alschuler, 1998; Liao, 2001). In the present studies we have tested our 
hypothesis that GT consumption would ameliorate GM induced nephrotoxic and other 
adverse effects in the kidney and other major tissues. 
A nephrotoxic dose of GM was administered to control and GT consuming rats and 
the activities of various enzymes of carbohydrate metabolism, brush border 
membrane, mitochondria and lysosomes were determined to ascertain potential 
beneficial effects of GT. As shown in the Results, GM administration to control rats 
produced a typical pattern of nephrotoxicity which was manifested by marked 
increase in serum creatinine and BUN accompanied by significant decrease in serum 
glucose, inorganic phosphate (Pi) and increase in serum cholesterol, phospholipids as 
-partially reported in the previous studies (Banday et al, 2008a). In contrast to GM. 
consumption had no effect on serum creatinine whereas BUN conspicuously 
declined. Serum glucose, cholesterol and Pi significantly decreased but serum 
phospholipids slightly increased. GM treatment to GT rats,Ae)wp\pr significantly 
Jowr'OTcd G M elicited increased levels of sefum creatinine, and BUN. Serum glucose 
and cholesterol remained depressed but serum phospholipids profoundly eiyianced 
upon GM treatment to GT consuming rats. GT induced reductions in serum glucose, 
cholesterol alongWith weight loss can be considered as healthy indicators. 
Since BBM and other intracellular organelles such as mitochondria and lysosomes 
are known GM target^(Farooq et al, 2007; Banday et al, 2008a), the 
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structural/functional integrity wais assessed by the status of their respective biomarker 
enzymes. GM causedksignificaQt decrease in the activities of ALP, GGTase, LAP 
(BBM enzymes) in renal cortical homogenates and isolated BBM preparations. GM 
caused similar decrease in medullary homogenates, indicating an overall GM mduced 
damage to the kidney. The lowering of ACPase, (lysosomal enzyme) appears to be 
due to lysosomal dysfunction in renal tissues. In contrast to kidney, GM, however, 
exerted differential effects oiLabove enzymes in the intestine and liver. As reported 
earlier (Farooq et al, 2007), GM significantly increased the activities of ALP, LAP in 
intestinal homogenates and BBM preparations. The activity of sucrase, an intestinal 
BBM marker enzyme was also profoundly increased. The activity of ALP, GGTase 
and LAP only slightly increased in the liver. Thus the effect of GM on various tissues 
appeared to be tissue specific. In contrast to GM, GT consumption, however, 
significantly increased the activities of BBM and lysosomal enzymes in the 
homogenate and BBM of the intestine indicating an overall improvement in mucosal 
BBM integrity. The partial restoration in the activity of ALP/GGTase by GT in the 
renal cortex and medulla can be considered due to their localization in the thickness of 
BBM (Yusufi et al, 1994) or due to differential access/accumulation of GT in these 
tissues. 
GT consumption in combination with GM treatment resulted in the reversal of GM-
induced alterations in various enzyme activities in the intestine and renal tissues. The 
activities of BBM enzymes GGTase, LAP and sucrase with-thfr-^ixccptiian^ ALP 
profoundly increased in GT+GM compared to GM alone in intestinal BBM. 
Similarly, the activities of ALP, GGTase and LAP were significantly increased in 
GT+GM compared to GM-treated BBM preparations in the kidney. The results 
convincingly demonstrate that GT consumption not only prevented the GM elicited 
decrease in many of the BBM enzyme activities and they remained significantly -
higher in TGM compared to control and much n^^^igher compared to GM treated \ 
rats. The results suggest that renal BBM and lysosomes were severely damaged by 
GM. This led to decrease in BBM enzymes especially in the kidney, apparently due to 
loss/release of enzymes from damaged BBM into the lumen. The released enzyme, \ ' 
were shown to be excreted in the urine (Banday et aU 2008a}. Alterations in ACPase 
activity demonstrate GM induced damage to lysosomes as shovvn by phospholipidosis ^ 
(Laurent ef^ aTT" 1990). Iti Mfttrast, "GT consumption appeared to prevent/reduce the 
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damage caused by GM by in£reasing the regeneration process. However, in the case 
of the intestine a different^ada^tiye,mechanism might bg initiated where the enzyme 
activity was increased both bj^GMm^SXl-
The reabsorption of Na"^  ions by renal proximal tubular BBM is coRsidered^ be the 
major function of the kidney bepatr^e the transport of other ions and various solutes 
including Pi depends directly or indirectly on Na reabsorption (Coux et al, 2001). 
Since these transports depend on structural integrity of BBM and available energy as^  
ATP whirh is siippHed by v^ HnnQ mpfahnlic pathw^y.^. It isQmperativeJ that any^ 
alterations to these metabolic pathways caused^byJoxic, msult or^hemise modified 
would determine the rate of transport function (Khundmiri et al, 2004; Banday et al, ' 
2008a). To assess the fianctional aspects' the activities of various enzymes of 
carbohydrate metabolism were determined under different experimental conditions. 
As shown in the Results, the activities of various enzymes involved in glycol) sis, 
TCA cycle, gluconeogenesis and HMP shunt pathway were variably altered in 
different tissues by GM treatment and/or by GT consumption. GM caused^ignificant 
increase in LDH and decrease in MDH activity in the intestine, renal cortex and 
medulla which was associated with simultaneous increase in hexokinase activity in 
the intestine and renal medulla. However, in the liver, an opposite GM effect was 
observed where the decrease in LDH activity was associated with increased MDH and 
hexokinase activity. Although the actual rates of glycolysis or TCA cycle were not 
determined, a marked decrease in MDH activity in some tissues appears to be due to 
GM induced damage to mitochondria. An impaired oxidative metabolism of 
glucose/fatty acid due to mitochondrial dysfunction would result in lower ATP 
production by oxidative metabolism and hence lower renal transport function. A 
marked increase in LDH and to some extent hexokinase activity appears to indicate an 
adaptive cellular effect in energy metabolism from aerobic metabolism alternatively 
to anaerobic glycolysis due to GM induced mitochondrial dysfunction. 
GM also caused differential effect on the enzymes of gluconeogenesis and HMP-
shunt pathway in different tissues. The activity of G6Pase and FBPase significantly 
increased in the intestine and slightly in liver but significantly decreased in renal 
tissues upon GM treatment. The activity of G6PDH, however, profoundly increased 
in the intestine and renal cortex and medulla but decreased in the liver. The activity of 
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NADP -malic enzyme (ME), however significantly but variably declined in all the 
tissues. The present data indicate that GM down regulated the enzymes of 
carbohydrate metabolism in the kidney but enhanced in the intestine. In contrast to 
GM, GT consumption caused selective alterations in the activities of various enzymes 
involved in carbohydrate metabolism in different rat tissues. The activity of HK, LDH 
(glycolysis), MDH (TCA cycle), G6Pase and FBPase (gluconeogenesis) significantly 
increased in the intestine and renal tissues but decreased in the liver as reported ejidiet/ 
(Khan et al, 2007). GT administration to GM treated rats resulted in overall' 
improvement of carbohydrate metabolism in various tissues as evident by increased 
activities of LDH, MDH and gluconeogenic enzymes in various tissues. GT might 
have lowered number of damaged mitochondria or affected macromolecules or may 
have increased number of normally active organelles or macromolecules. The 
decrease/increase in G6Pase and FBPase by GM/GT respectively, can be attributed to 
available oxaloacetate produced from malate by MDH. Thus a decrease/increase in 
MDH activity may affect both the TCA cycle and gluconeogenic activity as 
oxaloacetate is required by both pathways. In turn, ATP production would be 
influenced accordingly. 
The Pi required for the production of metabolites and ATP infact is conserved by the 
kidney. The transport of Pi by renal cortical BBM is an essential and regulatory step.""' 
It appears from the data that GM by lowering oxidative rnetabolism Ipwers ATP 
production, whereas GT consumption increased ATP production by increasing the i 
metabolic activities to support many cellular ftinctions especially in the kidney. In , 
confirming this notion, the present results show that Na-dependent transport of Pi 
significantly decreased by GM treatment whereas significantly increased by GT 
consumption according to the availability of ATP produced by cellular metabolic 
activities. GT given to rats showed further increase in renal BBM Pi transport. Thus it 
appears that GT induced Pi conservation by the kidney maintains and/or improves 
metabolic activities of not only kidney but also of other tissues. 
It has been reported that reactive oxygen species (ROS) are important mediators of 
GM nephropathy (Walker et al, 1999; Cuzzocrea et al, 2002; Ali, 2003; Banday et 
al, 2008a). It has been shown that GM generates ROS and stimulates lipid 
peroxidation in the kidney (Walker et al, 1999). GM also inhibits the activities of 
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antioxidant enzymes, SOD, catalase and GSH-peroxidase (GSH-Px) and depletes 
cellular thiols (Dean et al, 1991; Szabo et al, 1997). As a result the balance normally 
present in cells between free radical formation and protection against them is 
disturbed causing oxidative damage to cell components e.g. proteins, lipids and 
nucleic acids and/or certain organelles such as plasma membranes, mitochondria, 
microsomes and lysosomes in the kidney and other tissues (Sandhya et al, 1995; 
Parlakpinar et al., 2004; Karahan et al., 2005). In agreement with previous 
observations (Banday et al., 2008a), GM significantly decreased the activities of 
SOD, and catalase and enhanced LPO in the liver, intestine and renal tissues, 
indicating GM induced oxidative damage to these tissues. The severity of the damage 
appeared to be more prominent in the intestine and medulla than in the liver and 
cortex. In recent years, the concept of chemoprevention by naturally occurring dietary 
substances has been strengthened. Green tea provides a dietary source of biologically 
active compounds that help prevent a wide variety of diseases. Green tea extract 
contain polypohenols which possess antioxidant, antimutagenic and anticarcinogenic 
effects that reduce the risk of various forms of cancer, cardiovascular and renal 
disorders against certain envirormiental agents (Mukhtar and Ahmad, 2000; Khan et 
al., 2006; Khan and Mukhtar, 2007). 
GT has been shown to lower cyclosporine and cisplatin induced nephrotoxicity and 
oxidative stress (Leena and Balaraman, 2005; Mohamadin et al., 2005). The present 
results show that GT significantly enhanced antioxidant defense mechanism albeit 
differentially in different tissues. The activity of SOD significantly increased in the 
renal cortex and medulla but decreased in the intestine and liver. However, catalase 
activity profoundly increased in the intestine, liver and renal cortex but decreased in 
renal medulla. These alterations were associated with lowering of LPO in the liver 
and renal cortex. Thus, GT consumption offered ^significant protection from GM 
induced oxidative damage as evident bj^^ignificant increase of either SOD or catalase 
or both in various tissues especially in renal cortex in GM treated-GT consuming rats 
compared to the rats treated with GM alone. LPO significantly lowered in the liver 
and renal cortex, whereas total-SH levels were improved in certain tissues compared 
to values obtained in GM treated rats. GT has variable effects on antioxidant 
mechanism in different tissues. The activity of SOD significantly decreased in the 
intestine and liver but the activity of catalase profoundly increased in these tissues by 
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GT. Whereas the LPO decreased in the liver, it was increased in the intestine. 
However the activity of SOD and catalase significantly increased in the renal cortex 
which led to decrease in LPO. The results suggest that CLmrovide protection against 
GM nephropathy or oxidative damage either by SOD-mediated or catalase mediated 
mechanism or involving both mechanisms simultaneously in certain tissues. 
In conclusion, the results of present study show that GM induces generation of free 
radicals that causes oxidative damage to cellular organelles, macromolecules and 
especially to mitochondria and plasma membrane. This ultimately affects energy 
metabolism and renal transport of Pi. In contrast, GT reduces oxidative stress by 
virtue of its antioxidant properties thus improving the structural integrity of various 
organelles/macromolecules and eventually enhances metabolic capabilities and 
transport of Pi especially in the kidney. Taken together, these beneficial effects of GT 
were able to ameliorate GM induced nephrotoxic and oxidative damage. The dietary 
derived components of GT especially polyphenolic catechins can be an option in 
reducing the risk of chronic diseases including nephrotoxicity. 
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Hypothesis III; 
To determine whether green tea (GT) consumption would protect against cisplatin 
(CP) induced nephrotoxic and other adverse effects in major rat tissues. 
Experimental design III; 
Adult male Wistar rats (8 rats/group) weighing 150-180 g fed with standard rat chow 
(Aashirwaad Industries, Chandigarh, India) and water ad libitum were conditioned 
for one week before the start of the experiment (Fig 16). Initially two groups of rats 
entered the study after acclimatization. They were fed on a normal rat chow diet with 
one group consuming water (control) and the other consuming GT extract (3% w/v) in 
drinking water for 25 days as described in "Experimental design I". Nephrotoxicity 
was induced by intraperitoneal administration of CP (3 mg/kg bwt/day), in 0.9% 
saline every fifth day for 25 days to one of the sub-group designated as CP and TCP. 
The other sub-group from each group received an equivalent volume of normal saline 
for the same period. The rats were sacrificed on the fifth day after the last injection 
under light ether anesthesia. Blood samples were collected and the liver, kidney and 
intestine were extracted and processed for the preparation of homogenates and 
BBMVs. All the preparations and analyses of various parameters were carried out 
simultaneously under similar experimental conditions to avoid any day-to-day 
variations. Body weights of rats were recorded at the start and completion of the 
experimental procedure. 
Results III; 
To test the above hypothesis, the effect of green tea (GT) consumption and cisplatin 
(CP) was determined on various parameters in rat serum, intestine, liver and kidney. 
In general the rats remained active and alert throughout the study. The daily food and 
fluid intake was similar in various experimental groups of rats (data not shown). As 
shown in Table 1, there was a slight loss in body weight in GT, CP and GT+CP rats. 
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Figure 16: Experimental Design III 
(ND normal diet; GT green tea; CP cisplatin; TCP green tea + CP; i T 
i.p. administration of CP every fifth day for 25 days) 
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Effect of ereen tea (GT) on cisplatin (CP)-induced nephrotoxicity parameters in 
serum: 
The administration of cisplatin (CP) to control rats causedisignificant increase in 
serum creatinine (+38%), blood urea nitrogen (BUN) (+47%), cholesterol (+22%) and 
phospholipids (+36%) butdecrease in serum glucose (-28%) and inorganic phosphate 
(-21%) (Table 2). GT alone had no effect on serum creatinine whereas BUN 
conspicuously decreased. GT significantly decreasedasferum glucose, cholesterol and 
Pi i^ereas phospholipids significantly increased^TWhen GT was given to CP rats. CP 
elicited nephrotoxic alterations appeared to be ameliorated. CP^nduced increase in 
serum creatinine and BUN were prevented by prolonged GT consumption. CP-^  
induced increase in serum cholesterol was also l^jvcfed by GT. However, serum 
glucose and Pi remained depressed whereas phospholipidSy.further increased by GT 
consumption to CP rats compared to control rats. 
Effect of sreen tea (GT) on cisplatin (CP) induced alterations on biomarker 
enzymes ofBBM and lysosomes: 
To assess the structural integrity of various organelles e.g. plasma membrane (BBM) 
and lysosomes, the effect of CP and GT was determined on marker enzymes of brush 
border membrane in the homogenates of intestine, liver and kidney as well as in 
isolated renal and intestinal BBMV preparations. 
(a) Effect of cisplatin (CP) and green tea (GT) on biomarkers of BBM and 
lysosomes in the homogenates of various tissues: 
The activities of alkaline phosphatase (ALP), y-glutamyl transferase (GGTase), 
leucine aminopeptidase (LAP), sucrase and acid phosphatase (ACPase) were 
determined under different experimental conditions in the homogenates of different 
tissues (Tables 3 and 4; Fig 17 and 18) Administration of CP to control rats caused a 
significant decrease in the activities of all BBM and lysosomal enzymes in the 
intestinal homogenates. However the effect of CP was differentially observed on 
BBM and lysosomal enzymes in the liver homogenate. CP caused a significant 
increase in the activity of ALP (+25%), GGTase (+27%) and ACPase 
(+13%) whereas the activity of LAP declined (-11%) and the decrease was significant 
HI 
Table 1: Effect of green tea (GT) consumption on body weight (grams) of rats 
with/without cisplatin (CP) treatment. 
Groups Before After % change 
Treatment Treatment 
Control 164.3 ±7.4 162.5 ±12.5 -1.1 
CP 165.6 ±6.6 147.5 ±8.3 - l l 
GT 164.3 ±7.4 143.8 ±7.5 -12.5 
TCP 168.8 ±7.8 141.3 ±5.9* -16.3 
Results are expressed as Mean ± SEM 
* Significantly different at p< 0.05 from control by one way ANOVA. 
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Table 2: Effect of green tea (GT) consumption on several serum parameters 
with/without cisplatin (CP) treatment. 
Groups Creatinine BUN Glucose Cholesterol Phosphate Phospholipid 
(mg/dL) (mg/dL) (mg/dL) (mg/dL) (|amol/mL) (^g/mL) 
Control 1.07 ±0.4 22.60 ±1.89 32.9 ±1.6 119.88 ±1.3 3.72 ±0.26 97.2 ± 8.8 
QP 1.48 ±1.11* 33.12 ±0.4* 23.8 ±2.86* 146.24 ±3.8* 2.95 ± 0.25 132.05 ± 40.05* 
(+38%) (+47%) (-28%) (+22%) (-21%) (+36%) 
GT 0.96±0.33 12.6±0.23* 26.3±2.47 98.4±0.6 2.6±0.35* 142.15+2.35* 
(-10%) (-44%) (-20%) (-18%) (-30%) (-46%) 
TCP 1.07±0.28 19.1±0.48t 20.1±1.25* 102.12±1.7t 2.5 ± 0.2* 149±3.3* 
(-16%) (-39%) (-15%) (-33%) (+53%) 
Results are Mean ± SEM of six different samples 
* Significantly different from control, t significantly different from CP at p< 0.05 b> 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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compared to control values. In contrast to liver, CP caused a profound decrease in the 
activities of ALP, GGTase and LAP in a similar manner in both renal cortex and 
medulla. However, ACPase activity was markedly increased in both renal tissues but 
to a greater extent in the cortex (+43%) than in medulla (+18%). GT consumption, on 
the other hand, affected BBM and lysosomal enzymes differentially in different 
tissues. GT consumption significantly increased the activities of ALP, GGTase, LAP 
and ACPase (+25%) in intestinal homogenates. Whereas the activity of ALP and 
GGTase significantly increased the activity of LAP and ACPase decreased in liver 
homogenates. The effect of GT on BBM and lysosomal enzymes were differentially 
observed in renal cortex and medulla. The activity of ALP and ACPase significantly 
increased to varying magnitudes in cortex whereas the activity of GGTase and LAP 
significantly decreased. In contrast to cortex, the activities of ALP, GGTase and 
ACPase significantly increased but that of LAP decreased in the medulla. 
The co-administration of GT to CP»-treated rats caused a significant reversal in CP 
induced alterations in the activities of BBM and lysosomal enzymes in different 
tissues (Tables 3 and 4; Fig 17 and 18). The decrease caused in the activities of ALP, 
GGTase, LAP, sucrase and ACPase by CP treatment was significantly prevented by 
simultaneous GT consumption in the intestine and the activities of these enzymes 
remained significantly higher in TCP compared to control or CP-treated rats. In the 
liver homogenates, CP-induced increase in ALP and GGTase and decrease in LAP 
activities tended tn hp hark tn npar control values whereas ACPase activity was 
decreased by GT given to CP treated rats. Similarly, CP induced decrease in BBM 
enzyme activities in both renal cortex and medulla were increased whereas the 
activity of ACPase was also increased in both renal cortex and medulla by GT 
consumption. / ft e ^ • c"<' ( > , -' v 
(b) Effect of green tea (GT) on cisplatin (CP) Induced alterations on brush border 
membrane enzymes in isolated BBM preparations: 
The effect of CP, GT and their combination was further analyzed on the specific 
activities of BBM marker enzymes in BBMV isolated from renal cortex and intestinal 
mucosa. The results summarized in Tables 5 and 6, indicated that membrane 
preparations were several fold purified as reflected by the significant enrichment of 
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Table 3: Effect of green tea (GT) consumption on brush border membrane enzymes 
in intestinal and liver homogenates with/without cisplatin (CP) treatment. 
Tissue 
Intestine 
Control 
CP 
ALP GGTase LAP 
(^mol/mg (^moi/mg (|imol/mg 
protein/h) protein/h) protein/h) 
ACPase 
(|a,mol/mg 
protein/h) 
Sucrase 
(|j,iTiol/mg 
protein/h) 
1.38 ±0.06 2.96±0.07 3.2 ±0.05 2.5 ± 0.05 33.9 ±0.56 
1.10 ±0.01* 2.3±0.04* 2.4 ±0.07* 1.98 ±0.02* 27.96 ± 0.7* 
(-20%) (-22%) (-25%) (-21%) (-18%) 
GT 
TCP 
Liver 
Control 
CP 
GT 
TCP 
1.64 ±0.01* 
(+19%) 
1.48±0.02t 
(+7%) 
1.28 ±0.03 
1.6 ±0.09* 
(+25%) 
1.15 ±0.05* 
(-10%) 
1.33 ±0.05 
(+4%) 
3.98 + 0.17* 
(+34%) 
3.64±0.17*t 
(+23%) 
1.57 + 0.04 
1.99 ±0.02* 
(+27%) 
1.22 + 0.1* 
(-22%) 
1.56±0.07t 
4.5 ±0.12* 
(+41%) 
3.6±0.1t 
(+13%) 
1.38 + 0.04 
1.23 + 0.04 
(-11%) 
1.58 + 0.04 
(+14%) 
1.47 + 0.05t 
(+7%) 
3.13 + 0.15* 
(+25%) 
3.1±0.11*t 
(+25%) 
2.6 + 0.06 
2.95 + 0.09* 
(+13%) 
2.54 + 0.05 
(-2%) 
2.3 + 0.21t 
(-12%) 
38.4 + 0.64* 
(+13%) 
34.2±1.13t 
(+1%) 
Results are Mean + SEM of 3-4 different preparations. 
* Significantly different from control, f significantly different at p< 0.05 from CP by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 4: Effect of green tea (GT) consumption on brush border membrane enzymes 
in cortical and medullary homogenates with/without cisplatin (CP) treatment. 
Tissue 
Cortex 
Control 
CP 
GT 
TCP 
Medulla 
Control 
CP 
GT 
TCP 
ALP 
((xmol/mg 
protein/h) 
2.4 ±0.01 
1.84 ±0.4* 
(-23%) 
3.02 ± 0.28* 
(+26%) 
3.20±0.2*t 
(+33%) 
2.0 ±0.05 
1.4±0.1* 
(-30%) 
2.5 ± 0.05 
(+25%) 
2.45 ± 0.07*t 
(+23%) 
GGTase 
(|j,mol/mg 
protein/h) 
40.54 + 0.6 
25.33 ±0.89* 
(-38%) 
32.4 ±0.51* 
(-20%) 
28.56 ±1.96* 
(-30%) 
7.5 ±0.16 
6.11 ±0.13* 
(-19%) 
9.3 ± 0.8 
(+24%) 
8.1±0.45t 
(+8%) 
LAP 
(|xmol/mg 
protein/h) 
5.42 + 0.13 
2.89 ±0.25* 
(-47%) 
3.54 ±0.08* 
(-35%) 
3.23 ± 0.24* 
(-40%) 
5.22 ± 0.26 
2.3 ±0.2* 
(-56%) 
3.55 ±0.1* 
(-32%) 
2.77 ±0.09* 
(-44%) 
ACPase 
(|j,mol/mg 
protein/h) 
4.28 ±0.32 
6.13 ±0.2* 
(+43%) 
5.82 + 0.2* 
(+36%) 
6.31+0.25 
(+47%) 
2.25 + 0.11 
2.65 + 0.17 
(+18%) 
3.0 + 0.14* 
(+33%) 
3.2 + 0.11* 
(+42%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different at p< 0.05 from CP by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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their marker enzymes in the BBM compared to the homogenate (4-10 folds). 
The data summarized in Tables 5 and 6 ( Fig 17 and 18V showed a similar activit>^ 
pattern of BBM enzymes in BBM preparations as observed in respective. 
homogenates' however the magnitude of effects under different experimentaf 
conditions became more apparent. The increase or decrease in the activities of ALP, 
GGTase, LAP or sucrase (intestinal marker) by CP or GT was significantly higher in 
BBMVs as compared to homogenates from intestine and renal cortex respectively. 
The damaging effect of CP was clearly ameliorated by GT, asidecrease in the activity 
of GGTase, LAP and sucrase by CP was not only prevented but sometimes incj:©aged 
significantly by GT consumption as compared to respective control values. Thus, it 
appears from the data that co-administration of GT to CP-treated ratsJ to a largi^ 
extent reduced CP induced structural alterations in BBM's integrity and the activities 
of their components. 
c) Effect of green tea (GT) consumption on cisplatin (CP) induced alterations in 
Na-gradient dependent transport of^^Pi in BBMV(s) isolated from renal cortex: 
The bulk of filtered Pi in the kidney is reabsorbed by its proximal tubule. The Na-
gradient dependent {Na outside (Nao)>Na inside (Naj)} transport of Pi in renal proximal 
tubule across its luminal brush border membrane (BBM) is an initial and regulatory 
step. The Pi is transported by secondary active transport mechanism, requires 
expenditure of energy in the form of ATP that is generated by cellular metabolism. 
The uptake of ^^Pi was determined in the presence and absence of Na-gradient in the 
initial uphill phase (30 s) and after equilibrium (120 min) in BBM preparations. The 
rate of concentrative uphill uptake of ^^ Pi in the presence of a Na-gradient (NaCl in 
the medium) was markedly decreased in CP treated compared to control rats (Table 7; 
Fig 19). However, the uptake of ^^ Pi at the equilibrium phase (120 min) when Na-
o=Naj was not significantly different between the two groups. Also Na-independent 
uptake (in the absence of a Na gradient, when NaCl in the medium was replaced by 
KCl where Ko> Ki) of ^^ Pi at 30 s and 120 min was also not affected by CP treatment 
indicating specific alteration only when Na-gradient was present. The net uptake of 
Pi (Table-7c) was also significantly decreased. In contrast, dietary GT 
supplementation alone significantly increased the uptake of ^^ Pi in the uphill phase 
(30s) in the presence of a Na-gradient. When CP treatment was extended to GT rats. 
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Table 5: Effect of green tea (GT) consumption on brush border membrane enzymes 
in BBMV isolated from small intestine with/without cisplatin (CP) treatment. 
Groups 
Control 
CP 
GT 
TCP 
ALP 
(|j,mol/mg 
protein/h) 
7.5 ± 0.04 
3.6±0.11* 
(-52%) 
4.6 ±0.2* 
(-39%) 
3.64 ±0.05* 
(-51%) 
GGTase 
(^mol/mg 
protein/h) 
13.35 ±0.12 
7.85 ± 0.22* 
(-41%) 
15.9 ±0.86* 
(+19%) 
13.5±0.3t 
(+1%) 
LAP 
(|imol/mg 
protein/h) 
35.5 ± 1.3 
27.9 ±1.28* 
(-21%) 
47.8 ±2.88* 
(+35%) 
38.9±2.78t 
(+10%) 
Sucrase 
(^mol/mg 
protein/h) 
255.98 + 8.5 
190.5 ±6.5* 
(-26%) 
337.5 ±3.11* 
(+32%) 
289.01 ± 2.9*t 
(+13%) 
Results are Mean ± SEM of 3-4 different preparations 
* Significantly different from control, t significantly different from CP at p< 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 6: Effect of green tea (GT) consumption on brush border membrane enzymes 
in BBMV isolated from renal cortex with/without cisplatin (CP) treatment. 
Groups 
Control 
CP 
GT 
TCP 
ALP 
(|amol/mg 
protein/h) 
11.85 ±0.24 
9.2 ±0.28* 
(-22%) 
15.8 ±0.44* 
(+33%) 
16.2±1.2*t 
(+37%) 
GGTase 
(|imol/mg 
protein/h) 
177.4 ±2.7 
107.1 ±4.28* 
(-40%) 
224.1 ±5.1* 
(+26%) 
236.4 ±11.8*t 
(+33%) 
LAP 
(fimol/mg 
protein/h) 
44.4 ± 0.64 
14.35 ±1.27* 
(-68%) 
23.6 ±1.33* 
(-47%) 
28.9 + 0.7* 
(-35%) 
Results are Mean ± SEM of 3-4 different preparations 
Significantly different from control, t significantly different from CP at p< 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Figure 17: Effect of green tea (GT) consumption on (A) ALP (B) GGTase (C) LAP (D) 
Sucrase in Intestine Homogenate and BBM with/without cisplatin (CP) treatment. 
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Figure 18: Effect of green tea (GT) consumption on (A) ALP (B) GGTase (C) LAP in 
Cortex Homogenate and BBM with/without cisplatin (CP) treatment. 
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CP induced decrease in Pi transport was not observed. Moreover, the net rate of 
uptake of Pi remained significantly higher m TCP rats compared to control rats and 
significantly much more higher compared to CP treated rats. Similar to the effect of 
CP alone, the effect of GT alone or in combination with CP treatment was specific in 
the presence of a Na-gradient. The transport of ^^Pi in the absence of Na-gradient (i.e. 
where Ko> Kj) and after 120 min were not affected by any of these treatment. 
Effect of ereen tea (GT) on cisplatin (CPHnduced alterations on the enzymes of 
carbohydrate metabolism in various rat tissues: 
The effect of CP, GT and CP+GT was determined on the activities of various 
enzymes of carbohydrate metabolism in the kidney and other major tissues (Tables 8 
and 9). CP treatment to control rats significantly increased hexokinase activity in the 
intestine (+14%); liver (+30%), renal cortex (+5%) and medulla (+36%). The activity 
of LDH (a marker of anaerobic glycolysis), however profoundly increased in the 
intestine (+50%), renal cortex (+70%) and medulla (+27%)) whereas decreased in the 
liver (-30%)). However, the effect of CP was differentially observed on MDH activity 
(an enzyme of TCA cycle) in different tissues. CP caused significant decline in MDH 
activity in the intestine (-11%)), renal cortex (-23%)) and medulla (-27%) whereas 
increase in the liver (+66%). As previously reported (Khan et al., 2007), GT 
consumption significantly enhanced metabolic activities in almost all tissues studied. 
The activity of HK, LDH and MDH significantly increased in the intestine, liver and 
renal cortex and medulla with the exception of HK activity in the cortex and MDH 
activity in renal medulla which was decreased by GT. When CP treatment was 
extended to GT drinking rats, CP induced decrease in MDH activity was not only 
prevented but the activity remained significantly higher in TCP compared to either 
control or CP treated rats in the intestine, renal cortex and medulla (Tables 8 and 9). 
The activity of LDH was especially found to be profoundly enhanced in the intestine 
and renal cortex and medulla and CP-induced decrease in LDH activity was 
significantly reversed by GT consumption in the liver. 
The effect of CP and GT on the activity of glucose-6-phosphatase (G6Pase), a marker 
enzyme of gluconeogenesis was also observed in different tissues. CP significantly 
increased the activity of G6Pase in the intestine. However, CP caused marked 
reduction in G6Pase activity in renal cortex and medulla and liver (Tables 10 and 11). 
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Table 7: Effect of green tea (GT) consumption on uptake of ^^ Pi in brush border 
membrane vesicles (BBMV) from renal cortex with/without cisplatin (CP) treatment. 
(A) Na^ -
Groups 
Control 
CP 
GT 
TCP 
(B)K 
Groups 
Control 
CP 
GT 
TCP 
-gradient dependent uptake (Nao>Nai) (pmol/mg protein) 
30 s 
2246.7± 94.8 
896.2 ±38.2* 
(-60%) 
3024.3 ±161.5* 
(+35%) 
2507.9 ±154.4* 
(+12%) 
120 min 
395.9 ±16.4 
347.3 ± 8.97 
(-12%) 
459.8 + 28. 
(+16%) 
440.2+ 19.4 
(+11%) 
" -^gradient dependent uptake (Ko>Ki) (pmol/mg protein) 
30 s 
152.8 ±7.5 
147.8 ±5.3 
(-3%) 
171+6.9 
(+12%) 
160.7 ±12.2 
(+5%) 
(C) Net Na^-gradient dependent uptake 
Groups 
Control 
CP 
GT 
TCP 
Na*-gradient 
dependent uptake 
2246.7 ± 94.8 
896.24± 38.2* 
3024.3± 161.5* 
2507.9± 154.4* 
120min 
393.6 + 7.4 
357.8+13.9 
(-9%) 
429.3 + 4.8 
(+9%) 
415+13.2 
(+5%) 
at 30 s 
K^-gradient 
dependent uptake 
152.8+7.5 
147.8+5.3 
171+6.9 
160.7+ 12.2 
Net uptake 
(Na^-K^) 
2094.0 
748.4 
(-64%) 
2853.3 
(+36%) 
2347.2 
(+12%) 
Results are Mean ± SEM for five different preparations. 
* Significantly different from control, ^ significantly different from CP at p< 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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(A) Na^-dependent transport of Pi 
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Figure 19: Effect of green tea (GT) consumption on (A) Na^ dependent (B) 
K'^dependent (C) Net uptake of ^^ Pi in BBMV from renal cortex with/without 
cisplatin (CP) treatment. 
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Table 8: Effect of green tea (GT) consumption on the activity of metabolic enzymes 
in intestinal and liver homogenates with/without cisplatin (CP) treatment. 
Tissue 
Intestine 
Control 
CP 
GT 
TCP 
Hexokinase 
(|j.mol/mgprotein/h) 
161.4 ±2.2 
183.5 ±6.1* 
(+14%) 
189.4 ±4.8* 
(+17%) 
187.5 ±2.4* 
(+16%) 
LDH 
(|j,mol/mg protein/h) 
5.2 ±0.95 
7.78 ±1.24* 
(+50%) 
9.74 + 0.72* 
(+87%) 
10.8 + 0.2* 
(+108%) 
MDH 
(|j.mol/mgprotein/h) 
12.65 + 0.54 
11.24+1.15 
(-11%) 
14.75+1.26* 
(+17%) 
12.13 + 0.28 
(-4%) 
Liver 
Control 
CP 
GT 
TCP 
28.2 ± 0.7 
36.6 + 0.3* 
(+30%) 
32.5 ± 0.72* 
(+15%) 
32.5 + 1.22* 
(+15%) 
10.6 + 0.8 
7.4+1.2* 
(-30%) 
12.2 + 0.88* 
(+15%) 
10.68+ 0.28t 
(+0.8%) 
3.2 + 0.25 
5.3 + 1.3* 
(+66%) 
3.42 + 0.28 
(+7%) 
3.75 + 0.62t 
(+17%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, •^  significantly different from CP at p< 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 9: Effect of green tea (GT) consumption on the activity of metabolic enzymes 
in cortical and medullary homogenates with/without cisplatin (CP) treatment. 
Tissue 
Cortex 
Control 
CP 
GT 
TCP 
Medulla 
Control 
CP 
GT 
TCP 
Hexokinase 
(|j,mol/m gprotei n/h) 
123.7 ±1.6 
130.41 ±2.8 
(+5%) 
106.2 ±1.7* 
(-14%) 
118.7±1.3 
(-4%) 
99.87 ± 2.9 
136.01 ±5.67* 
(+36%) 
130.6 ±4.43* 
(+31%) 
141.8 + 0.5* 
(+42%) 
LDH 
(|j,mol/mg protein/h) 
13.77 + 0.3 
23.4 ±6.91* 
(+70%) 
24.6 + 0.99* 
(+79%) 
26.0+1.06* 
(+89%) 
23.14 + 0.8 
29.4 + 0.89* 
(+27%) 
28.85+1.75* 
(+25%) 
30.58 + 0.98* 
(+32%) 
MDH 
(|j.mol/mgprotein/li) 
33.05+1.57 
25.5 ±1.77* 
(-23%) 
45.2 ±3.25* 
(+37%) 
52.13 ±3.99*t 
(+58%) 
41.4 + 3.3 
30.3 + 1.35* 
(-27%) 
35.7 + 0.32 
(-14%) 
40.7+1.551-
(-2%) 
Results are Mean + SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different from CP at p< 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 10: Effect of green tea (GT) consumption on the activity of metabolic enzymes 
in intestinal and liver homogenates with/without cisplatin (CP) treatment. 
Tissue 
Intestine 
Control 
CP 
GT 
TCP 
G6Pase 
(fj,mol/mgprotein/h) 
0.97 ± 0.08 
1.5 ±0.17* 
(+55%) 
1.2 ±0.03 
(+24%) 
l . l±0.05t 
(+13%) 
G6PDH 
(mno l/mgprote in/h) 
0.7 ± 0.05 
0.6 ±0.09 
(-14%) 
0.26 ±0.01* 
(-63%) 
0.53 ± 0.05 
(-24%) 
ME 
(|j,mol/mgprotein/h) 
1.2 ±0.07 
1.34 ±0.05 
(+12%) 
0.46 ± 0.07* 
(-62%) 
1.02±0.01t 
(-15%) 
Liver 
Control 
CP 
GT 
TCP 
0.14 + 0.02 
0.11 ±0.03* 
(-21%) 
0.12 ±0.03* 
(-14%) 
0.11 ±0.03* 
(-21%) 
0.82 ± 0.07 
0.63 ±0.15 
(-23%) 
0.63 ±0.13 
(-23%) 
0.56 ±0.1* 
(-32%) 
1.4±0.1 
1.4±0.15 
0.89 + 0.03* 
(-36%) 
1.15±0.15 
(-18%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different from CP at p< 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control 
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Table 11: Effect of green tea (GT) consumption on the activity of metabolic enzymes 
in cortical and medullary homogenates with/without cisplatin (CP) treatment. 
Tissue 
Cortex 
Control 
CP 
GT 
TCP 
Medulla 
Control 
CP 
GT 
TCP 
G6Pase 
(l^ mol/mgprotein/h) 
0.29 ± 0.03 
0.17 ±0.01* 
(-41%) 
0.36 ±0.01* 
(+24%) 
0.32 ± 0.02t 
(+10%) 
0.22 ±0.01 
0.15 ±0.01* 
(-32%) 
0.34 ±0.03* 
(+55%) 
0.26 ± 0.01 *t 
(+18%) 
G6PDH 
(^mol/mgprotein/h) 
0.30 ± 0.03 
0.23 ± 0.04 
(-23%) 
0.65 + 0.13* 
(+117%) 
0.54±0.09*t 
(+80%) 
0.47 ± 0.05 
0.21 ±0.01* 
(-55%) 
0.34 ± 0.04* 
(-28%) 
0.23 ± 0.05* 
(-51%) 
ME 
(|imol/mgprotein/h) 
0.38 ± 0.07 
0.48 ±0.01 
(+26%) 
0.3 ± 0.24 
(-21%) 
0.31±0.14t 
(-18%) 
0.96 ± 0.24 
1.12±0.03 
(+17%) 
0.52 + 0.07* 
(-46%) 
0.87±0.04t 
(-9%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different from CP at p< 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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In contrast, GT significantly enhanced the activity of G6Pase in the intestine, 
renal cortex and medulla but lowered in the liver. As a result GT consumption by CP 
treated rats resulted insignificant increase of G6Pase in all the tissues and CP-induced 
decrease in enzyme activity was markedly prevented. The effect of GT-extract alone 
and with CP was also determined on the activities of glucose-6-phosphate 
dehydrogenase (G6PDH, HMP-shunt) and malic enzyme (ME), source ^ .of NADPH 
needed in reductive anabolic reactions. CP treatment to control rats significantly 
decreased G6PDH activity in the control rats significantly decreased G6PDH activity 
in the intestine (-14%), renal cortex (-23%) and medulla (-55%) and liver (-23%). The 
activity of ME, however, significantly increased by CP treatment in the intestine 
(+12%), renal cortex (+26%) and medulla (+17%) but remained unchanged in liver 
(Tables 10 and 11). The activities of G6PDH and ME, however, were differentially 
altered by GT. The activity of G6PDH profoundly increased in renal cortex (+117%) 
whereas decreased in the intestine (-63%)), liver (-23%)) and medulla (-28%)). ME 
activity on the other hand was lowered by GT in all the tissues. GT consumption by 
CP -treated rats resulted in significant increase in G6PDH activity in the cortex, 
however, the activity of both G6PDH and ME slightly improved but remained lower 
in other tissues compared to control rats. 
Effect ofereen tea (GT) on cisplatin (CP) induced alterations in antioxidant defense 
parameters in different rat tissues: 
The effect of CP, GT and CP+GT was determined on the parameters of antioxidant 
defense system such as lipid peroxidation (LPO), total SH, SOD and catalase (Tables 
12 and 13). Antioxidant status is a potential biomarker to determine the physiological 
state of a cell, tissue or organ. The drug including GM or CP and chemical induced 
nephrotoxicity and tissue injury has been suggested to be mediated in part by' 
perturbation in the balance of antioxidant defense system (Kuhlmann et al, 1997; 
Walker et al, 1999). CP administration to control rats resulted in a profound increase 
in the production of malondialdehyde (MDA), an end product of lipid peroxidation in 
the intestine, liver and renal cortex and medulla. However, the increase in LPO was 
much more pronounced in the intestine and renal cortex followed by liver and medulla. 
CP caused marked reduction in total SH levels in the intestine and liver whereas in 
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Table 12: Effect of green tea (GT) consumption on enzymic and non-enzymic 
antioxidant parameters in intestinal and liver homogenates with/without cisplatin (CP) 
treatment. 
Tissue 
Intestine 
Control 
CP 
GT 
TCP 
LPO 
(nmol/gmtissue) 
18.6 ±0.46 
30.4 ±1.3* 
(+63%) 
24.9±1.8t 
(+34%) 
23.5±1.5t 
(+26%) 
Total-SH 
(fimoi/gmtissue) 
3.78 ±0.06 
2.69 ±0.15* 
(-29%) 
4.3 ± 0.22* 
(+14%) 
4.22±0.15*t 
(+12%) 
SOD 
(Units/mgprotein) 
4.0 + 0.7 
2.1+0.16* 
(-48%) 
1.5 ±0.12* 
(-63%) 
3.11 ±0.82* 
(-22%) 
Catalase 
(^mo 1/mgprote i n/m i n) 
5.1+0.40 
2.83 ±0.33* 
(-45%) 
10.17±1.3* 
(+99%) 
10.9 + 4.9*1-
(+114%) 
Liver 
Control 
CP 
GT 
TCP 
244.2+10.5 
321.4 ±29.14* 
(+32%) 
224.0+12.51 
(-8%) 
196.3 +18. l t 
(-20%) 
13.88 ±1.33 
11.68 ±0.54* 
(-16%) 
12.65 ±1.15 
(-9%) 
11.7±0.125 
(-16%) 
32.4 ± 0.23 
29.03 ±1.5 
(-10%) 
22.6 ±2.58* 
(-30%) 
24.6 ± 0.74* 
(-24%) 
9.2 ±0.9 
10.96 ± 1.4 
(+19%) 
13.14+1.2* 
(+43%) 
11.15+1.49 
(+21%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different from CP at p< 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 13: Effect of green tea (GT) consumption on enzymic and non-enzymic 
antioxidant parameters in cortical and medullary homogenates with/without cisplatin 
(CP) treatment. 
Tissue 
Cortex 
Control 
CP 
GT 
TCP 
LPO 
(nmol/gmtissue) 
147.2 ± 5.89 
207.3 ±11.9* 
(+41%) 
107.9 ±5.8* 
(-27%) 
133.3 ±4.5t 
(-9%) 
Total-SH 
((imol/gmtissue) 
8.1 ±0.1 
8.84 ± 0.46 
(+9%) 
6.4 ±0.07* 
(-21%) 
6.5 ±0.13* 
(-20%) 
SOD 
(Units/mgprotein) 
12.8 ±0.4 
9.9 ±0.63* 
(-23%) 
20.9 ± 0.96* 
(+63%) 
21.1±0.8*t 
(+65%) 
Catalase 
(}xmol/mgprotein/min) 
133.7 + 5.2 
110.9 ±4.2* 
(-17%) 
176.5 ±6.3* 
(+32%) 
177.7 ±2.6*t 
(+33%) 
Medulla 
Control 
CP 
GT 
TCP 
127+11.2 
143 ±3.8 
(+13%) 
176.75 + 1.35* 
(+39%) 
146.45 ± 3.8 
(+15%) 
2.66 ± 0.24 
3.14 ±0.24 
(+18%) 
3.2 + 0.15 
(+20%) 
3.2 ± 0.42 
(+20%) 
9.9+1.3 
7.02 ±1.28 
(-29%) 
14.4 ±0.45* 
(+46%) 
J1.25±0.6t 
(+14%) 
143.6 + 6.0 
128.9 ±3.2 
(-10%) 
105.7±0.11* 
(-26%) 
110.6 ±4.2* 
(-23%) 
Results are Mean ± SEM of 3-4 different preparations. 
* Significantly different from control, t significantly different from CP at p< 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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renal tissues total SH was slightly increased. These changes in LPO and total SH 
were associated with|piarked decrease in the activity of both SOD and catalase in the 
intestine and to some extent in the cortex and medulla. However, in the liver the 
activity of SOD slightly decreased whereas catalase increased W CP. In contrast, the 
effect of GT consumption was differentially observed on the activity of these enzymes 
and other parameters in the intestine, liver and kidney. GT consumption significantly 
increased the activity of SOD in renal cortex and medulla whereas SOD activity 
significantly decreased in the intestine and liver by GT consumption. On the other 
hand, the activity of catalase significantly increased in the intestine, liver and renal 
cortex but decreased in the medulla. These alterations in the antioxidant enzymes 
were associated with ifnarked decrease of LPO in renal cortex and liver. However, 
LPO was significantly higher in the intestine and medulla in GT compared to control 
rats. The total SH levels were increased in both intestine and medulla but the levels 
decreased in the cortex and did not change significantly in the liver. 
Consumption of GT along with CP treatment significantly prevented CP induced 
increase in LPO in almost all the tissues studied. CP induced decrease in total SH was 
also prevented in the intestine whereas total SH levels remained significantly higher 
in TCP to control or CP treated rats. GT consumption showed marked protection 
^,aga^t CP-induced decrease in SOD activity in the cortex, medulla and to some 
extent in the intestine and liver. CP-induced decrease in catalase activity was also 
prevented by GT consumption in the intestine and renal cortex whereas catalase 
activity remained higher in the liver and lower in the medulla after GT consumption 
by ClVtreated rats. In general, the present results demonstrate marked protection by 
GT against CP induced alterations in oxidative stress parameters albeit differentially 
in different tissues. 
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DISCUSSION 
Cisplatin (cis-diamminedichloroplatinum II) is one of the most potent antitumor agent 
and is highly effective agent against a diverse spectrum of malignancies (Cohen and 
Lippard, 2001). However, the use of this agent is limited by the development of 
nephro- and ototoxicity (Ward and Fauvie, 1976), along with various untoward side 
effects including nausea, vomiting, diarrhea and myelosuppression (McKeage, 1995; 
Markman, 2003). CP exerts its nephrotoxic effects primarily in the S3 segment of the 
proximal tubule situated in the outer stripe of outer medulla. A spectrum of changes 
was seen including focal loss of brush border, cellular swelling, condensation of 
nuclear chromatin and focal areas of necrosis (Dobyan et al, 1980). The 
mitochondria, lysosomes and microsomes appeared to be critical targets of CP (Zhang 
and Lindup, 1993; Leibbrandt et al, 1995). CP induced alterations in mucosal 
structure were also demonstrated (Choie et al, 1983). Several strategies and agents 
were utilized to prevent CP induced toxicity, however, a viable approach for clinical 
practice could not be achieved. 
Tea is the second most consumed beverage in the world, aside/water. It provides a 
dietary source of biologically active components namely catechins that help prevent a 
wide variety of diseases (Graham, 1999). In particular, green tea (GT) has been shown 
to retard various forms of cancers due to its antimutagenic and anticarcinogenic 
properties (Mukhtar and Ahmad, 2000; Khan and Mukhtar, 2007). It was also found 
to be cardioprotective, neuroprotective, antidiabetic and antibacterial besides other 
health benefits (Alschuler, 1998; Liao, 2001). The present studies were carried out to 
test the hypothesis that GT consumption would ameliorate CP induced nephrotoxic 
and other adverse effects in the kidney and other major tissues. 
Multiple injections of CP were administered to control and GT consuming rats and 
the effects on various serum parameters and on the activities of various enzymes of 
carbohydrate metabolism, brush border membrane, mitochondria and lysosomes were 
determined to ascertain potential beneficial effects of GT. As shown in the Results, 
CP administration to control rats resulted injnarked increase in serum creatinine and 
BUN, diagnostic indicators of nephrotoxicity, accompanied by ^ significant decrease in 
serum glucose, inorganic phosphate (Pi) and„increase in serum cholesterol and 
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phospholipids. In contrast to CP, GT consumption caused a decrease in serum 
creatinine and BUN. Serum glucose, cholesterol and Pi significantly decreased but 
serum phospholipids slightly increased jp^GT. GT given to CP treated rats,J]owt>vw 
significantly lowered CP-elicited increased levels of serum creatinine and BUN. 
Serum glucose and cholesterol remained depressed whereas serum phospholipids 
profoundly enhanced upon CP treatment to GT consuming rats. GT induced 
reductions in serum glucose, cholesterol alongwith weight loss can be considered as 
healthy indicators. 
The brush border membranes (BBM) of renal proximal tubules Itavo been shorwn as 
an early and prominent site of CP«-induced renal injury (Ikuno et al, 1995; 
Vijayalakshmi et al, 2006). As a step towards understanding the biochemical 
mechanisms of CP toxicity as well as its effect on the structural and functional 
integrity of the plasma membrane, the activity of BBM enzymes was studied in 
different tissue homogenates, as well as in isolated BBM preparations. CP caused 
significant decrease in the activities of ALP, GGTase and LAP in cortical 
homogenates and isolated BBM vesicles. A similar decrease was observed in medulla, 
suggesting an overall CP induced damage to the kidney. In addition, ALP, GGTase, 
LAP and sucrase were also significantly decreased in the intestinal homogenate. and 
in mucosal BBMV in agreement with previous observations (Arivarasu et al, 2007). 
The decrease in BBM enzymes in the kidney and intestine suggest a severe damage to 
the structural architecture of these tissues by CP as reported by morphological studies 
(Dobyan et al, 1980; Choie et al, 1983). However, the effect of CP was differentially 
observed in the liver homogenate. The activity of ALP and GGTase only significantly 
increased but LAP decreased in the liver. The activity of lysosomal enzyme, ACPase 
was significantly increased in the cortex, medulla and liver but decreased in the 
intestine. Thus the effect of CP on various BBM and lysosomal enzymes appeared to 
be tissue specific. In contrast to CP, GT consumption,,, h§s«a6iEs, significantly 
increased the activities of BBM and lysosomal enzymes in the homogenate and BBM 
of the intestine and kidney indicating an overall improvement in mucosal and renal 
BBIyPintegrity;-^ variable increase in the activity of ALP/GGTase in the-renal cortex 
and inedulla nan in. LuiijRl>.ti.iJ due to their localization in thevthickness of BBM 
(Yusufi et al, 1994) or due to differential access/accumulation of GT in these tissues. 
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GT consumption in combination with CP treatment resulted in the reversal of CP-
induced alterations in the activities of certain BBM enzymes in the intestine and renal 
tissues. CP^induced decrease in the activities of GGTase, LAP and sucrase wrthThe 
exception of ALP was markedly prevented by GT+CP compared to CP alone in 
intestinal BBM. The activities of ALP and GGTase in renal BBMV remained 
significantly higher in GT+CP compared to CP treated renal BBM preparations, 
indicating a marked reversal of CP induced effect by GT consumption on these 
enzymes. CP induced decrease in LAP was also reduced by GT in renal BBM 
preparations. The results convincingly demonstrate that GT consumption not only 
prevented the CP elicited decrease in the activities of certain enzymes and they 
remained significantly higher in TCP compared to control and much higher than CP 
treated rats. The results indicate that renal BBM and lysosomes were severely 
damaged by CP. This led to decrease in BBM enzymes especially in the kidney, 
apparently due to loss/release of enzymes from damaged BBM into the lumen 
(Banday et al, 2008a) and may have been excreted in the urine as shown earlier. 
Alterations in ACPase activity demonstrate CP induced loss of lysosomal function 
(Courjault-Gautier et al, 1995; Kuhlmann et al, 1997). In contrast, GT consumption 
prevented this loss by lessening the damage caused by CP or by increasing the 
regeneration process or both. However, in the case of the intestine a different adaptive 
mechanism might be initiated where ACPase activities were increased both by CP and 
GT. 
The reabsorption (JF Na"^  ions by renal proximal tubular BBM is considered to be the 
major function of the kidney because the transport of other ions and various solutes 
including Pi depends directly or indirectly on Na reabsorption (Coux et al 2001). 
Since these transports depend on structural integrity of BBM and available energy as 
ATP which is supplied by various metabolic pathways. It is imperative that any 
alterations to these metabolic pathways caused by toxic insult or otherwise modified 
would determine the rate of transport function (Khundmiri et al, 2004; Banday et al, 
2008a). To assess the functional aspects, the activities of various enzymes of 
carbohydrate metabolism were determined under different experimental conditions. 
As shown in the Results, the activities of various enzymes involved in glycolysis, 
TCA cycle, gluconeogenesis and HMP shunt pathway were differentially altered in 
different tissues by CP treatment and/or by GT consumption. CP caused significant 
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increase in LDH but decrease in MDH activity in the intestine, renal cortex and 
medulla which was associated with simultaneous increase in hexokinase activity in 
the intestine and renal tissues. However, in the liver, an opposite CP effect was 
observed where the decrease in LDH activity was associated with increased MDH and 
hexokinase activity. Although the actual rates of glycolysis or TCA cycl^ were not 
determined, marked decrease in MDH activity in some tissues appears to be di^ e to CP 
induced damage to mitochondria (Zhang and Lindup, 1993; Kuhlmann et al, 1997). 
An impaired oxidative metabolism of glucose/fatty acid due to mitochondrial 
dysfunction would result in lower ATP production by oxidative metabolism and 
hence lower renal transport function. A marked increase in LDH and to some extent 
hexokinase activity with simulyaneous decline in TCA cycle enzyme, MDH appears 
to be an adaptive cellular effect in energy metabolism from aerobic metabolism 
alternatively to anaerobic glycolysis due to CP induced mitochondrial dysfunction. 
CP also caused differential effect on the enzymes of gluconeogenesis and HMP-shunt 
pathway in different tissues. The activity of G6Pase significantly increased in the 
intestine but significantly decreased in the liver and renal tissues upon CP treatment. 
The activity of G6PDH, however, profoundly decreased in all the tissues studied. The 
activity of NADP -malic enzyme (ME), however variably increased in the intestine 
and renal tissues but decreased in the liver. The present data indicate that CP caused 
variable effect on different enzymes of carbohydrate metabolism in different tissues. 
Jn contrast to CP, GT consumption caused selective alterations in the activities of 
various enzymes involved in carbohydrate metabolism in different rat tissues. The 
activity of HK, LDH (glycolysis), MDH (TCA cycle) and G6Pase significantly 
increased in the intestine and renal tissues but decreased in the liver as reported earlier 
(Khan et al, 2007). GT administration to CP-treated rats resulted in overall 
impfevement of carbohydrate metabolism in various tissues as evident by higher 
activities of LDH, MDH and gluconeogenic enzymes in various tissues in GT+CP 
compared to CP alone or control rats. GT might have lowered number of damaged 
mitochondria or affected macromolecules or may have increased number of normally 
active organelles or macromolecules. The decrease/increase in G6Pase by CP/GT, 
respectively can be attributed to the availability of oxaloacetate produced from malate 
by MDH. Thus decrease/increase in MDH activity may affect both the TCA cycle and 
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gluconeogenic activity as oxaloacetate is required by both pathways. In turn, ATP 
production would be influenced accordingly. 
The Pi required for the production of metabolites and ATP irlfact is conserved by the 
kidney. The transport of Pi by renal cortical BBM is an essejUial and-regulatary step. 
It appears from the data that CP by lowering oxidative metabolism lowers ATP 
production, whereas GT consumption increased ATP production by increasing the 
metabolic activities to support many cellular functions especially in the kidney. Thus, 
in both the situations the transport functions were affected accordingly. The present 
results show that Na-dependent transport of Pi significantly decreased by CP 
treatment but significantly increased by GT consumption. GT given to CP rats further 
enhanced renal BBM Pi transport capacity. Thus it appears that GT induced Pi 
conservation by the kidney maintained a positive'balance'^fThe "Pt in the-serum to 
support metabolic activities of not only kidney but also of other tissues. 
It has been reported that som^ toxicantyincluding certain drugs (Walker et al, 1999; 
Cuzzocrea et al, 2002; Banday et al, 2008a) and heavy metals (Baliga et a/., 1998; 
Fatima et al, 2004, 2005) exert their toxic effects by inducing the generation of 
reactive oxygen species (ROS). However, oxidative stress can occur as a result of 
either increased ROS generation and/or decreased antioxidant enzyme system 
comprising SOD, catalase and GSH-Px. These antioxidant enzymes protect the cell 
against cytotoxic ROS. CP has been found to increase mitochondrial generation of 
oxidative stress and ROS and subsequent cell death (Qian et al, 2005). CP has been 
shown to enhance lipid peroxidation (LPO), an indicator of tissue injury and deplete 
GSH and protein thiols (Nakano and Gemba, 1989; Mistry et al, 1991). The activities 
of antioxidative enzymes were shown to be decreased by CP in the kidney and 
intestine (Fatima et al, 2004; Arivarasu et al, 2007). In agreement with previous 
observations, CP significantly decreased the activities of SOD, and catalase and 
enhanced LPO in the intestine and renal tissues indicating CP induced oxidative 
damage. The severity of the damage appeared to be more prominent in the intestine 
and renal cortex than in the medulla or liver. 
The present results show that GT, by virtue of its antioxidant properties, significantly 
enhanced antioxidant defense mechanism albeit differentially in different tissues. The 
activity of SOD significantly increased in the renal cortex and medulla whereas 
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decreased in the intestine and liver. However, catalase activity profoundly increased 
in intestine, liver and renal cortex but decreased in renal medulla. These alterations 
were associated with lowering of LPO in the liver and renal cortex. GT consumption 
selectively prevented CP induced increase in LPO and decrease in the activities of 
SOD and catalase in the intestine and renal cortex. CP induced reduction in SOD 
activity in the medulla and increase in LPO in the liver were also prevented by GT 
consumption. The results suggest that GT provide protection against CP nephropathy 
or oxidative damage either by SOD-mediated or catalase mediated mechanism or 
involving both mechanisms simultaneously in certain tissues. 
In conclusion, the results of present study show that CP induces generation of free 
radicals that causes oxidative damage to cellular organelles, macromolecules and 
especially to mitochondria and plasma membrane. In contrast, GT reduces oxidative 
stress by virtue of its antioxidant properties thus improving the structural integrity of 
various organelles/macromolecules and eventually enhances metabolip capabilities 
and transport of Pi especially in the kidney. 
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SUMMARY AND CONCLUSION 
A nvimber of environmental contaminants and pharmaceutical agents including heavy 
metals and antibiotics dramatically alter the structure and function of various tissues 
and produce muhiple adverse effects in the liver, kidney, intestine and heart (Soberon 
et al, 1979; Ozturk et al, 1997; Kohn et al, 2005). These environmental variables 
are also knovra to influence the incidence and expression of various diseases. The 
heavy metals such as mercury, lead, chromium, platinum and uranium have been 
shown to cause severe damage to kidney leading to acute renal failure (ARF) 
(Sanchez et al, 2001; Fatima et al, 2004, 2005; Barbier et al, 2005). 
Cisplatin (CP) is an anti-neoplastic agent that has a remarkably broad spectrum of 
clinical activity in the treatment of solid tumors, while gentamicin (GM), an 
aminoglycoside is used in a variety of infections caused by Gram negative bacteria. 
The limiting side-effect of both these drugs is the nephrotoxicity associated with their 
use (Humes, 1988; Tulkens, 1989; Barry, 2000). 
The specificity of GM for renal toxicity is apparently related to its accumulation in the 
renal proximal convoluted tubule causing a number of morphological and biochemical 
alterations in humans and experimental animals (Kacew and Bergeron, 1990; Ali, 
1995; Mingeot-Leclercq and Tulkens, 1999). GM has been shown to cause marked 
histological damage in particular to renal proximal convoluted tubules (SI and S2 
subsegments) (Humes and Cormor, 1988; Abdel-Gayoum et al, 1994) resulting in 
swelling, vacuolization and necrosis of epithelial cells and accumulation of myelin-
like bodies (Ali and Bashir, 1994; Pedraza-Chaverri et al, 2000). The adverse 
interaction of the drug with critical intracellular processes leads to renal cortical 
phospholipidosis disrupting functions of membranes and organelles including BBM, 
BLM, mitochondria, lysosomes and microsomes (Laurent et al, 1990; Cronin and 
Henrich, 1996; Mingeot-Leclercq e? a/., 1999). 
The optimal use of cisplatin as a chemotherapeutic drug has been limited by its 
nephrotoxicity. Following administration, CP is widely distributed into body fluids 
and tissues. The highest concentration can be seen in the kidneys, liver and intestine 
although it has also been found in all other tissues (McEvoy, 1992). Induction of 
nephrotoxicity is assumed to be a rapid process involving reactions with proteins in 
renal tubules. In tubular cells a primary target for CP is probably the genomic DNA. 
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Light and electron microscopy have shown that the CP induced injury and necrosis in 
the rat kidney are predominantly localized in the S3 segment of proximal tubule in the 
corticomedullary region (Townsend et al, 2003). CP toxicity in proximal tubular 
epithelial cells is morphologically characterized by tubular necrosis, loss of microvilli, 
alterations in the number and size of lysosomes and mitochondrial vacuolization 
accompanied by functional disturbance of various cell organelles (Kuhlmann et al, 
1997). 
Although both GM and CP cause alterations in the structure and functions of the 
kidney and other major tissues, these appear to be two dissimilar models of ARF 
(Annie et al, 2005). GM appears to primarily affect the structure and function of 
membrane phospholipids (Cronin et al, 1986) whereas CP causes renal damage due 
to interactions with enzyme protein thiol groups in the membrane (Nakano and 
Gemba, 1989). GM produces marked histological damage in particular to SI and 82 
subsegments whereas CP primarily affects the S3 segment of renal proximal tubule 
(Abdel-Gayoum et al, 1994; Townsend et al, 2003; Banday et al, 2008a). A 
relationship between oxidative stress and nephrotoxicity has been well-demonstrated 
in many experimental animal models (Devipriya and Shyamaladevim, 1999). 
Evidence points out that cisplatin and gentamicin induce nephrotoxicity partly via 
oxidative stress. Another mechanism proposed is that cisplatin induces renal damage 
by free-radical generation, by altering arginine metabolism and by increasing the 
activity of calcium independent nitric oxide synthase (Devipriya and Shyamaladevim, 
1999). Gentamicin activates phospholipases and alters the lysosomal membrane in 
addition to causing oxidative stress (Lindquist, 1986). 
There is a continuous search for agents which provide nephroprotection against the 
renal impairment by the drugs, GM and CP. Several approaches, utilizing different 
mechanisms, have been attempted to reduce GM nephrotoxicity and related 
aminoglycoside antibiotics. These mechanisms include decreasing or preventing drug 
accumulation by the kidneys or decreasing binding to BBM (Mingeot-Leclercq et al., 
1989). Many different agents and strategies have been reported to ameliorate GM 
nephrotoxicity in experimental animals (Ali, 2003; Nagai and Takano, 2004). Among 
them protection against GM nephrotoxicity was mainly focused on the use of various 
antioxidant agents including the extracts from medicinal plants with antioxidant 
properties (Ali, 2003). Similarly several agents have been tested to see whether they 
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could ameliorate the nephrotoxicity of platinum drugs (Ali and Al-Moundhri, 2006). 
The agents that have been shown to prevent experimental CP nephrotoxicity include 
antioxidants, modulators of nitric oxide, agents interfering with metabolic pathways 
and cytoprotective and antiapoptotic agents. Only few of these agents have been 
tested in humans. However, none of these approaches have been found safe/suitable 
for clinical practice due to known and unexplored side effects. 
In past few years, much interest has been centered on the role of naturally occurring 
dietary substances for the control and management of various chronic diseases such as 
cancer and cardiovascular disorders (Alschuler, 1998; Weisburger, 1999; Connor, 
2000). From ancient times the physicians and scholars in Asia have understood that 
food^have both preventive and therapeutic value and are integral part of health. 
Omega-3 polyunsaturated fatty acids (co-3 PUFA) enriched fish oil and green tea 
provide such dietary sources of biologically active components that has been shown to 
be co-preventive and co-therapeutic in a wide variety of ailments (Doughman et al. 
IQOl; Khan and Mukhtar, 2007). 
Since ancient times GT consumption has been known to maintain and improve health. 
It has been shown to have extensive health benefits. GT consumption has been linked 
to lowering of various forms of cancers (Katiyar and Mukhtar, 1997; Ahmad and 
Mukhtar, 1999). GT and its constituents have been shown to have cardioprotective, 
neuroprotective, antidiabetic, anti-inflammatory, antiatherosclerotic, anti-microbial 
and anti-aging properties (Alschuler, 1998; Liao, 2001). In addition, GT has been 
found to be useful in the treatment of arthritis, high cholesterol levels, and impaired 
immune function (Van het Hof et al, 1999). GT consumption has also resulted in 
improved kidney function in animal models of renal failure (Yokozawa et al, 1996, 
2005). GT polyphenols have been shown to exhibit strong antioxidant properties 
(Alschuler, 1998). Most beneficial health effects ascribed to GT are considered to be 
mediated by potential antioxidant properties of GT polyphenols that scavenge free 
radicals and reduce oxidative damage (Augustyniak et al, 2005). 
In a preliminary report, GT has been shown to mitigate gentamicin and CP induced 
nephrotoxicity by lowering the level of serum urea, creatinine and tissue LPO content 
(Upaganlawar et al, 2006). Green tea extract has also been found to offer significant 
protection from cisplatin induced oxidative damage in rat kidney and testes (Leena 
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and Balaraman, 2005). Although there are several studies supporting the preventive 
potential of green tea, a proper understanding of the mechanisms by which they 
reduce the risk is necessary to establish the efficacy. In view of numerous beneficial 
health effects of GT we hypothesized that: ''Green tea enriched in polyphenols 
would be able to prevent/reduce GM/CP induced nephrotoxicity and other adverse 
effects caused by them in rat kidney, intestine and liver". 
To address this hypothesis the present work was undertaken to study the detailed 
biochemical events/cellular response/mechanism of GM and CP induced nephrotoxic 
and other adverse effects in rat kidney and intestine. The effect of GT was also 
determined to observe any protection provided by it against GM/CP nephrotoxicity. 
The following parameters were determined under various experimental conditions: 
(a) Certain biochemical parameters in serum. 
(b) The activities of BBM and lysosomal marker enzymes in the renal cortical, 
medullary, mucosal and liver homogenates and BBM marker enzymes in 
isolated BBM preparations from renal cortex and intestinal mucosa. 
(c) The transport of •'^ Pi in renal cortical BBM. 
(d) The activities of certain enzymes of carbohydrate metabolism involved in 
glycolysis, TCA cycle, gluconeogenesis, HMP-shunt pathway in the renal 
cortex, medulla, small intestine and liver. 
(e) The 0nz>^ic and non-enzynufc parameters of antioxidant defense system in 
the renal cortex, medulla, small intestine and liver. 
THE RESULTS OBTAINED ARE SUMMARIZED AS FOLLOWS: 
Part I; 
Effect of Green tea (GT) consumption via diet (GTD) or via drinkim fluid (GTE) 
(a) Serum parameters: 
In general, GT consumption either via diet (GTD) or drinking GT extract (GTE) 
resulted in slight loss of body weight and BUN that was associated with decrease in 
serum glucose, cholesterol and Pi and increase in phospholipids. 
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(b) Marker enzymes ofBBM and lysosomes: 
The effect of GT consumption was determined on marker enzymes of BBM and 
lysosomes in different rat tissues. GT consumption caused significant increase in the 
activities of BBM enzymes, ALP, GGTase, LAP and sucrase and lysosomal enzyme 
ACPase in mucosal homogenates. The activity of BBM enzymes except ALP was 
also increased in BBM preparations isolated from intestinal mucosa. The activities of 
BBM and lysosomal enzymes were differentially altered by GT in the cortex, medulla 
and liver homogenates. In the liver, the activity of ALP and GGTase were 
significantly decreased whereas LAP and ACPase were not changed. However, the 
activities of ALP and ACPase increased but GGTase and LAP decreased in cortical 
homogenates whereas the activities of ALP, GGTase and ACPase also slightly 
increased but LAP decreased in renal medulla. The activities of ALP and GGTase 
markedly increased but LAP significantly lowered in BBM vesicles isolated from 
renal cortex by GT consumption. The differential effects of GT on BBM and 
lysosomal enzymes observed in different tissues can be attributed to their different 
organization in the thickness of BBM and/or to differential accumulation/accessibility 
of GT in different tissues. 
(c) Enzymes of carbohydrate metabolism: 
GT consumption caused significant increase in the activities of various enzymes of 
carbohydrate metabolism, however, to different extent in different rat tissues. The 
activity of HK, LDH (glycolysis), MDH (TCA cycle) significantly increased to much 
greater extent in the intestine and renal cortex but to a lesser extent in the liver. The 
activity of HK and LDH increased, whereas MDH activity decreased in the medulla 
by GT consumption. The activity of G6Pase and FBPase, enzymes of 
gluconeogenesis significantly increased in the intestine, renal cortex and medulla but 
decreased in the liver. The activity of G6PDH (HMP-shunt pathway) significantly 
lowered by GT consumption in the intestine, liver and medulla whereas profoundly 
increased in the cortex. The activity of NADP-malic enzyme (ME), however, 
decreased in all the tissues although to much different extent. 
143 
(d) Enzymic and non-enzymic parameters of antioxidant defense mechanism: 
GT consumption appeared to perturb antioxidant defense system although 
differentially in different rat tissues. The activity of Cu, Zn superoxide dismutase 
(SOD) significantly decreased in the intestine and liver but significantly increased in 
the renal cortex and medulla. In contrast, catalase activity markedly increased in the 
intestine and liver but did not change in renal tissues by GT ingestion. The alterations 
in the activity of SOD and catalase were associated with significant lowering of lipid 
peroxides (LPO), measured as malondialdehyde in the liver and renal cortex. 
However, LPO levels were enhanced in the intestine and renal medulla by GT 
consumption. Taken together, the results imply that biological defense system 
perturbed by GT as a result of free radical scavenging properties chiefly of its 
polyphenols. 
:^ Interpretation: In general, GT consumption significantly enhanced the activities 
of the enzymes of carbohydrate metabolism involved in glycolysis, TCA cycle, 
gluconeogenesis, BBM and oxidative stress in the intestine and kidney. GT 
consumption appeared to exert numerous beneficial health effects by improving 
nutrition/energy metabolism and in part by strengthening cellular antioxidant 
defense mechanism. 
Part II: 
Influence ofureen tea (GT) consumption on sentamicin (GM) induced nephrotoxic 
and other adverse effects 
(a) Serum parameters: 
GM administration caused severe nephrotoxicity as characterized by significant 
increase in serum creatinine, cholesterol, phospholipids and BUN accompanied by 
significant decrease in serum glucose and Pi. Prolonged GT consumption prior to and 
together with 10 day GM treatment significantly lowered GM induced increase in 
serum creatinine and BUN, indicating reduction in GM nephropathy. GM elicited 
increase in serum cholesterol was also lowered whereas serum glucose remained 
depressed but serum Pi and phospholipids increased. 
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(b) Marker enzymes ofBBM: 
GM treatment to control rats caused significant decrease in the activities of ALP, 
GGTase and LAP in renal cortex and medulla, indicating GM induced damage to the 
kidney. However, the activities of these enzymes along with sucrase increased in the 
intestine. GM caused small decrease in BBM enzymes in liver homogenates. GT 
consumption caused significant reversal in GM induced decrease in BBM enzyme 
activities in the cortex and medulla, whereas the enzyme activities further enhanced in 
the intestine by GT in GM co-administered rats. GM induced alterations and GT 
elicited changes in BBM enzyme activities were more apparent in isolated renal and 
mucosal BBM vesicles compared to the effect observed in the respective 
homogenates. The activity of ACPase (a lysosomal enzyme) variably decreased by 
GM whereas GT partially restored ACPase activity in various tissues. 
(c) Na-dependent transport of^^Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of ^^ Pi in the presence of a Na-gradient 
measured at 30 s was markedly decreased by GM but significantly increased by GT. 
GM induced decrease in ^^Pi uptake was not only prevented by GT consumption but 
remained significantly higher in GM and GT co-administered than in control rats. The 
uptake of ^^Pi in the absence of Na-gradient and after equilibrium at 120 min did not 
change under any experimental conditions, indicating the specificity of the effect on 
•^ P^i transport by GM or GT or their combination. 
(d) Enzymes of carbohydrate metabolism: 
The activities of various enzymes involved in glycolysis, TCA cycle, gluconeogenesis 
and HMP shunt pathway were variably altered by GM/GT and GM+GT in different 
tissues. The activity of HK and LDH significantly increased but MDH activity 
decreased in the intestine, cortex and medulla by GM treatment. In the liver, GM 
increased the activity of HK and MDH but decreased LDH activity. The activity of 
G6Pase and FBPase increased in the intestine and liver but decreased in renal tissues. 
However, G6PDH activity decreased in the liver but increased in the intestine and 
renal tissues whereas ME activity decreased in all the tissues. 
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As shown in Part 1, many of these metabolic enzymes were enhanced by GT. GT 
consumption by GM treated rats resuhed not only in the prevention of GM induced 
decrease in many of the enzyme activities but their activities remained significantly 
higher compared to control/GM treated rats. The activity of LDH was especially 
enhanced to much greater extent by GT in GM treated rats. 
(e) Enzymic and non-enzymic parameters of antioxidant defense mechanism 
GM caused significant decrease in the activities of SOD and catalase in the intestine, 
liver and renal cortex and medulla which was associated with marked increase in LPO 
and decrease in total-SH, indicating that GM caused severe damage to various tissues 
by generating free radicals and by suppressing the activities of antioxidant enzymes. 
GT consumption protected well against GM induced perturbation of 
oxidants/antioxidants or GM induced oxidative damage. GM induced decrease in 
SOD and/or catalase activity was markedly reversed/reduced by GT consumption. 
GM induced increase in LPO was also lowered by GT components at least in the liver 
and renal tissues. 
=^ Interpretation: GM caused severe damage to kidney and produced multiple 
adverse effects to other tissues as refected by nephrotoxicity parameters, 
decrease in BBM and lysosomal enzymes, certain enzymes of carbohydrate 
metabolism and suppression of antioxidant enzymes SOD and catalase. GT 
consumption markedly reversed/reduced GM induced oxidative damage and 
cellular functions by enhancing carbohydrate metabolism and antioxidant 
defense mechanism most likely due to intrinsic biochemical and antioxidant 
properties of GT polyphenols. 
Part III; 
Influence of sreen tea (GT) consumption on cisplatin (CP) induced nephrotoxicity 
and other adverse effects 
(a) Serum parameters: 
CP administration resulted in marked nephrotoxicity as manifested by increased 
serum creatinine and BUN. Serum cholesterol, phospholipids significantly increased 
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but serum glucose and Pi significantly declined by CP treatment. GT significantly 
decreased glucose, cholesterol and Pi but phospholipids increased. CP elicited 
increase in serum creatinine and BUN was markedly lowered by GT consumption, co-
administered to CP treated rats. CP induced increase in serum cholesterol was also 
prevented by GT. 
(b) Marker enzymes ofBBMand lysosomes: 
CP treatment to control rats caused significant decrease in the activity of ALP, 
GGTase, LAP and sucrase (only in the intestine) in the homogenates of intestine, 
liver, renal cortex and medulla and in BBMV isolated from renal cortex and intestinal 
mucosa. GT, in general significantly increased the activities of ALP, GGTase, LAP 
and sucrase in the intestine; the activity of ALP in the cortex and ALP and GGTase in 
the medulla were increased by GT consumption. CP induced decrease in most BBM 
enzymes in the intestine and ALP and GGTase in the cortex and medulla was 
markedly prevented/reduced by GT co-administration to CP treated rats. The changes 
observed by CP and/or GT were more apparent in the BBMVs isolated from renal 
cortex and intestinal mucosa than observed in the respective homogenates. The 
protection provided by GT against CP induced alterations was also more marked in 
isolated BBM preparations. 
(c) Na-dependent transport of Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of ^^ Pi in the presence of a Na-gradient 
measured at 30 s was markedly decreased by CP but significantly increased by GT. 
CP induced decrease in ^^Pi uptake was not only prevented by GT consumption but 
remained significantly higher in CP and GT co-administered than in control rats. The 
uptake of Pi in the absence of Na-gradient and after equilibrium at 120 min did not 
change under any experimental conditions, indicating the specificity of the effect on 
Pi transport by CP or GT or their combination. 
(d) Enzymes of carbohydrate metabolism: 
The activities of various enzymes involved in glycolysis, TCA cycle, gluconeogenesis 
and HMP shunt pathway were variably affected by CP and GT and CP+GT in 
different rat tissues. The activity of LDH and to some extent that of HK significantly 
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increased, whereas MDH activity significantly decreased in the intestine, cortex and 
medulla by CP treatment. However, the activity of HK and MDH increased but LDH 
activity decreased in the liver. The activity of G6Pase (enzyme of gluconeogenesis) 
significantly increased in the intestine but significantly decreased in the liver, cortex 
and medulla by CP. In contrast to GM, CP significantly decreased the activity of 
G6PDH in all the tissues along with significant increase in NADP-malic enzyme 
(ME) activity in the intestine, cortex and medulla. As shown in Part I, many of these 
metabolic enzymes were increased by GT consumption. Prolonged GT consumption 
by CP treated rats markedly prevented CP induced decrease in MDH, G6Pase, 
G6PDH activities in the cortex, medulla and liver. The decrease of MDH activity by 
CP was also prevented by GT in the intestine. However, the activity of LDH remained 
significantly higher in the intestine, cortex and medulla in CP treated rats after GT 
consumption. 
(d) Enzymic and non-enzymic parameters of antioxidant defense mechanism: 
CP caused significant decrease in the activities of SOD and catalase in the intestine 
and renal cortex and medulla which was associated with marked increase in LPO and 
decrease in total-SH, indicating that CP caused severe damage to these tissues by 
generating free radicals and by suppressing the activities of antioxidant enzymes. In 
the liver, the increase in LPO was however associated with a slight decrease in SOD 
but increase in catalase activity. GT consumption protected well against CP induced 
perturbation of oxidants/antioxidants or CP induced oxidative damage. CP induced 
decrease in SOD and/or catalase activity was markedly reversed/reduced by GT 
consumption in most tissues. CP induced increase in LPO was also lowered by GT in 
the intestine, liver and renal cortex. 
^ Interpretation: CP caused severe damage to kidney and produced multiple 
adverse effects to other tissues as reflected by increase in nephrotoxicity 
parameters, decrease in BBM and lysosomal enzymes, certain enzymes of 
carbohydrate metabolism and suppression of antioxidant enzymes, SOD and 
catalase. GT consumption markedly reversed/reduced CP induced oxidative 
damage and cellular functions by enhancing carbohydrate metabolism and 
antioxidant defense mechanism most likely due to intrinsic biochemical and 
antioxidant properties of GT polyphenols. 
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Conclusion: 
In conclusion, GM/CP elicited deleterious nephrotoxic effects by causing major 
damage to mitochondria, lysosomes and in particular to BBM of renal proximal 
tubule and intestinal mucosa as reflected by significant decrease in the activities of 
their specific biomarker enzymes, confirming the morphologic and toxicogenomic 
observations that showed these organelles as prime GM/CP targets. Both GM and CP 
seem to enhance glycolytic enzyme LDH in order to increase energy dependence on 
glycolysis due to mitochondrial damage and depressed TCA cycle enzymes. These 
nephrotoxic and other adverse effects appeared to be mediated in part due to GM/CP 
elicited oxidative damage. GT consumption to a larger extent prevented GM/CP 
induced nephrotoxicity parameters by enhancing nutrition/energy metabolism and Pi 
transport capacity, by strengthening antioxidant defense mechanism and by altering 
membrane organization. It is apparent that green tea is a source of a wide range of 
phytochemicals that are digested, absorbed and metabolized by the body and that tea 
constituents exert their effects at the cellular level. Tea's status as a functional food 
lends credibility to what has been believed by tea drinkers for centuries. Based on our 
present observations and already known numerous health benefits, we propose that 
GT polyphenols may provide a cushion for a prolonged therapeutic option against 
drug/chemical induced nephropathy without harmful side effects. 
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Influence of green tea on enzymes of carbohydrate metabolism, 
antioxidant defense, and plasma membrane in rat tissues 
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Abstract Objective: Green tea, consumed worldwide since ancient times, is considered beneficial to human 
health. We hypothesized that green tea would enhance antioxidant defenses and specific metabolic 
activities of rat intestine, liver, and kidney to improve their fimctions 
Methods: The effect of green tea given to rats in the diet or drinking water for 25 d was determined 
on blood chemistry and on activities of enzymes of carbohydrate metabolism, brush border 
membrane, and antioxidant defense 
Results: Senim glucose, cholesterol, phosphate, and body weight decreased, whereas the activities 
of lactate and malate dehydrogenases and glucose-6- and fructose 1,6-bis-phosphatases increased m 
the intestine and kidney but slightly changed m the liver Activity of glucosc-6-phosphatc dehy-
drogenase profoundly increased m the renal cortex but decreased in other tissues Lipid peroxidation 
increased in the intestine and renal medulla and decreased in the renal cortex and liver, catalase 
increased in all tissues but the medulla. Superoxide dismutase activity decreased in the intestine but 
increased in renal tissues Activities of brush border membrane enzymes in general increased in the 
intestine and kidney. 
Conclusion: Green tea consumption resulted m enhanced enzyme activities of carbohydrate 
metabolism and antioxidant defenses, which may lead to improved health. © 2007 Elsevier Inc 
All rights reserved. 
Kewvords Green lea (Camellia sinensis): Carbohydrate metabolism. Antioxidant enzymes. Intestine, Liver, Kidney 
Introduction 
Tea in the form of green tea (GT) or black tea is one of 
the most widely consumed beverages in the world today 
second only to water [1]. Since ancient times GT consump-
tion has been known to maintain and improve health. Poly-
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phenols are plant metabolites occurring widely in plant food 
and exhibit outstanding antioxidant and free radical scav-
enging properties [2]. GT is an excellent source of polyphe-
nols such as catechins [3], orgallotannins, flavonols, flavan-
diols, and phenolic acids [4]. In pailicular GT catechins and 
their derivatives are known to contribute beneficial health 
effects ascribed to tea by their antioxidant [5], antimuta-
genic, and anticarcinogenic properties [6]. GT consumption 
has been linked to lowering of various forms of cancers 
[7,8]. GT constituents also have been shown to have car-
dioprotective, neuroprotective, antidiabetic, and antimicro-
bial properties [9,10]. In addition, GT has been found to be 
useful in the treatment of arthritis, high cholesterol levels, 
infection, and impaired immune function [11]. GT con-
sumption also has resulted in improved kidney functions in 
animal models of renal failure [12,13]. We hypothesized 
that GT enhances specific metabolic activities and anti-
0899-9007/07/$ - see front matter ( 
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oxidant defenses in various rat tissues due to its intrinsic 
free radical scavenging properties to improve their func-
tioning. To address this hypothesis the effect of GT 
consumption was investigated on the activities of certain 
enzymes of carbohydrate metabolism, brush border mem-
branes (BBMs), lysosomes, and antioxidant defense system 
in the rat model. 
Green tea consumption resulted in decreases in serum 
gluco.se, cholesterol, and inorganic phosphate (Pi) and an 
increase in semm phospholipids. The activities of enzymes 
of glucose oxidation and its production selectively but vari-
ably increased in intestine and kidney tissues. Lipid peroxi-
dation (LPO), an indicator of cell injury, and enzyme ac-
tivities of the antioxidant defense system, e.g., superoxide 
dismutase (SOD) and catalase, and BBM were also altered 
but differentially in different tissues by GT consumption. 
The results indicate an overall improvement in metabolic 
activities in various tissues most likely by GT-polyphenol-
mediated reduction of oxidative damage under normal phys-
iologic conditions in the rat model. 
Materials and methods 
Materials 
Green tea (Kangra, Himanchal Pradesh, India and Lip-
ton-Unilever, Englewood Cliffs, NJ, USA) was purchased 
from commercial sources (Jain Pan House, New Delhi, 
India). All other chemicals used were of analytical grade 
and were purchased from Sigma Chemical Co. (St. Louis, 
MO, USA) or Sisco Research Laboratory (Mumbai, India). 
Experimental design 
The animal experiments were conducted according to the 
guidelines of the Committee for Purpose of Control and 
Supervision of Experiments on Animals, Ministry of Envi-
ronment and Forests, Government of India. Adult male 
Wistar rats, weighing 150-180 g, fed with a standard pellet 
diet (Aashirwad Industries, Chandigarh, India) and water ad 
libitum, were conditioned for 1 wk before the start of the 
experiment. All animals were kept under conditions that 
prevented them from experiencing unnecessary pain and 
discomfort according to guidelines approved by the ethical 
committee. A known amount of diet (250 g) and waler/GT 
extract (2 X 125 mL = 250 mL/d) was provided in two 
servings to each group of rats and was found to be sufficient. 
Three groups of rats (six to eight rats/group/cage) were 
studied. The rats of group 1 (control) received the standard 
diet and water for 25 d. The rats of group 2 (GT extract) 
were given the standard diet and GT extract (3% w/v) in 
drinking water, whereas the rats of group 3 (GT diet) re-
ceived GT in the diet (3% w/w) and 250 mL of water as 
mentioned above also for 25 d. After 25 d of tea adminis-
tration, the rats were sacrificed under light ether anesthesia. 
Blood samples were collected from non-fasted rats and the 
liver, kidney, and entire intestine (starting from the ligament 
of Trietz to the end of ileum) were extracted. The intestines 
were washed by flushing them with ice-cold buffered saline 
(1 niM Tris-HCl, 9 g/L of NaCI, pH 7.4). The liver and 
kidney were placed in Tris buffered saline. All preparations 
and analyses of various parameters were carried out simul-
taneously under similar experimental conditions to avoid 
any day-to-day variations. 
Preparation of GT extract and GT diet 
Green tea (30 g ) was added to 500 mL of boiling water 
and was steeped for 15-20 min. Infusion was cooled to 
room temperature and then filtered. The tea leaves were 
extracted a second time with 500 mL of boiling water and 
filtered, and the two filtrates were combined to obtain 3% 
GT extract (3 g of tea leaves/100 mL of H^O). The resulting 
clear solution is similar to tea brews consumed by humans. 
The GT diet was prepared by adding GT (3 g/100 g of diet) 
in powdered rat diet, mixed well with small amounts of 
water, and then made in the form of cookies, after drying in 
an oven (50-60°C) for 30 min. GT polyphenols were de-
tected by thin layer chromatography as reported by Malik 
et al. [14]. According to the manufacturer's information, the 
antioxidant content was 95 mg/g of GT. 
Preparation of homogenates 
The washed intestines were slit in the middle and the 
entire mucosa was gently scraped with a glass slide and 
weighed. A 6.5% homogenate of this mucosa was prepared 
in 50 mM mannitol, pH 7.0, in a glass Teflon homogenizer 
(Remi Motors, Mumbai, India) with five complete strokes. 
The homogenate was then subjected to a high-speed Ultra-
Turrex homogenizer (Type T-25, Janke & Kunkel GMBH 
& Co. KG., Staufen, Germany) for three pulses of 30 s each 
with an interval of 30 s between each stroke. 
The kidneys were decapsulated and kept in ice-cold 154 
mM NaCl and 5 mM Tris-HEPES buffer, pH 7,5. The 
cortical and medullary regions were carefully separated and 
homogenized (as mentioned above) in 50 mM mannitol 
buffer to obtain 10% (w/v) homogenate. The 10% liver 
homogenate was similarly prepared in 10 mM Tris-HCl 
buffer, pH 7.5. 
One part of the homogenates (of intestine, kidney, and 
liver) was centrifuged at 2000g for 10 min at 4°C and the 
supernatant was saved for assaying the enzymes of car-
bohydrate metabolism; the second part was centrifuged at 
3000g for 15 min at 4°C and the supernatant was used for 
assay of free radical scavenging enzymes; and the third 
part was used for estimation of total thiol (-SH) and 
LPO. 
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Preparation of BBM 
Intestinal BBM was prepared at 4°C using dvfferential 
precipitation by CaC^ [15]. Mucosa scraped from four to 
five washed intestines was used for each BBM preparation. 
CaClj was added to the homogenate to a final concentration 
of 10 mM and the mixture was stirred for 20 min on ice. The 
final membrane preparations were suspended in 50 mM 
sodium maleate buffer, pH 6.8. 
Kidney BBM was prepared from whole cortex homoge-
nate using the MgClj precipitation method as described by 
Yusufi and Dousa [16]. The final membrane preparations 
were suspended in 300 mM mannitol, pH 7.4, and the 
BBMs thus prepared were saved and stored at -20°C until 
further analysis for BBM enzymes. Each sample of BBM 
was prepared by pooling tissues from two to three rats. 
Serum chemistries 
Serum samples were deproteinated with 3% trichloroace-
tic acid at a ratio of 1.3, left for 10 min, and then centrifuged 
at 2000g for 10 min. The protein-free supernatant was used 
to determine Pi. The precipitate was used to quantitate total 
phospholipids. Serum urea nitrogen and cholesterol levels 
were determined directly in serum samples. Glucose was 
estimated by an o-toluidine method using a kit from Span 
Diagnostics (Mumbai, India). These parameters were deter-
mined by standard procedures as mentioned in a previous 
study [17]. 
Assay of enzymes involved in free radical scavenging 
Superoxide dismutase (B.C. 1.15.1.1) was assayed by the 
method of Marklund and Marklund [22]. Catalase 
(B.C. 1.11.1. 6) activity was assayed by the method of Giri 
et al. [23]. 
LPO and total -SH group estimation 
Total SH groups were determined by the method of 
Sedlak and Lindsay [24] and LPO by the method of Ohkawa 
et al. [25]. 
Definition of unit 
One unit of enzyme activity is the amount of enzyme 
required for the formation of 1 fi-mol of product per hour 
under specified experimental conditions. Specific activity is 
enzyme units per milligram of protein. 
Statistical analysis 
All results are expressed as mean ± SEM for at least 
three to four separate preparations. The data were analyzed 
for statistical significance by Student's t test for group 
comparisons or by analysis of variance. P < 0.05 was 
considered statistically significant. 
Results 
Assay of carbohydrate metabolism enzymes 
The activities of the enzymes involving oxidation of re-
duced nicotinamide adenine dinucleotide or reduction of nic-
otinamide adenine dinucleotide phosphate were determined 
spectrophotometrically on a Cintra 5 (GBC Scientific Equip-
ment, Pty, Victoria, Australia) fixed for 340 nm using 3 mL of 
assay in a 1-cm cuvette at room temperature (28-30°C). The 
enzyme assays of lactate dehydrogenase (LDH; E.C. 1.1.1.27), 
malate dehydrogenase {E.C. 1.1.1.37), malic enzyme (ME; 
E.C. 1.1.1.40), glucose-6-phosphate dehydrogenase (G6PDH; 
E.G. 1.1.1.49), glucose-6-phosphatase (G6Pase; EC.3.1.3.3), 
and fmctose-l, 6-bisphosphatase (FBPase; E.C.3.1.3.11) activities 
were studied as described by Khundmiri et al. [18]. Hexokinase 
was estimated by the method of Crane and Sols [19] and the 
remaining glucose was measured by method of Nelson [20]. 
Assay of BBM marker enzymes and lysosomal marker 
enzymes 
The activities of alkaline phosphatase (ALP), leucine 
amino peptidase (LAP), y-glutamyl transferase (GGTase), 
sucrase, and acid phosphatase (ACPase) were determined as 
described by Farooq et al. [21]. 
Considering reported numerous health benefits of GT, 
the effect of GT given in the diet (GT diet) or as tea extract 
(GT extract) in drinking water was determined on certain 
enzymes involved in various pathways of carbohydrate me-
tabolism, biomarkers of renal and intestinal BBMs, and 
various parameters of antioxidant defense mechanism were 
determined in different rat tissues used as a model for 
humans. 
Effect of GT on body weight and serum parameters 
In general, the rats remained active and alert throughout 
the study. The daily food and fluid intakes were similar in 
Table 1 
Effect of GT consumption via drinking fluid or diet on body weight 
(grams) of rats* 
Groups 
Control 
GT extract 
GT diet 
Before treatment 
1667 + 5 3 
168 8 ± 6 3 
164 3 ± 7 4 
After treatment 
162 5 ± 8 53 
150 ± 7 9 
145 ± 10* 
GT, green tea 
* Results are expressed as mean ± SEM 
* Significantly different at P < 0 05 from control 
% Change 
- 2 5 
-11 I 
-11 7 
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Table 2 
Effects of GT consumption via drinking fluid or diet on serum parameters* 
Groups BUN (mg/dU Glucose (mg/dL) Cholesterol (mg/dL) Inorganic PO^ (/xmol/mL) Phospholipid (/j,gs/mL) 
Control 25 43 ± 0 36 
GT extract 20 99 ± 0 61* (-17%) 
GTdiet 2 1 0 9 + 1 17* (-17%) 
141 09 ± 4 64 
116 11 ± 5 62* (-18%) 
107 78 ± 6 89* (-24%) 
137 60 + 30 20 164 ± 0 04 
103 97 ± 2 03 (-24%) 1 29 + 0 04* (-21%) 
98 35 ± 2 80 (-29%) 1 07 + 0 14* (-35%) 
BUN, serum urea nitrogen, GT, green tea 
* Results are mean + SEM of six different samples Values in parentheses represent percent change from control 
* Significantly different at P < 0 05 from control 
109 4 0 = I 96 
162 00= 13 8" (+48%) 
14190 = 9 30' (+30%) 
control and GT rats (data not shown). The amount of GT 
ingested m the diet or by drinking was approximately the 
same. As shown in Table 1, GT consumption resulted in 
slight loss of body weight (—11%) compared with control 
rats. Serum glucose, cholesterol, and Pi significantly de-
clined, whereas phospholipids significantly increased by 
both forms of GT consumption. Serum urea nitrogen was 
slightly lowered (Table 2). The changes caused by the GT 
diet or GT extract on various parameters varied in magni-
tude, but the changes were always in the same direction. 
renal cortical homogenates. The activities of ALP, GGTase, 
and ACPase also slightly increased, whereas LAP decreased 
in the renal medulla. In liver homogenates ALP and 
GGTase decreased, whereas LAP and ACPase were not 
affected. Similar to homogenates, the activity of ALP de-
creased, whereas GGTase, LAP, and sucrase activities sig-
nificantly increased in intestinal BBM by GT consumption 
(Table 4). The activities of ALP and GGTase increased, 
whereas LAP activity significantly lowered in BBM vesi-
cles isolated from the renal cortex (Table 4) 
Effect of GT on biomarkers of BBM and lysosomes in 
different tissues 
The influence of GT consumption was determined on 
BBM and lysosomal enzymes in the liver, intestine, and 
renal cortical and medullary homogenates and in BBM 
vesicles isolated from the renal cortex and intestinal mu-
cosa. The results summarized in Table 3 show that the 
activities of ALP, GGTase, LAP, sucrase, and ACPase 
significantly increased in intestinal homogenates m GT 
compared with control rats. The activities of ALP and 
ACPase increased, whereas GGTase and LAP decreased in 
Effect of GT on enzymes of carbohydrate metabolism 
The effect of GT consumption was determined on the 
activities of carbohydrate metabolism enzymes in the intes-
tine, liver, and kidney. The activity of hexokinase slightly 
increased in the liver (-^25%) and renal medulla (+20%) 
when GT was given in the diet and in the intestine (+18%) 
when given in the drinking water but did not change in the 
renal cortex with either method. However, the activity of 
LDH markedly increased m the intestine and kidney tissues 
but only slightly increased m the liver. The effect on LDH 
activity was more expressive in GT extract than in GT diet 
Table 3 
Effects of GT consumption via dnnking fluid or diet on brush border membrane enzymes in different tissue homogenates* 
Tissue 
Intestine 
Control 
GT extract 
GT diet 
Liver 
Control 
GT extract 
GT diet 
Cortex 
Control 
GT extract 
GT diet 
Medulla 
Control 
GT extract 
GT diet 
ALP 
(/xmol/mg protein/h) 
1 30 ± 0 04 
161 ± 0 0 2 t ( + 2 4 % ) 
1 38 ± 0 06 (+6%) 
124 ± 0 0 3 
103 ±006*( -17%) 
105 ± 0 06* (-15%) 
2 93 ± 0 14 
3 5 6 ± 0 11* (+22%) 
3 35 ± 0 08* (+14%) 
1 71 ± 0 1 
2 07 ± 0 18* (+21%) 
171 ± 0 08 
GGTase 
(/i.mol/mg protein/h) 
4 46 ± 0 14 
6 63 ± 0 26t (+49%) 
4 9 4 ± 0 15* (+11%) 
2 25 ± 0 0 8 
1 12 ± 0 13* (-50%) 
1 48 ± 0 08* (-34%) 
40 52 ± 0 56 
37 42 ± 0 65* (-8%) 
33 54 ± 129* (-17%) 
10 59 ± 0 41 
1264 ±072*( + 19%) 
10 65 ± 0 54 (+0 6%) 
LAP 
(;j.mol/mg protein/h) 
7 26 ± 0 15 
8 45 ± 0 1 4 T ( + 1 6 % ) 
9 07 ± 0 09* (+25%) 
0 59 ± 0 02 
063 ± 0 02 (+7%) 
0 59 ± 0 03 
4 75 ± 0 32 
3 18 ± 0 27* (-33%) 
2 91 ± 0 19" (-39%) 
1 3 0 4 ± 0 8 1 
7 19 ± 0 22* (-45%) 
7 44 ± 0 22* (-43%) 
ACPase 
(^imol/mg protein/h) 
3 50 ± 0 08 
3 9 3 ± 0 1 5 T ( + 1 2 % ) 
4 97 ± 0 15* (+42%) 
7 33 ± O 24 
7 07 ± 0 35 (-4%) 
6 89 ± 0 50 ( - 6 0%) 
604 ± 0 14 
6 40 ± 0 22 (+6%) 
7 93 ± 0 33" (+31%) 
6 29 ± 0 26 
7 53 ± 0 2'(+20%) 
8 06 ± 0 39* (+28%) 
Sucrase 
(/xmol/mg protein/h) 
22 53 ± 0 88 
24 46 ± 1 45 (+9%) 
25 99 ± 1 36 (+15%) 
ACPase, acid phosphatase, ALP, alkaline phosphatase, GGTase, y-glutamyl transferase, GT, green tea, LAP, leucine amino peptidase 
* Results are mean ± SEM of three to four different preparations Values in parentheses represent percent change from control 
* Significantly different at P < 0 05 from control 
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compared with control rats in the intestine (+672%) and 
renal cortex (+111%) The activity of maldte dehydroge-
nase, an en/yme of the Tricarboxylic acid cycle (TCA) 
cycle, was similarly enhanced in the intestine ( + 31%) and 
renal cortex (+67%) to a greater extent by GT extiact than 
by GT diet but was slightly lowered in the renal medulla 
(-18%; Table 5). 
The effect of GT was also determined on the activities of 
enzymes involved in gluconeogenesis and the hexose mono-
phosphate (HMP)-shunt pathway (Table 6) The activities 
of G6Pase, FBPase, G6PDH, and ME changed similarly 
with the GT extract and the GT diet in all tissues. The 
activity of G6Pase significantly increased in the intestine 
(+34% to +42%), renal cortex (+13% to +16%), and 
medulla (+27% to +43%) but decreased in the liver 
( -13% to -20%). The activity of FBPase also increased 
but to a much lesser extent than G6Pase in these tissues. The 
activity of FBPase similarly to G6Pase was lowered in the 
hver. The activity of G6PDH (HMP-shunt) significantly 
decreased in the intestine (-40% to -48%), liver ( -73% to 
-79%), and renal medulla (-32% to -58%) but pro-
foundly increased in the renal cortex (+121% to +146%) 
The activity of ME, which is a source of cellular reduced 
nicotinamide adenine dinucleotide phosphate, together with 
G6PDH significantly decreased in all tissues except the 
renal cortex. It should be noted that the activities of various 
metabolic enzymes studied in the liver altered in a narrow 
range except G6PDH, which was significantly lowered by 
GT consumption. 
Ejfect of GT on activities of antioxidant enzymes and 
related parameters of oxidative stress 
Because GT has been reported to exert its biological 
effects primarily by perturbation of the antioxidant defense 
system, the activities of SOD and catalase and related pa-
rameters of oxidative stress were determined in control and 
GT rats. It was observed that GT given in the diet or in 
drinking water caused similar alterations in these parame-
ters. LPO measured as the level of malondialdehyde was 
significantly lowered in the liver and renal cortex but sig-
nificantly enhanced in the intestine and renal medulla by GT 
consumption. Total SH levels were significantly decreased 
in the liver and renal cortex but significantly increased in the 
renal medulla in GT compared with control rats. The activ-
ity of SOD significantly decreased in the intestine and liver 
but significantly increased in the renal cortex and medulla 
(Table 7). In contrast, catalase activity markedly increased 
in the intestine and liver but did not change in renal tissues 
by GT ingestion. 
Discussion 
Tea is the most consumed beverage in the world, aside 
from water. Studies carried out in laboratories and on 
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Table 5 
Effects of GT consumption via drinking fluid or diet on the activity of metabolic enzymes in different tissue homogenates 
Tissue 
Intestine 
Control 
GT extract 
GT diet 
Liver 
Control 
GT extract 
GT diet 
Cortex 
Control 
GT extract 
GT diet 
Medulla 
Control 
GT extract 
GT diet 
Hexokinase (\x.mo\lm% protein/h) 
116.92 ±3.58 
138.02 ±6.36^ (+18%) 
117.68 ± 5.25 ( + 0.65%) 
30.08 ± 1.03 
30.71 ± 1.13 ( + 2%) 
37.68 ± 1.72* (+25%) 
86.88 ± 2.09 
82.39 ± 2.34 (-5%) 
80.92 ± 1.46* (-7%) 
66.60 ±1.191 
70.13 ± 1.80 (+5%) 
80.18 ± 1.87* (+20%) 
LDH (pimol/mg protein/h) 
1.13 ±0.27 
8.72 ± 0.26* (+672%) 
4.98 ± 0.34* ( + 341%) 
35.85 ± 2.41 
40.41 ±0.99 (+13%) 
43.13 ± 1.76* (+20%) 
6.46 ± 0.56 
13.6 ± 1.22* (+111%) 
7.23 ±0.46 (+12%) 
11.69 ±0.60 
15.89 ±0.86* (+36%) 
15,83 ± 0.96* (+35%) 
MDH (/umol/mg protein/h) 
21.52 ± 1.29 
28.11 ±4.24 ( + 31%) 
22.41 ± 1.38 (^  4%) 
3.78 ± 0.24 
3.97 ± 0.38 ( + 5%) 
4.58 ±0.14* ( + 21%) 
23.26 ± 0.90 
38.92 ± 5.35* (-f 67%) 
33.43 ± 2.66* (+44%) 
26.99 ± 0.65 
22.24 ± 1.85* (-18%) 
26.17 ± 1.25 (-3%) 
GT, green tea; LDH, lactate dehydrogenase; MDH, malate dehydrogenase 
* Results are mean ± SEM of three to four different preparations. Values in parentheses represent percent change from control. 
* Significandy different at P < 0.05 from control. 
animaKs have suggested thai GT in particular has exten-
sive health benefits. Most of these effects are considered 
to be due to the presence of chiefly tea catechins, poly-
phenolic compounds [8] that exhibit antioxidative, anti-
inflammatory, anticarcinogenic, anti-arteriosclerotic, and 
antibacterial effects [9]. We propose that GT polyphenols 
and other constituents cause specific adaptive alterations 
in the cellular metabolism of certain tissues and thus 
improve their functioning. To address this proposal, the 
rats were given GT in the diet or in drinking water and 
the activities of various enzymes involved in carbohy-
drate metabolism, antioxidant defense system, and BBM 
were determined in the intestine, liver, and renal tissues. 
In general, GT consumption resulted in slight loss of 
body weight that was associated with lowering of blood 
glucose, cholesterol, and Pi. These observations are in 
partial agreement with some previous reports in humans 
and animals [26]. Oral administration of GT has been 
shown to decrease plasma total cholesterol and blood 
triacylglycerols and serum glucose in fasted and non-
fasted human subjects [27,28]. The suppressive effects of 
GT catechins on the postprandial levels of triacylglycer-
ols and cholesterol have also been reported in humans 
[29]. Taken together, these observations may be respon-
Table 6 
Effects of GT consumption via drinking fluid or diet on the activity of metabolic enzymes in different tissue homogenates* 
Tissue 
Intestine 
Control 
GT extract 
GT diet 
Liver 
Control 
GT extxact. 
GT diet 
Cortex 
Control 
GT extract 
GT diet 
Medulla 
Control 
GT extract 
GT diet 
FBPase, fructose-1, 
G6Pase 
(/xmol/mg protein/h) 
1.96 ± 0.05 
2.79 ±0.17* (+42%) 
2.62 ±0.13* (+34%) 
0.15 ± 0.002 
0.12 ±0.002* (-20%) 
0.13 ±0.005* (-13%) 
0.56 ± 0.01 
0.65 ±0,02* (+16%) 
0.63 ±0.01* (+13%) 
0.45 ± 0,01 
0.57 ± 0,02* ( + 27%) 
0.64 ±0,02* (+43%) 
, 6-bisphosphatase; G6Pase, 
FBPase 
(/bimol/mg protein/h) 
2.70 ± 0.09 
2.89 ±0.09 (+7%) 
2.81 ±0.06 (+4%) 
0.85 ± 0.02 
0.77 ± 0.02* (-9%) 
0.75 ±0.03* (-12%) 
2.57 ± 0.05 
2.85 ±0.06* ( + 11%) 
2.72 ±0.15 (+6%) 
1.76 ±0.04 
2.08 ±0.12* (+18%) 
2.05 ±0.06* ( + 17%) 
glucose-6-phosphatase; G6PDH, glucose 
G6PDH 
(/xmol/mg protein/h) 
1.08 ±0.05 
0,56 ±0.13* (-48%) 
0.65 ± 0.08* (-40%) 
3.23 ±0.21 
0.87 ±0.11* (-73%) 
0.69 ±0 .11 ' ( -79%) 
0.24 ± 0.02 
0.53 ±0.03* (+121%) 
0.59 ±0.01* (+146%) 
0.57 ± 0.05 
0.24 ± 0.04* (-58%) 
0.39 ±0.01 (-32%) 
-6-phosphate dehydrogenase; GT, 
ME 
((xmol/mg protein/h) 
0.68 i 0.09 
0.35 - 0.06* (-49%) 
0.42 ± 0.05* (-38%) 
0.69 ± 0.05 
0.60 ± 0.06 (-13%) 
0.58 ±0.07 (-16%) 
0.45 ± 0.08 
0.44 r 0.06 (-2%) 
0.42 ± 0.09 (-7%) 
1.53 ± 0.11 
1.19 ± a i 5 ( - 2 2 % ) 
0.86 = 0.09* (-44%) 
green tea; ME. malic enzyme 
* Results are mean ± SEM of three to four different preparations. Values in parentheses represent percent change from control. 
* Significantly different at P < 0.05 from control. 
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Table? 
Effects of GT consumption via dnnking fluid or diet on enzymic and non enzymic antioxidant parameteri, in different tissue homogenates* 
Tissue 
Intestine 
Control 
GT extract 
GT diet 
Liver 
Control 
GT extract 
GT diet 
Cortex 
Control 
GT extract 
GT diet 
Medulla 
Control 
GT extract 
GT diet 
LPO (nmol/gm tissue) 
6142 ± 2 60 
87 20 ± 6 75" (+42%) 
105 60 ± 7 04* (+72%) 
408 20 ± 43 20 
265 4 0 + 14 40 ' ( -35%) 
21601 ± 13 80* (-47%) 
272 60 ± 20 43 
228 00 ± 16 00 (-16%) 
171 70 ± 21 90" (-37%) 
73 26 ± 5 58 
131 70 ± 10 55* (+80%) 
89 31 ± 2 00* (+22%) 
Total - S H (/imol/gm tissue) 
1 88 ± 0 05 
2 00 ± 0 08 (+6%) 
2 45 ± 0 08* (+30%) 
10 67 ± 0 40 
7 60 ± 0 25* (-29%) 
6 89 ± 0 59" (-35%) 
7 49 ± 0 38 
5 73 ± 0 22* (-24%) 
6 42 ± 0 75 (-14%) 
2 90 ± 0 04 
3 64 ± 0 01" (+26%) 
4 66 ± 0 2 3 (+61%) 
SOD (Units/mg protein) 
7 04 ± 0 63 
4 73 ± 0 40" (-33%) 
3 40 ± 0 30* (-52%) 
82 90 ± 1 94 
72 9 0 ± 140* (-12%) 
75 80 ± I 30" (-9%) 
12 31 ± 1 24 
18 20 ± 1 60* (+48%) 
21 31 ± 1 50 (+73%) 
22 92 ± 0 65 
28 6 ± 1 82* (+25%) 
36 90 ± 0 75* (+61%) 
Catalase (jxmol/ing protein/mm) 
2 90 ± 0 55 
6 30 ± 0 45 (+117%) 
10 79 ± I 23* ( + 272%) 
1342 ± 2 15 
36 75 ± 5 90 (+174%) 
42 88 ± 2 37 ( + 220%) 
108 40 ± 9 80 
129 90 ± 5 20 (+20%) 
135 9 ± 6 90 ( + 25%) 
139 40 ± 7 34 
1045 ± 3 88 (-25%) 
132 03 ± 5 42* (-5%) 
GT green tea LPO, lipid peroxidation, -SH thiol, SOD, superoxide dismutase 
* Results are mean ± SEM of three to four different preparations Values in parentheses represent percent change from control 
* Significantly different at f < 0 05 from control 
sible for body weight loss and in lowering the incidence 
of cardiovascular diseases [29,30] 
The present results further demonstrate that GT causes 
selective adaptive alterations in the activities of certain 
enzymes involved in glycolysis, TCA cycle, gluconeogen-
esis, and HMP-shunt pathway in the intestine, liver, and 
renal cortex and medulla The activities of hexokinase ex-
cept m the renal cortex and that of LDH variably increased 
The acUviUes of malale dehydrogenase, a TCA cycle en-
zyme, except in the renal medulla, were also increased in 
the same manner These observations suggest that GT con-
sumption enhanced glucose degradation in the intestine, 
liver, and kidney albeit to different extents m these tissues 
The profound increase of LDH activity in the intestine and 
renal medulla are suggestive of an increase in anaerobic 
glycolysis as a major source of energy because these tissues 
function in a low oxygen environment [17] Further, GT 
consumption resulted in an increase in the activities of 
G6Pase and FBPase in the intestine and renal tissues, indi-
cating that the production of glucose by gluconeogenesis 
was also enhanced in these tissues However, the activities 
of these enzymes significantly decreased in the liver Thus 
the effect of GT on glucose degradation and its production 
appear to be tissue specific 
The effect of GT on carbohydrate metabolism has not 
been studied in detail in major tissues except m the liver and 
adipocytes GT consumption increased glucose metabolism 
in adipocytes [30,31], whereas hepatic glucose production 
was reported to be inhibited by GT, leading lo lower blood 
glucose levels [32] A GT polyphenol, epigallocatechin-3-
gallate, was reported to be an insulin mimetic in that it 
lowered blood glucose in obese Zucker rats [33,34] More-
over, Waltner-Law et al [32] reported a significant decrease 
in the expression of genes that control gluconeogenesis such 
as poshhoenol pyruvate carboxykmase and G6Pase genes m 
liver cells The observed decrease m the activities of glu 
coneogenic enzymes (G6Pase and FBPase) in liver homog-
enates IS compatible with these observations 
In contrast to the enzymes of glycolysis, TCA cycle, and 
gluconeogenesis, the activity of G6PDH (HMP shunt) and 
ME were differentially altered by GT The activity of 
G6PDH significantly declined in the intestine, liver, and 
renal medulla but profoundly increased in ihe renal cortex 
The activity of ME was selectively decreased m the intes 
tine and renal medulla but not affected in the liver and renal 
cortex These enzymes act to produce cellular reduced nic 
otinamide adenine dmocleotide phosphates that play an im 
portant role in reducing anabolic pathways and the antiox 
idant defense mechanism The increased activity of G6PDH 
in the renal cortex might support reducing anabolic reac 
tions, e g , lipid biosynthesis, and improve the antioxidant 
defense mechanism to lower oxidative damage In contrast, 
lower activities of G6PDH and ME in the intestine, liver, 
and renal medulla may have resulted in lower cholesterol 
synthesis and thus lower blood cholesterol GT has been 
shown to increase energy expenditure and fat oxidation in 
humans [35,36] The observed increase in oxidative metab-
olism (mitochondrial enzymes) and increased glucose pro 
duction by gluconeogenesis is in partial agreement with 
these reports Pi is an essential component of intermediary 
metabolism, energy conservation as adenosine triphosphate, 
and biosynthesis of cellular membranes (as phospholipids) 
and other important biomolecules such as nicotinamide ad-
enine dinucleotide, nicotinamide adenine dinucleotide phos-
phate, and vanous RNAs The decrease m serum Pi may 
suggest Its overutilization in these processes Moreover, Pi 
may have been converted to phospholipids as indicated by 
higher serum phospholipids levels needed for much re-
quired synthesis of membranes such as the endoplasmic 
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reticulum, mitochondria, and plasma membrane to support 
higher metabolic activities. 
Most beneficial health effects ascribed to GT are consid-
ered to be mediated by potential antioxidant properties of its 
constituents that scavenge free radicals and reduce oxidative 
damage [37]. Several lines of evidence suggest that pro-
oxidant and antioxidant actions of plant polyphenols may be 
important mechanisms for their anticancer properties [38]. 
Reactive oxygen species (ROS) are normal byproducts of 
aerobic metabolism. Most intracellular ROS are generated 
via mitochondrial electron transport, although other normal 
biological processes contribute. It has been reported that GT 
exerts its biological effects on the basis of the redox state of 
a particular cell/tissue [39,40] and according to the level of 
GT polyphenols accumulated in the tissues [41]. To main-
tain proper redox balance, many defense systems have 
evolved. A major cellular defense against ROS is provided 
by SOD and catalase, which together convert superoxide 
radicals first to HjOj and then to water and molecular 
oxygen. Other enzymes, e.g., glutathione (GSH) peroxidase, 
use the thiol reducing power of glutathione to reduce oxi-
dized lipids and protein targets of ROS. It has been reported 
that GT causes increases in the activities of catalase, SOD, 
GSH-peroxidase, and GSH-transferase and reduces LPO in 
the liver and kidney [42]. The present results demonstrated 
that GT consumption increased LPO in the intestine and 
renal medulla but markedly decreased in the liver and renal 
cortex. The activities of SOD and catalase were also af-
fected largely by GT consumption in these tissues. The 
activity of SOD was significantly lower in the intestine and 
liver but increased in the renal cortex and medulla. In 
contrast, the activity of catalase profoundly increased in the 
intestine and liver and to a lesser extent in the renal cortex 
but decreased in the renal medulla. 
The present results imply that the biological defense 
system was perturbed by GT consumption as a result of free 
radical scavenging properties of its polyphenols and other 
active constituents. The profound lowering of LPO in the 
renal cortex and liver in GT compared with control rats 
suggests that oxidative damage even under normal physio-
logic conditions was significantly lowered by GT constitu-
ents. The reduction in LPO in the liver was associated with 
a profound increase in catalase activity, whereas in the renal 
cortex it appeared to be due to increases in catalase and 
SOD activities. In contrast, an increase in LPO in the intes-
tine was associated with a marked decrease of SOD activity, 
although there was a significant increase in catalase activity. 
However, in the renal medulla enhanced LPO can be attrib-
uted to decreased catalase activity. The cellular response to 
oxidative stress in the intestine and renal medulla compared 
with the liver and renal cortex might have been due to the 
nature of metabolic activities in these tissues. Although the 
liver and renal cortex have higher oxidative metabolism, an-
aerobic metabolism is more prevalent in the intestine and renal 
medulla due to lower oxygen tension in these tissues. The 
significant effects of GT consumption on various parameters in 
different tissues can also be attributed to the presence of active 
tea components after digestion/absorption/extraction or due to 
accumulation in various tissues. However, these observations 
clearly demonstrate that GT consumption activates the antiox-
idant defense system in all tissues. GT-induced antioxidant 
defense mechanism in the intestine and liver appeared to be 
largely catalase mediated, whereas in renal tissues it was pre-
dominantly SOD mediated. The activities of certain marker 
enzymes except LAP in the kidney and ALP in the intestine 
were also increased significantly in BBMs, which is major 
target of oxidative damage. It is very likely that the increase in 
activities of these enzymes was due to protection provided by 
GT polyphenol-induced lowering of oxidative damage to 
membranes compared with non-GT-consuming control rats. 
Conclusions 
We conclude that the ingestion of GT produced a signif-
icant increase in the activities of certain enzymes of glucose 
degradation and its synthesis in the intestine, liver, and 
kidney. The effects seem in part to be mediated by GT 
polyphenols having antioxidant free radical scavenging 
properties that lower oxidative damage. The results strongly 
support the notion that GT consumption helps maintain and 
improve health by increasing antioxidant defense and cel-
lular metabolic activities in various tissues of normal rats, as 
people have benefited by GT consumption since ancient 
times. 
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